
<html lang="en"     class="pb-page"  data-request-id="13d2503a-4e49-4d90-8ada-123c567e6280"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm300248q;issue:issue:10.1021/jmcmar.2012.55.issue-11;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-a]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779" /></meta><meta name="dc.Creator" content="Benjamin J.  Dugan" /></meta><meta name="dc.Creator" content="Diane E.  Gingrich" /></meta><meta name="dc.Creator" content="Eugen F.  Mesaros" /></meta><meta name="dc.Creator" content="Karen L.  Milkiewicz" /></meta><meta name="dc.Creator" content="Matthew A.  Curry" /></meta><meta name="dc.Creator" content="Allison L.  Zulli" /></meta><meta name="dc.Creator" content="Pawel  Dobrzanski" /></meta><meta name="dc.Creator" content="Cynthia  Serdikoff" /></meta><meta name="dc.Creator" content="Mahfuza  Jan" /></meta><meta name="dc.Creator" content="Thelma S.  Angeles" /></meta><meta name="dc.Creator" content="Mark S.  Albom" /></meta><meta name="dc.Creator" content="Jennifer L.  Mason" /></meta><meta name="dc.Creator" content="Lisa D.  Aimone" /></meta><meta name="dc.Creator" content="Sheryl L.  Meyer" /></meta><meta name="dc.Creator" content="Zeqi  Huang" /></meta><meta name="dc.Creator" content="Kevin J.  Wells-Knecht" /></meta><meta name="dc.Creator" content="Mark A.  Ator" /></meta><meta name="dc.Creator" content="Bruce A.  Ruggeri" /></meta><meta name="dc.Creator" content="Bruce D.  Dorsey" /></meta><meta name="dc.Description" content="Members of the JAK family of nonreceptor tyrosine kinases play a critical role in the growth and progression of many cancers and in inflammatory diseases. JAK2 has emerged as a leading therapeutic ..." /></meta><meta name="Description" content="Members of the JAK family of nonreceptor tyrosine kinases play a critical role in the growth and progression of many cancers and in inflammatory diseases. JAK2 has emerged as a leading therapeutic ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 18, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300248q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300248q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300248q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300248q" /></link>
        
    
    

<title>A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-a]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300248q" /></meta><meta property="og:title" content="A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-a]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0013.jpeg" /></meta><meta property="og:description" content="Members of the JAK family of nonreceptor tyrosine kinases play a critical role in the growth and progression of many cancers and in inflammatory diseases. JAK2 has emerged as a leading therapeutic target for oncology, providing a rationale for the development of a selective JAK2 inhibitor. A program to optimize selective JAK2 inhibitors to combat cancer while reducing the risk of immune suppression associated with JAK3 inhibition was undertaken. The structure–activity relationships and biological evaluation of a novel series of compounds based on a 1,2,4-triazolo[1,5-a]pyridine scaffold are reported. Para substitution on the aryl at the C8 position of the core was optimum for JAK2 potency (17). Substitution at the C2 nitrogen position was required for cell potency (21). Interestingly, meta substitution of C2-NH-aryl moiety provided exceptional selectivity for JAK2 over JAK3 (23). These efforts led to the discovery of CEP-33779 (29), a novel, selective, and orally bioavailable inhibitor of JAK2." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300248q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300248q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300248q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300248q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300248q&amp;href=/doi/10.1021/jm300248q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 5243-5254</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300246n" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300259r" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-<i>a</i>]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin+J.++Dugan">Benjamin J. Dugan</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Diane+E.++Gingrich">Diane E. Gingrich</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eugen+F.++Mesaros">Eugen F. Mesaros</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen+L.++Milkiewicz">Karen L. Milkiewicz</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+A.++Curry">Matthew A. Curry</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allison+L.++Zulli">Allison L. Zulli</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pawel++Dobrzanski">Pawel Dobrzanski</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cynthia++Serdikoff">Cynthia Serdikoff</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mahfuza++Jan">Mahfuza Jan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thelma+S.++Angeles">Thelma S. Angeles</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+S.++Albom">Mark S. Albom</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+L.++Mason">Jennifer L. Mason</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa+D.++Aimone">Lisa D. Aimone</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sheryl+L.++Meyer">Sheryl L. Meyer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zeqi++Huang">Zeqi Huang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+J.++Wells-Knecht">Kevin J. Wells-Knecht</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+A.++Ator">Mark A. Ator</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+A.++Ruggeri">Bruce A. Ruggeri</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+D.++Dorsey">Bruce D. Dorsey</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States </span></div><div class="corresp-info"><strong>*</strong>Phone: 610-738-6733. Fax: 610-738-6643. E-Mail: <a href="/cdn-cgi/l/email-protection#f6949283919798b69593869e979a9998d895999b"><span class="__cf_email__" data-cfemail="37555342505659775452475f565b58591954585a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300248q&amp;href=/doi/10.1021%2Fjm300248q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 5243–5254</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 10, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 February 2012</li><li><span class="item_label"><b>Published</b> online</span>18 May 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 June 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300248q" title="DOI URL">https://doi.org/10.1021/jm300248q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5243%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBenjamin%2BJ.%2BDugan%252C%2BDiane%2BE.%2BGingrich%252C%2BEugen%2BF.%2BMesaros%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D11%26contentID%3Djm300248q%26title%3DA%2BSelective%252C%2BOrally%2BBioavailable%2B1%252C2%252C4-Triazolo%255B1%252C5-a%255Dpyridine-Based%2BInhibitor%2Bof%2BJanus%2BKinase%2B2%2Bfor%2BUse%2Bin%2BAnticancer%2BTherapy%253A%2BDiscovery%2Bof%2BCEP-33779%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5254%26publicationDate%3DJune%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300248q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3644</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">36</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300248q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-a]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;J. Dugan&quot;},{&quot;first_name&quot;:&quot;Diane&quot;,&quot;last_name&quot;:&quot;E. Gingrich&quot;},{&quot;first_name&quot;:&quot;Eugen&quot;,&quot;last_name&quot;:&quot;F. Mesaros&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;L. Milkiewicz&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;A. Curry&quot;},{&quot;first_name&quot;:&quot;Allison&quot;,&quot;last_name&quot;:&quot;L. Zulli&quot;},{&quot;first_name&quot;:&quot;Pawel&quot;,&quot;last_name&quot;:&quot;Dobrzanski&quot;},{&quot;first_name&quot;:&quot;Cynthia&quot;,&quot;last_name&quot;:&quot;Serdikoff&quot;},{&quot;first_name&quot;:&quot;Mahfuza&quot;,&quot;last_name&quot;:&quot;Jan&quot;},{&quot;first_name&quot;:&quot;Thelma&quot;,&quot;last_name&quot;:&quot;S. Angeles&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;S. Albom&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;L. Mason&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;D. Aimone&quot;},{&quot;first_name&quot;:&quot;Sheryl&quot;,&quot;last_name&quot;:&quot;L. Meyer&quot;},{&quot;first_name&quot;:&quot;Zeqi&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;J. Wells-Knecht&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;A. Ator&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;A. Ruggeri&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;D. Dorsey&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;5243-5254&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300248q&quot;},&quot;abstract&quot;:&quot;Members of the JAK family of nonreceptor tyrosine kinases play a critical role in the growth and progression of many cancers and in inflammatory diseases. JAK2 has emerged as a leading therapeutic target for oncology, providing a rationale for the development of a selective JAK2 inhibitor. A program to optimize selective JAK2 inhibitors to combat cancer while reducing the risk of immune suppression associated with JAK3 inhibition was undertaken. The structure–activity relationships and biological evaluation of a novel series of compounds based on a 1,2,4-triazolo[1,5-a]pyridine scaffold are reported. Para substitution on the aryl at the C8 position of the core was optimum for JAK2 potency (17). Substitution at the C2 nitrogen position was required for cell potency (21). Interestingly, meta substitution of C2-NH-aryl moiety provided exceptional selectivity for JAK2 over JAK3 (23). These efforts led to the discovery of CEP-33779 (29), a novel, selective, and orally bioavailable inhibitor of JAK2.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300248q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300248q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300248q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300248q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300248q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300248q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300248q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300248q&amp;href=/doi/10.1021/jm300248q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300248q" /></input><a href="/doi/pdf/10.1021/jm300248q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300248q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300248q%26sid%3Dliteratum%253Aachs%26pmid%3D22594690%26genre%3Darticle%26aulast%3DDugan%26date%3D2012%26atitle%3DA%2BSelective%252C%2BOrally%2BBioavailable%2B1%252C2%252C4-Triazolo%255B1%252C5-a%255Dpyridine-Based%2BInhibitor%2Bof%2BJanus%2BKinase%2B2%2Bfor%2BUse%2Bin%2BAnticancer%2BTherapy%253A%2BDiscovery%2Bof%2BCEP-33779%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D11%26spage%3D5243%26epage%3D5254%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jmcmar.2012.55.issue-11/production/jmcmar.2012.55.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Members of the JAK family of nonreceptor tyrosine kinases play a critical role in the growth and progression of many cancers and in inflammatory diseases. JAK2 has emerged as a leading therapeutic target for oncology, providing a rationale for the development of a selective JAK2 inhibitor. A program to optimize selective JAK2 inhibitors to combat cancer while reducing the risk of immune suppression associated with JAK3 inhibition was undertaken. The structure–activity relationships and biological evaluation of a novel series of compounds based on a 1,2,4-triazolo[1,5-<i>a</i>]pyridine scaffold are reported. <i>Para</i> substitution on the aryl at the C8 position of the core was optimum for JAK2 potency (<b>17</b>). Substitution at the C2 nitrogen position was required for cell potency (<b>21</b>). Interestingly, <i>meta</i> substitution of C2-NH-aryl moiety provided exceptional selectivity for JAK2 over JAK3 (<b>23</b>). These efforts led to the discovery of CEP-33779 (<b>29</b>), a novel, selective, and orally bioavailable inhibitor of JAK2.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">Atomic coordinates for the cocrystal structure of JAK2 with inhibitor <b>28</b> can be accessed using PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AQC">4AQC</a>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The JAK/STAT signaling pathway is constitutively activated in a wide spectrum of hematopoietic and solid<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> human tumors and high levels of activation are often associated with a more malignant and refractory disease, suggesting an important role in tumor growth and progression. Indeed, there is a growing understanding that the constitutively activated JAK/STAT signaling contributes to tumorigenesis and tumor progression through multiple mechanisms including promoting proliferation and increased antiapoptotic signaling in tumor cells as well as mediating tumor-promoting functions of the stromal compartment. The latter includes tumor-associated inflammation,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> tumor immune evasion, and angiogenesis. The vast preclinical and clinical evidence supports targeting the JAK/STAT pathway in oncology and inflammatory diseases.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">The Janus (JAK) family of nonreceptor tyrosine kinases consists of four members: JAK1, JAK2, JAK3, and TYK2.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> There is growing evidence demonstrating that JAK2 activation may be particularly critical for tumor growth and progression,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> supporting its selection as a therapeutic target. In addition, JAK3 inhibition has been shown to be immunosuppressive,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> providing further rationale for development of a highly selective JAK2 inhibitor. JAK1 and TYK2 have been implicated in disease and immune suppression;<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> however, activity or selectivity against these kinases coupled with inhibition of JAK2 is not adequately understood.</div><div class="NLM_p">Several JAK inhibitors from a range of chemical classes, including 2-aminopyrimidines, 2,4-diaminopyrimidines, pyrrolopyrimidines, indolocarbazoles, and macrocycles, have been disclosed in the literature with several inhibitors such as CYT387 (<b>1</b>),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> TG101348 (<b>2</b>),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> INCB018424, ruxolitinib (<b>3</b>),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> AZD1480 (<b>4</b>),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> CEP-701, lestaurtinib (<b>5</b>),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and SB1518, pacritinib<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> advancing to clinical development (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of reported JAK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 1,2,4-triazolo[1,5-<i>a</i>]pyridine heterocycle<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> provided a novel hinge binding motif for the design of small-molecule ATP-competitive JAK2 inhibitors. The hypothesis was that triazole nitrogen N3 and the exocyclic NH would serve as the H-acceptor and H-donor, respectively, forming hydrogen bonds with the NH and the carbonyl of Leu-932, leading to a strong two-point interaction with the hinge (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). On the basis of knowledge from our work with other kinase inhibitor scaffolds,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> the core would then be modified with various substituents that would drive potency and selectivity while the exocyclic nitrogen would be substituted with various solubilizing groups, as this portion of the molecule would be directed toward the solvent region. This design hypothesis and working model was confirmed later in our program when a JAK2/inhibitor cocrystal structure was solved by X-ray (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B, vide infra).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Design rationale. (B) Ribbon representation of JAK2/inhibitor cocrystal structure with <b>28</b>: N-terminal domain in orange, C-terminal domain in green, hinge region in yellow, glycine rich P-loop in darker orange. Key amino acid residues: gatekeeper Met-929, hinge binder Leu-932, and back-pocket salt-bridge of Asp-994 and Lys-882 are explicitly shown in element color-coded stick model. Inhibitor <b>28</b> is represented in a stick model: C, green; N, blue; O, red; S, yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A number of literature<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> methods to prepare the 1,2,4-triazolo[1,5-<i>a</i>]pyridine core are known and were evaluated and adapted to meet our design modifications. Initially, we had envisioned target molecules arising from the addition of 2-aminopyridines <b>6</b> to arylisothiocyanates <b>7</b> to give key intermediates <b>8</b>, followed by cyclization to triazolopyridines <b>9</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). This methodology was employed for the initial target, 2-phenylamino-1,2,4-triazolo[1,5-<i>a</i>]pyridine <b>9</b> (X, R = H) via cyclization of the corresponding commercially available thiourea <b>8</b> (X, R = H). The core triazolopyridines <b>9</b> (where X = Br, R = OCH<sub>3</sub>) were prepared similarly and were subjected to Suzuki–Miyaura cross coupling with 4-methanesulfonylphenylboronic acid to furnish inhibitors <b>22</b>–<b>24</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). However, this synthetic route was complicated by poor coupling reactivity for the 2-aminopyridines and arylisothiocyanates and tedious workups and purifications required at several intermediate steps. The thiourea moiety required activation by <i>S</i>-alkylation before addition of hydroxylamine hydrochloride, limiting the use of certain desirable heterocyclic arylisothiocyanates. The cyclization step required the use of phosgene, as ethylchloroformate did not effect this transformation.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Ultimately, low overall yields coupled with the scarcity of commercially available arylisothiocyanates or appropriately substituted thioureas precluded further SAR optimization by this methodology.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Initial Synthesis of Triazolopyridine Derivatives <b>9</b> and <b>22</b>–<b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, <i>p</i>-dioxane, 0 °C to RT, 66–96%; (b) (CH<sub>3</sub>O)<sub>2</sub>SO<sub>2</sub>, <i>p</i>-dioxane, 60 °C; (c) NH<sub>2</sub>OH hydrochloride, (<i>i</i>-Pr)<sub>2</sub>NEt or K<sub>2</sub>CO<sub>3</sub>, <i>p</i>-dioxane, 90 °C; (d) 20% phosgene in toluene, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, RT, 12–58%; (e) Pd(OAc)<sub>2</sub>, TPP, 4-methanesulfonylboronic acid, Na<sub>2</sub>CO<sub>3</sub>, water, <i>p</i>-dioxane, 80 °C, 39–67%. See also Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> (<b>22</b>–<b>24</b>).</p></p></figure><div class="NLM_p">Therefore, a convergent synthesis, suitable for medicinal chemistry purposes, was brought to fruition. Preparation of a core building block substituted with orthogonal synthetic handles (cf. <b>11</b> in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), in which diversity could be built upon to develop SAR in a timely manner, was accomplished. The core 2-amino-8-bromo-1,2,4-triazolo[1,5-<i>a</i>]pyridine<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><b>11</b> was prepared in a “one-pot” process from 2-amino-3-bromopyridine <b>10</b>. This synthetic methodology did not require the use of phosgene or ethylchloroformate to effect cyclization. The ethoxycarbonyl isothiocyanate reagent coupled with various aminopyridines to provide activated thioureas that readily reacted with hydroxylamine hydrochloride. Subsequent, in situ, cyclization with concomitant loss of carbon dioxide yielded desired intermediate in good yields.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The core was sequentially decorated utilizing a Suzuki–Miyaura cross-coupling reaction with diverse arylboronic acids or esters, followed by subjecting the intermediates <b>12</b>–<b>18</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) to Buchwald–Hartwig coupling with arylbromides to furnish the desired <i>N</i>-arylated products <b>19</b>–<b>21</b> and <b>25</b>–<b>41</b> in moderate overall yields and in relatively few synthetic steps.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Improved Synthesis of Triazolopyridine Derivatives <b>12</b>–<b>21</b> and <b>25</b>–<b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethoxycarbonyl isothiocyanate, <i>p</i>-dioxane, RT; (b) NH<sub>2</sub>OH hydrochloride, (<i>i</i>-Pr)<sub>2</sub>NEt, EtOH, MeOH, 60 °C, 70%; (c) Pd(OAc)<sub>2</sub>, TPP, R<sup>1</sup>-boronic acid/ester, Na<sub>2</sub>CO<sub>3</sub>, water, <i>p</i>-dioxane, 80 °C, 8–95%; (d) Pd(OAc)<sub>2</sub>, ligand, arylbromide, Cs<sub>2</sub>CO<sub>3</sub>, <i>p</i>-dioxane, 80 °C, 6–77%. See also Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (<b>12</b>–<b>18</b>), Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> (<b>19</b>–<b>21</b>), and Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> (<b>25</b>–<b>41</b>).</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22427" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22427" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The 1,2,4-triazolo[1,5-<i>a</i>]pyridine scaffold was quickly shown to exhibit inherent activity against JAK2, as demonstrated by compound <b>9</b> (JAK2 IC<sub>50</sub> = 1089 nM; X, R = H), a molecule that attained moderate potency despite its structural simplicity: a C2 NH-phenyl scaffold. Initial structure–activity relationship studies focused on the C8 position of the triazolopyridine. Substitution in this position greatly influenced JAK2 binding potency, even without an aryl group at the C2 nitrogen (i.e., C2-NH<sub>2</sub>, see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). An electron rich aryl such as the <i>ortho</i> methoxy <b>12</b> showed moderate loss of JAK2 activity compared to <b>9</b> (X, R = H). Surprisingly, an electron deficient heterocycle like the 3-pyridyl <b>13</b> was essentially devoid of activity at the highest concentration tested; however, activity was regained upon addition of a methoxy containing pyridyl moiety <b>14</b>. Some electron-deficient heterocycles such as the 4-pyridyl (<b>15</b>) and substituted aryl moieties containing electron-withdrawing groups (<b>16</b>–<b>18</b>) showed promising activity against JAK2 especially when substituted at the <i>para</i> position (cf. <b>17</b> and <b>18</b>). Selectivity for JAK2 over JAK3 was observed for <b>17</b> and <b>18</b>. However, cellular potency was poor for compounds unsubstituted at the C2 nitrogen (e.g., <b>17</b>, IC<sub>50</sub> >10 μM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of C8 Substitution on C2-NH<sub>2</sub> Triazolopyridines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0005.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0006.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values are reported as the average of at least two separate determinations; for ≥ three determinations, standard deviations are included.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">see ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a> for JAK2 assay information.</p></div></div><div></div></div><div class="NLM_p">Improving cellular activity was targeted next in order for this scaffold to receive further consideration. On the basis of knowledge developed on other internal programs, it was hypothesized that an increase in lipophilicity would positively impact cellular activity. Efforts to increase the cell membrane permeability focused on appending an aryl group on C2-NH<sub>2</sub> molecules to raise lipophilicity.</div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> outlines the activity of <i>N</i>-phenyl molecules: C2-NHPh substitution was combined with selected C8 substituents (cf. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), which caused a >20-fold boost in JAK2 potency (compare <b>19</b>–<b>21</b> to <b>9</b>, and <b>12</b>, <b>16</b>, <b>17</b>). Notably, <b>21</b> showed excellent JAK2 potency and selectivity. This molecule also exhibited activity, albeit modest, in the cellular assay. The combination of the <i>para</i>-substituted aryl at the C8 position and N-arylation at the C2 position displayed the favorable properties of potent JAK2 enzyme inhibition and submicromolar cellular potency and was explored further.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect of C8 Substitution of C2-NH-Phenyl Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0007.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0008.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values are reported as the average of at least three separate determinations, standard deviations are included.</p></div></div><div></div></div><div class="NLM_p">A methoxy scan was undertaken to optimize the C2-NH-aryl moiety (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). While <i>ortho</i> substitution was not favored (<b>22</b>), either <i>meta</i> or <i>para</i> substitution showed a positive response, both <b>23</b> and <b>24</b> having single-digit nanomolar activity against JAK2 with selectivity against JAK3. An increase in cell potency was also observed. Optimization was continued by varying the substituents in the <i>meta</i> and <i>para</i> positions. Addition of the electron withdrawing methanesulfonyl moiety (<b>25</b> and <b>26</b>) resulted in potent JAK2 inhibitors with selectivity against JAK3 but at the expense of JAK2 cell potency with <b>25</b>. Saturated heterocycles, especially those containing basic functionality, were considered to be good in improving cell permeability and pharmacokinetics. A systematic probe was initiated to evaluate this hypothesis. Addition of a morpholine moiety in compounds <b>27</b> and <b>28</b> provided subnanomolar inhibitors with selectivity against JAK3 and good cell potency. Importantly, greater selectivity over JAK3 was observed for compound <b>27</b>. This improved selectivity for JAK2 over JAK3 with a <i>meta</i> substituted aryl group was observed throughout the optimization process. The addition of the basic <i>N</i>-methyl-piperazine moiety was beneficial: molecules <b>29</b> and <b>30</b> exhibited good JAK2 enzyme and cell potency. The <i>meta</i> derivative <b>29</b> was superior to <b>30</b> in terms of selectivity versus JAK3 and JAK1 (JAK1 IC<sub>50</sub> = 81 and 22 nM, respectively), suggesting that further SAR refinement of the <i>meta</i> regioisomers should be targeted. Moving the basic functionality away from the aryl group by inserting a methylene– (<b>31</b>, <b>32</b>) to the saturated heterocycles yielded potent JAK2 inhibitors. Unfortunately, this modification had a deleterious effect on JAK2 cell potency compared to <b>29</b>. The basic functionality was extended toward the solvent to give morpholinyl-piperidine <b>33</b> and piperidinyl-piperidine <b>34</b>. Both compounds were selective against JAK3, and <b>33</b> showed good cell activity. C-linked piperidine <b>35</b> exhibited excellent cell potency and good selectivity against JAK3 and JAK1 (JAK1 IC<sub>50</sub> = 43 nM).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effect of Aryl Substitution in C2-NH-Aryl Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0009.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0010.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values are reported as the average of at least three separate determinations, standard deviations are included.</p></div></div><div></div></div><div class="NLM_p">Investigations into the role of the <i>para</i>-methanesulfonyl group at C8 with bioisosteric electron withdrawing group replacements lead to some interesting results (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Increasing the size of the alkyl group from methyl to isopropyl (<b>36</b>) decreased selectivity against JAK3. Replacement of the sulfone with trifluoromethyl (<b>37</b>) led to a potent inhibitor; however, a disappointing loss of cell activity was observed. The fluoro derivative <b>38</b> showed a significant loss of potency when compared to the methanesulfonyl derivative <b>29</b>. Bioisosteric replacement of methanesulfonyl with dimethylphosphine oxide<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> generated <b>39</b>, which exhibited good potency and JAK3 selectivity; however, cellular activity dropped 5-fold.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Optimization of the <i>para</i> Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0011.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">IC<sub>50</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ex</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center" char="±">JAK2</th><th class="colsep0 rowsep0" align="center" char="±">JAK3</th><th class="colsep0 rowsep0" align="center" char="±">JAK2 Cell</th><th class="colsep0 rowsep0" align="center" char=".">JAK3/2 ratio</th><th class="colsep0 rowsep0" align="center" char=".">cell/enz ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">150 ± 37</td><td class="colsep0 rowsep0" align="char" char="±">61 ± 12</td><td class="colsep0 rowsep0" align="char" char=".">83</td><td class="colsep0 rowsep0" align="char" char=".">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>-<i>i</i>-propyl</td><td class="colsep0 rowsep0" align="char" char="±">1.27 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">38 ± 11</td><td class="colsep0 rowsep0" align="char" char="±">85 ± 10</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">4 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">218 ± 27</td><td class="colsep0 rowsep0" align="char" char="±">476 ± 70</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">119</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">26 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">547 ± 119</td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">(P═O)(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">3 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">286 ± 122</td><td class="colsep0 rowsep0" align="char" char="±">318 ± 49</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">106</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are reported as the average of at least three separate determinations, standard deviations are included.</p></div></div></div><div class="NLM_p">On the basis of their in vitro activity and selectivity profile, compounds <b>29</b>, <b>33</b>, and <b>35</b> were selected for evaluation of off-target liabilities. Compound <b>33</b> showed an unfavorable CYP 3A4 inhibition (IC<sub>50</sub> = 0.2 μM) and was deprioritized. Compounds <b>29</b> and <b>35</b> did not exhibit CYP 3A4 concerns (IC<sub>50</sub> = 11 and 24 μM, respectively). Both molecules exhibited acceptable in vitro liver microsome stability in mouse, rat and human (all >15 min) while stability in dog was less than desirable (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Inhibitors <b>29</b> and <b>35</b> showed excellent kinase selectivity<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (S(90) = 0.090 and 0.097, respectively) and were evaluated in vivo (vide infra).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Liver Microsome Stability Expressed as Half-Lives (<i>t</i><sub>1/2</sub>)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="."><i>t</i><sub>1/2</sub> (min)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ex</th><th class="colsep0 rowsep0" align="center" char=".">mouse</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">dog</th><th class="colsep0 rowsep0" align="center" char=".">human</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">40</td></tr></tbody></table></div></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> X-Ray Crystallographic Data</h3><div class="NLM_p last">A cocrystal structure obtained with <b>28</b> in JAK2 catalytic domain (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B) confirmed the initial hypothesis on the docking of triazolopyridine into the JAK2 ATP-binding site. Intermolecular hydrogen bonding was observed as designed: triazolopyridine nitrogen N(3) and exocyclic N(2)-H established interactions with the NH and the carbonyl, respectively, of JAK2 hinge residue Leu-932. The heterocyclic-aromatic aniline fragment at position 2 was exposed to solvent region. The C(8) substituent was located in the binding pocket adjacent to the Lys-882–Asp-994 salt bridge and extended toward the glycine rich P-loop where the methanesulfonyl moiety was involved in water mediated hydrogen bonding interactions. The C(6)-H portion of the core was in the proximity of the gate keeper residue Met-929. Indeed, substitution at the C6 position of the triazolopyridine core in <b>30</b> to give derivatives <b>40</b> (R(C6) = CF<sub>3</sub>) and <b>41</b> (R(C6) = F) was accompanied by a severe drop in intrinsic potency for <b>40</b> (JAK2 IC<sub>50</sub> = >10 μM), likely from a steric clash of the large −CF<sub>3</sub> fragment with Met-929, and only by a moderate loss of potency in case of <b>41</b> (JAK2 IC<sub>50</sub> = 32 nM), with a significantly smaller fluorine substituent.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Lead Evaluation/Pharmacokinetics/Pharmacodynamics/Efficacy</h3><div class="NLM_p">On the basis of their intrinsic and cellular potency, JAK3/2 selectivity, kinase selectivity, CYP450 inhibition profile, and liver microsome stability, lead molecules <b>29</b> and <b>35</b> were selected to advance to single dose pharmacokinetic (PK) experiments in mouse. Plasma exposure post oral dosing in CD-1 mouse of each molecule was evaluated. At a single 30 mg/kg, po dose, plasma levels observed for <b>29</b> and <b>35</b> at 6 h were 535 and 257 ng/mL, respectively. Compound <b>29</b> was also tested in nude mouse (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>) and exhibited a favorable PK profile, an iv half-life of 1 h, moderate distribution (<i>V</i><sub>d</sub> = 2.6 L/kg), and measurable oral exposure with an estimated bioavailability of 33%. On the basis of the 2-fold higher plasma exposure in CD-1 mouse, the PK profile in nude mouse, JAK2 enzyme selectivity of 83 and the cellular to enzyme ratio of 34, <b>29</b> was selected for in vivo PK/PD evaluation in a single dose study. JAK2 inhibition was monitored by determining levels of STAT3 phosphorylation.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Single Dose Pharmacokinetic Profiles of <b>29</b> in Nude Mouse (Nu/Nu)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">dose<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a>(mg/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0→∞</sub>(ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>d</sub>(L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">CL ((mL/min)/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub>(ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i>(%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nude</td><td class="colsep0 rowsep0" align="left">1 iv</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">590</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">30 po</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">5791</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1331</td><td class="colsep0 rowsep0" align="char" char=".">33</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Formulated as solutions in 25% hydroxyl-propyl-β-cyclodextrin (iv) and 100% PEG400 (po).</p></div></div></div><div class="NLM_p">The results from the single dose PK/PD experiments with <b>29</b> in CWR22<a onclick="showRef(event, 'cit5a'); return false;" href="javascript:void(0);" class="ref cit5a">(5a)</a> prostate carcinoma tumor xenografts in nude mouse are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. The 55 mg/kg oral dose exhibited a pharmacodynamic effect in CWR22 xenografts over 24 h postdose with ≥90% inhibition of STAT3 phosphorylation at the 2 and 6 h time points (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). The levels in plasma reached 4–5 μM for up to 6 h, with levels dropping below the minimum quantifiable level (MQL) at 24 h (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). Tumor levels were approximately 3-fold higher than plasma levels out to 6 h and were still measurable 24 h postdose. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, compound <b>29</b> demonstrated antitumor efficacy in the CWR22 xenograft model; oral dosing for 14 days at 30 mg/kg bid resulted in tumor stasis and partial regressions in 5/10 animals. No body weight loss or overt toxicity was noted with this dosing regimen.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Results of PK/PD experiment in CWR22 xenograft in nude mouse: (A) percent inhibition of STAT3 activation with a single dose of <b>29</b> (55 mg/kg po as a solution in PEG400), (B) plasma and tumor compound concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0015.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antitumor efficacy of <b>29</b> in CWR22 xenograft model, dosed po as a solution in PEG400.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to solid tumors, the JAK/STAT pathway is implicated in the tumorigenesis of multiple hematopoietic cancers. Classical Hodgkin lymphoma (cHL) is characterized by a frequent amplification of the JAK2 locus and high levels of constitutive JAK2/STAT signaling. Inhibitor <b>29</b> was evaluated in HDLM-2<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (cHL) tumor xenografts in SCID/NOD mouse. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A, compound <b>29</b> exhibited dose related tumor growth inhibition with oral dosing at 30 mg/kg bid for 19 days and 55 mg/kg bid for 7 days; the 55 mg/kg group was switched to a single daily dose schedule (qd) at day 7 due to moderate body weight loss (<10% average). Despite switching to qd dosing with the 55 mg/kg group, a dose-related response was maintained in the efficacy study up to day 19. The increase of tumor volume in the treated groups beginning around day 12 was likely due to a clonal selection of more resistant cells in the tumors in response to treatment. A dose related increase in plasma (7 and 9 μM, respectively) and tumor levels (6 and 10 μM, respectively) were observed at 3 h post last dose, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0016.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Results of PK and efficacy experiment in HDLM-2 xenograft in SCID/NOD mouse: (A) antitumor efficacy of <b>29</b>, dosed po as a solution in PEG400, 55 mg/kg bid switched to qd dosing at day 7, (B) plasma and tumor compound levels at 3 h post last dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17020" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17020" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Optimization of the 1,2,4-triazolo[1,5-<i>a</i>]pyridine scaffold as a kinase hinge binding element led to the discovery of a novel, selective JAK2 inhibitor. The optimization process was greatly enhanced by the straightforward synthetic sequence developed. The readily prepared, multisubstituted 1,2,4-triazolo[1,5-<i>a</i>]pyridine core was sequentially appended via Suzuki–Miyaura cross coupling followed by a Buchwald–Hartwig coupling to provide desired targets.</div><div class="NLM_p last">The developed SAR led to the understanding that <i>para</i> substitution of the aryl ring at the C8-position of the core was optimal, with the methanesulfonyl moiety displaying excellent JAK2 potency. The serendipitous discovery of enhanced JAK2 selectivity based solely on moving a saturated heterocycle from the <i>para</i> to the <i>meta</i> position on the solvent exposed side of the molecule was key to reducing the potential risk of immune suppression related to undesired JAK3 inhibition. The <i>N</i>-methylpiperazine heterocycle resulted in excellent intrinsic and cellular potency. The moderate basicity of the heterocycle enhanced the physiochemical properties of this scaffold to achieve oral bioavailability. CEP-33779,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a><b>29</b>, exhibited excellent JAK2 potency, selectivity, and oral bioavailability in mouse. Additionally, <b>29</b> has demonstrated antitumor efficacy in multiple JAK2-driven tumor xenografts and efficacy in inflammation models in mouse and has potential as a preclinical development candidate.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18020" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18020" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Methods</h3><div class="NLM_p last">All commercial reagents and solvents were used as received unless otherwise indicated. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance spectrometer at 400 or 100 MHz, respectively, in the deuterated solvent noted with tetramethylsilane as the internal standard. Mass spectrometry (LC/MS) data were collected on either an Agilent 1100 series HPLC coupled to Bruker Esquire 2000 ion trap mass spectrometer (2.1 mm × 30 mm Agilent Eclipse XBD C8 3.5 μm column, elution with 10–100% acetonitrile and water with 0.1% formic acid solvent gradient, over 5 min) or a Waters Acquity Ultra Performance LC coupled to a Waters Micromass ZQ quadrapole mass spectrometer (2.1 mm × 30 mm Acquity BEH C18 1.7 μm column, elution with 5–95% acetonitrile and water with 0.1% formic acid solvent gradient, over 2 min) and are reported as (M + H)<sup>+</sup>, i.e., molecular ion plus hydrogen. Analytical HPLC data was collected using an Agilent 1100 series HPLC coupled with an Agilent Eclipse XDB C18 5 μm (4.6 mm × 150 mm) column, elution with 10–100% acetonitrile and water (with 0.1% trifluoroacetic acid as modifier) solvent gradient, over 5 min. Reverse phase chromatography was performed with a Gilson apparatus coupled to a Phenomenex Gemini-NX C18 5 μm column, either (150 mm × 30 mm) or (100 mm × 21 mm) using an acetonitrile and water (with 0.1% trifluoroacetic acid as modifier) solvent gradient. Automated normal phase chromatography was performed with a Teledyne ISCO CombiFlash Companion apparatus using RediSep Rf flash columns (SiO<sub>2</sub> or amine modified SiO<sub>2</sub>). Melting point temperatures were collected using a Mel-Temp device and are uncorrected. Compounds have ≥95% purity except where indicated and compound purity is listed as the area percentage (A%) [peak mAU·s/total mAU·s] at a wavelength of 254 nm.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Select Examples</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Phenyl-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl-amine (<b>9</b>, X and R = H)</h4><div class="NLM_p last">To a suspension of 1-phenyl-3-pyridin-2-yl-thiourea (1.00 g, 4.40 mmol) in acetonitrile (6 mL) was added dimethyl sulfate (0.45 mL, 4.8 mmol) and heated at reflux for 4 h, cooled to room temperature, and the volatiles were evaporated to yield viscous yellow oil. To a solution of the yellow oil in dichloromethane (8 mL) was added hydroxylamine hydrochloride (0.67 g, 9.6 mmol) followed by <i>N</i>,<i>N</i>-diisopropylethylamine (3.3 mL, 19.0 mmol). The mixture was stirred at room temperature for 18 h. Water (10 mL) was added, and a nitrogen sparge tube connected to a bleach scrubber was fitted to the reaction flask. The mixture was sparged with nitrogen. The resulting oily liquid was partitioned between ethyl acetate (100 mL) and water (20 mL). The organic layer was washed with water (3 × 20 mL), dried over magnesium sulfate, filtered, and evaporated to a waxy solid. To a cooled solution of waxy solid in acetonitrile (10 mL) at −5 °C was added potassium carbonate (1.5 g, 0.011 mol) followed by dropwise addition of 20% phosgene in toluene (2.6 mL, 4.9 mmol). The mixture was stirred for 1 h at −5 °C and then warmed to room temperature. Additional 20% phosgene in toluene (1.0 mL) and potassium carbonate (1.0 g) was added to the mixture and stirred for 48 h. The volatiles were evaporated, and the residue was partitioned between ethyl acetate (100 mL) and water (20 mL). The organic layer was washed with water (3 × 20 mL), dried over magnesium sulfate, filtered, and evaporated to an orange waxy solid. The product (0.17 g, 18% yield) was isolated via column chromatography (silica gel 40 g, 5%→100% ethyl acetate/heptane). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.46–8.42 (m, 1H), 7.63–7.59 (m, 2H), 7.51–7.41 (m, 2H), 7.38–7.33 (m, 2H), 7.31 (br s, 1H), 7.02–6.97 (m, 1H), 6.90–6.85 (m, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 162.51, 150.24, 140.38, 129.60, 129.16, 127.85, 121.37, 117.19, 113.83, 111.96; mp 180–184 °C. High resolution mass spectrum (ESI+) <i>m</i>/<i>z</i> 211.0990 [(M + H)<sup>+</sup> calcd for C<sub>12</sub>H<sub>10</sub>N<sub>4</sub>: 211.0984]. HPLC: 96 A%.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 8-(2-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (<b>12</b>)</h4><div class="NLM_p">To a solution of 3-bromo-pyridin-2-ylamine (10.0 g, 57.8 mmol) in 1,4-dioxane (100 mL) was added dropwise ethoxycarbonyl isothiocyanate (6.8 mL, 58 mmol). The mixture was stirred under nitrogen for 18 h and then volatiles were evaporated. The recovered material was triturated with hexane (250 mL) and then filtered. The off-white solid was added to a stirred suspension of hydroxylamine hydrochloride (20.0 g, 288 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (30.0 mL, 172 mmol) in a mixture of methanol (80 mL) and ethanol (80 mL). A nitrogen sparge tube connected to a bleach scrubber was fitted to the reaction flask. The mixture was stirred at room temperature for 2 h, heated to 60 °C for 18 h, and then cooled to room temperature. The suspension was filtered, rinsed with methanol and then water and methanol again. 8-Bromo-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (<b>11</b>) was isolated as an off-white solid (9.66 g, 78%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.58 (d, <i>J</i> = 6.5 Hz, 1H), 7.73 (d, <i>J</i> = 7.5 Hz, 1H), 6.80 (dd, <i>J</i> = 7.0, 7.0 Hz, 1H), 6.25 (br s, 2H); mp 219–222 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> = 213.05, 214.80 (M + H)<sup>+</sup>. HPLC: 85 A%</div><div class="NLM_p last">A dry tube was charged with palladium acetate (0.10 g, 0.47 mmol), triphenylphosphine (0.31 g, 1.2 mmol), and 1,4-dioxane (5 mL) and then purged under vacuum then backflushed and stirred under nitrogen for 10 min. 8-Bromo-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (<b>11</b>) (0.50 g, 2.3 mmol), 2-methoxybenzeneboronic acid (0.71 g, 4.7 mmol), <i>N</i>,<i>N</i>-dimethylformamide (5 mL), and 1.50 M of sodium carbonate in water (4.7 mL, 7.0 mmol) were added, respectively. The tube was sealed, and the reaction mixture was heated at 80 °C for 18 h. The mixture was cooled to room temperature and transferred to a round-bottom flask, and the volatiles were evaporated under reduced pressure. 8-(2-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (<b>12</b>) (0.41 g, 34%) was isolated via column chromatography (amine modified silica gel 47 g, 0%→10% methanol/dichloromethane). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.50 (dd, <i>J</i> = 6.6,1.0 Hz, 1H), 7.51 (dd, <i>J</i> = 7.5,1.6 Hz, 1H), 7.43–7.36 (m, 2H), 7.13 (d, <i>J</i> = 8.2 Hz, 1H), 7.03 (t, <i>J</i> = 7.3 Hz, 1H), 6.91 (t, <i>J</i> = 6.8 Hz, 1H), 5.97 (br s, 2H), 3.73 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.92, 156.57, 149.81, 131.10, 129.46, 129.01, 126.29, 124.65, 122.73, 120.02, 111.53, 110.78, 55.47; mp 200–202 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 240.98 (M + H)<sup>+</sup>. HPLC: 97 A%.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 8-Pyridin-3-yl-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (<b>13</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.28 (d, <i>J</i> = 2.1 Hz, 1H), 8.62–8.58 (m, 2H), 8.49 (m, 1H), 7.82 (dd, <i>J</i> = 7.4, 0.7 Hz, 1H), 7.53 (dd, <i>J</i> = 8.0, 4.7 Hz, 1H), 7.01 (t, <i>J</i> = 7.0 Hz, 1H), 6.18 (br s, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 166.17, 148.91, 148.84, 135.40, 131.17, 127.31, 126.90, 123.32, 121.18, 111.46; mp 185–187 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 211.99 (M + H)<sup>+</sup>. HPLC: 91 A%.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 8-Pyridin-4-yl-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (<b>14</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.69 (dd, <i>J</i> = 4.8, 1.4 Hz, 2H), 8.65 (dd, <i>J</i> = 6.5, 0.8 Hz, 1H), 8.18 (dd, <i>J</i> = 4.7, 1.6 Hz, 2H), 7.94 (dd, <i>J</i> = 7.5, 0.9 Hz, 1H), 7.03 (t, <i>J</i> = 6.8 Hz, 1H), 6.24 (s, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 166.23, 149.82, 148.85, 142.48, 128.16, 127.44, 122.27, 120.94, 111.34; mp 209–215 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 212.00 (M + H)<sup>+</sup>. HPLC: 92 A%.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 8-(6-Methoxy-pyridin-3-yl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (<b>15</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.91 (d, <i>J</i> = 2.5 Hz, 1H), 8.54 (dd, <i>J</i> = 6.6, 0.9 Hz, 1H), 8.44 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.73 (dd, <i>J</i> = 7.6, 1.0 Hz, 1H), 6.97 (t, <i>J</i> = 6.9 Hz, 1H), 6.96 (d, <i>J</i> = 8.7 Hz, 1H), 6.12 (s, 2H), 3.92 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 166.01, 163.15, 148.81, 146.32, 138.69, 126.54, 125.74, 124.74, 121.29, 111.46, 109.96, 53.28; mp 157–158 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 241.95 (M + H)<sup>+</sup>. HPLC: 89 A%.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 8-(3-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (<b>16</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.64–8.60 (m, 1H), 8.59 (t, <i>J</i> = 1.6 Hz, 1H), 8.50–8.46 (m, 1H), 7.98–7.94 (m, 1H), 7.86–7.83 (m, 1H), 7.78 (dd, <i>J</i> = 7.8, 7.8 Hz, 1H), 7.02 (dd, <i>J</i> = 7.1, 7.1 Hz, 1H), 6.18 (s, 1H), 3.29 (S, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 166.17, 148.91, 141.17, 136.59, 133.11, 129.51, 127.49, 127.36, 126.30, 126.21, 122.39, 111.44, 43.48; mp 173–183 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 289.03 (M + H)<sup>+</sup>. HPLC: 85 A%.</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine Hydrochloride (<b>17</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.69–8.65 (m, 1H), 8.37–8.32 (m, 2H), 8.07–8.02 (m, 2H), 7.88–7.85 (m, 1H), 7.11–7.06 (m, 1H), 5.32 (br s, 3H), 3.29 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ 165.40, 148.23, 140.14, 140.03, 128.95, 128.21, 127.90, 127.03, 122.31, 111.98, 43.51; mp 237–239 °C. High resolution mass spectrum (ESI+) <i>m</i>/<i>z</i> 289.0767 [(M + H)<sup>+</sup> calcd for C<sub>13</sub>H<sub>12</sub>N<sub>4</sub>O<sub>2</sub>S: 289.0759]. HPLC: 98 A%.</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 8-(4-Trifluoromethyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (<b>18</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.62 (d, <i>J</i> = 6.3 Hz, 1H), 8.34 (d, <i>J</i> = 8.0 Hz, 2H), 7.88–7.80 (m, 3H), 7.02 (t, <i>J</i> = 6.8 Hz, 1H), 6.18 (s, 2H); mp 186–187 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 279.05 (M + H)<sup>+</sup>. HPLC: 91 A%.</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> [8-(2-Methoxy-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-phenyl-amine (<b>19</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.42 (dd, <i>J</i> = 6.6, 0.9 Hz, 1H), 7.62 (dd, <i>J</i> = 7.5, 1.7, 1H), 7.58–7.52 (m, 3H), 7.44–7.38 (m, 1H), 7.36–7.30 (m, 2H), 7.10 (t, <i>J</i> = 7.5 Hz, 1H), 7.05 (d, <i>J</i> = 8.3 Hz, 1H), 6.97 (t, <i>J</i> = 7.4 Hz, 1H), 6.93 (t, <i>J</i> = 7.1 Hz, 1H), 6.87 (s, 1H), 3.82 (s, 3H); mp 141–145 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 317.06 (M + H)<sup>+</sup>. HPLC: 89 A%.</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> [8-(3-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-phenyl-amine (<b>20</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.68 (t, <i>J</i> = 1.8 Hz, 1H), 8.49 (dd, <i>J</i> = 6.7, 1.3 Hz, 1H), 8.38 (m, 1H), 8.01 (m, 1H), 7.74 (dd, <i>J</i> = 7.8, 7.8 Hz, 1H), 7.70–7.60 (m, 5H), 7.58–7.51 (m, 1H), 7.49–7.43 (m, 2H), 7.40–7.34 (m, 2H), 7.04–6.99 (m, 2H), 6.91 (s, 1H), 3.14 (s, 3H); mp 184–191 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 365.04 (M + H)<sup>+</sup>. HPLC: 82 A%.</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-phenyl-amine (<b>21</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.51 (dd, <i>J</i> = 6.6, 0.9 Hz, 1H), 8.26–8.21 (m, 2H), 8.11–8.06 (m, 2H), 7.66 (dd, <i>J</i> = 7.3, 0.9 Hz, 1H), 7.61–7.57 (m, 2H), 7.39–7.32 (m, 2H), 7.05–6.99 (m, 2H), 6.94 (s, 1H), 3.10 (s, 3H); mp 197–201 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 365.11 (M + H)<sup>+</sup>. HPLC: 79 A%.</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-(2-methoxy-phenyl)-amine (<b>22</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.53–8.49 (m, 1H), 8.38 (dd, <i>J</i> = 8.0, 1.3 Hz, 1H), 8.24 (d, <i>J</i> = 8.4 Hz, 2H), 8.10 (d, <i>J</i> = 8.5 Hz, 2H), 7.66–7.62 (m, 1H), 7.61 (s, 1H), 7.08–6.89 (m, 4H), 3.92 (s, 3H), 3.11 (s, 3H); mp 211–213 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 395.10 (M + H)<sup>+</sup>. HPLC: 88 A%.</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-(3-methoxy-phenyl)-amine (<b>23</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.50 (d, <i>J</i> = 6.1 Hz, 1H), 8.24 (d, <i>J</i> = 7.8 Hz, 2H), 8.08 (d, <i>J</i> = 7.7 Hz, 2H), 7.66 (d, <i>J</i> = 7.4 Hz, 1H), 7.37 (s, 1H), 7.28–7.22 (m, 1H), 7.08–7.00 (m, 2H), 6.92 (s, 1H), 6.58 (d, <i>J</i> = 7.6 Hz, 1H), 3.86 (s, 3H), 3.10 (s, 3H); mp 204–206 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 395.15 (M + H)<sup>+</sup>. HPLC: 90 A%.</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-(4-methoxy-phenyl)-amine (<b>24</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.47 (d, <i>J</i> = 6.6 Hz, 1H), 8.23 (d, <i>J</i> = 8.5 Hz, 2H), 8.09 (d, <i>J</i> = 8.5 Hz, 2H), 7.64 (d, <i>J</i> = 7.4 Hz, 1H), 7.00 (dd, <i>J</i> = 6.8, 6.8 Hz, 1H), 6.95–6.90 (m, 2H), 6.71 (s, 1H), 3.82 (s, 3H), 3.10 (s, 3H); mp 208–212 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 395.13 (M + H)<sup>+</sup>. HPLC: 89 A%.</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (3-Methanesulfonyl-phenyl)-[8-(4-methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amine (<b>25</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.55 (d, <i>J</i> = 6.9 Hz, 1H), 8.47 (s, 1H), 8.26 (d, <i>J</i> = 7.9 Hz, 2H), 8.12 (d, <i>J</i> = 7.5 Hz, 2H), 7.74–7.69 (m, 2H), 7.58–7.50 (m, 2H), 7.17 (s, 1H), 7.12–7.07 (m, 1H), 3.11 (s, 6H); mp 230–234 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 443.11 (M + H)<sup>+</sup>. HPLC: 94 A%.</div></div><div id="sec5_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (4-Methanesulfonyl-phenyl)-[8-(4-methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amine (<b>26</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.56 (d, <i>J</i> = 5.7 Hz, 1H), 8.22 (d, <i>J</i> = 8.0 Hz, 2H), 8.10 (d, <i>J</i> = 7.6 Hz, 2H), 7.92 (d, <i>J</i> = 7.8 Hz, 2H), 7.77 (d, <i>J</i> = 7.3 Hz, 2H), 7.72 (d, <i>J</i> = 7.3 Hz, 1H), 7.32 (s, 1H), 7.14–7.09 (m, 1H), 3.11 (s, 3H), 3.06 (s, 3H); mp 280–282 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 443.10 (M + H)<sup>+</sup>. HPLC: 92 A%.</div></div><div id="sec5_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-(3-morpholin-4-yl-phenyl)-amine (<b>27</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.50 (dd, <i>J</i> = 6.6, 1.1 Hz, 1H), 8.26–8.22 (m, 2H), 8.10–8.05 (m, 2H), 7.66 (dd, <i>J</i> = 7.3, 1.1 Hz, 1H), 7.36 (t, <i>J</i> = 2.2 Hz, 1H), 7.25 (t, <i>J</i> = 8.0 Hz, 1H), 7.05–6.98 (m, 2H), 6.85 (s, 1H), 6.59 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 3.91–3.87 (m, 4H), 3.24–3.20 (m, 4H), 3.10 (s, 3H); mp 234–236 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 450.17 (M + H)<sup>+</sup>. HPLC: 94 A%.</div></div><div id="sec5_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-(4-morpholin-4-yl-phenyl)-amine (<b>28</b>)</h4><div class="NLM_p last">To an oven-dried tube was added 8-(4-methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (100.0 mg, 0.3468 mmol), 4-(4-bromo-phenyl)-morpholine (100.0 mg, 0.4130 mmol), palladium acetate (10.0 mg, 0.0445 mmol), and 9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene (75.0 mg, 0.130 mmol), cesium carbonate (240.0 mg, 0.7366 mmol), and 1,4-dioxane (5 mL). The mixture was purged under vacuum and backflushed with nitrogen three times. The tube was sealed and heated at 80 °C for 72 h. The mixture was cooled to room temperature and diluted with dichloromethane (10 mL), filtered, and the filtrate was evaporated. The product (0.063 g, 40%) was isolated via column chromatography (silica gel 40 g, 20%→100% ethyl acetate/hexane). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.49–8.45 (m, 1H), 8.25–8.20 (m, 2H), 8.11–8.06 (m, 2H), 7.63 (dd, <i>J</i> = 7.4, 0.9 Hz, 1H), 7.53–7.48 (m, 2H), 6.99 (t, <i>J</i> = 7.0 Hz, 1H), 6.97–6.93 (m, 2H), 6.73 (s, 1H), 3.90–3.86 (m 4H), 3.14–3.09 (m, 7H); mp 244–246 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 450.08 (M + H)<sup>+</sup>. HPLC: 88 A%.</div></div><div id="sec5_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-[3-(4-methyl-piperazin-1-yl)-phenyl]-amine (<b>29</b>)</h4><div class="NLM_p last">To an oven-dried tube was added 8-(4-methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-ylamine (50.0 mg, 0.173 mmol), 1-(3-bromo-phenyl)-4-methyl-piperazine (53.0 mg, 0.208 mmol), palladium acetate (8.0 mg, 0.036 mmol), 2,2′-bis-dicyclohexylphosphanyl-biphenyl (20.0 mg, 0.0366 mmol), cesium carbonate (140.0 mg, 0.4297 mmol), and 1,4-dioxane (2 mL) under an atmosphere of nitrogen. The tube was vacuum purged and backflushed with nitrogen three times and then the tube was sealed and the mixture was heated at 100 °C for 3 days. The reaction mixture was cooled to room temperature diluted with dichloromethane (10 mL), filtered, and the filtrate was evaporated. The product was isolated (0.029 g, 36%) via column chromatography (amine modified silica gel 47 g, 0%→10% methanol:dichloromethane). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.49 (dd, <i>J</i> = 6.6, 1.0 Hz, 1H), 8.25 (d, <i>J</i> = 8.4 Hz, 2H), 8.08 (d, <i>J</i> = 8.4 Hz, 2H), 7.66 (dd, <i>J</i> = 7.5, 0.9 Hz, 1H), 7.39–7.36 (m, 1H), 7.23 (t, <i>J</i> = 8.2 Hz, 1H), 7.02 (t, <i>J</i> = 7.1 Hz, 1H), 6.97 (dd, <i>J</i> = 7.8, 1.4 Hz, 1H), 6.88 (s, 1H), 6.60 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 3.30–3.25 (m, 4H), 3.10 (s, 3H), 2.63–2.58 (m, 4H), 2.38 (s, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ 162.65, 152.28, 148.87, 141.00, 140.91, 140.05, 129.64, 129.29, 128.18, 127.85, 127.76, 124.77, 112.03, 109.40, 108.59, 104.80, 55.19, 49.02, 46.19, 44.59; mp 208–211 °C. High resolution mass spectrum (ESI+) <i>m</i>/<i>z</i> 463.1925 [(M + H)<sup>+</sup> calcd for C<sub>24</sub>H<sub>26</sub>N<sub>6</sub>O<sub>2</sub>S: 463.1916]. HPLC: 95 A%.</div></div><div id="sec5_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-[4-(4-methyl-piperazin-1-yl)-phenyl]-amine (<b>30</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.47 (dd, <i>J</i> = 6.7, 1.1 Hz, 1H), 8.25–8.20 (m, 2H), 8.10–8.06 (m, 2H), 7.63 (dd, <i>J</i> = 7.4, 1.1 Hz, 1H), 7.51–7.46 (m, 2H), 7.01–6.95 (m, 2H), 6.67 (s, 1H), 3.20–3.15 (m, 4H), 3.10 (s, 3H), 2.62–2.58 (m, 4H), 2.36 (s, 3H); mp 242–244 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 463.13 (M + H)<sup>+</sup>. HPLC: 91 A%.</div></div><div id="sec5_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-[3-(4-methyl-piperazin-1-ylmethyl)-phenyl]-amine (<b>31</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.51 (d, <i>J</i> = 6.6 Hz, 1H), 8.24 (d, <i>J</i> = 8.5 Hz, 2H), 8.09 (d, <i>J</i> = 8.5 Hz, 2H), 7.66 (dd, <i>J</i> = 7.4, 0.9 Hz, 1H), 7.58 (dd, <i>J</i> = 7.8, 1.9 Hz, 1H), 7.46 (s, 1H), 7.31 (t, <i>J</i> = 7.8 Hz, 1H), 7.02 (t, <i>J</i> = 7.2 Hz, 1H), 6.98 (d, <i>J</i> = 7.5 Hz, 1H), 6.90 (s, 1H), 3.54 (s, 2H), 3.10 (s, 3H), 2.70–2.32 (m, 8H), 2.29 (s, 3H). LC/MS (ESI+) <i>m</i>/<i>z</i> 477.18 (M + H)<sup>+</sup>. HPLC: 90 A%.</div></div><div id="sec5_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-{3-[(1,1-Dioxidothiomorpholin-4-yl)methyl]phenyl}-8-[4-(methylsulfonyl)phenyl][1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-amine (<b>32</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.52 (dd, <i>J</i> = 6.7, 1.0 Hz, 1H), 8.23 (d, <i>J</i> = 8.H Hz, 2H), 8.09 (d, <i>J</i> = 8.4 Hz, 2H), 7.68 (dd, <i>J</i> = 7.4,0.9 Hz, 1H), 7.62–7.60 (m, 1H), 7.48 (dd, <i>J</i> = 8.1, 1.8 Hz, 1H), 7.32 (t, <i>J</i> = 7.7 Hz, 1H), 7.05 (t, <i>J</i> = 7.1 Hz, 1H), 6.97–6.93 (m, 2H), 3.70 (s, 2H), 3.13–3.01 (m, 11H). LC/MS (ESI+) <i>m</i>/<i>z</i> 512.08 (M + H)<sup>+</sup>. HPLC: 94 A%.</div></div><div id="sec5_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-[3-(4-morpholin-4-yl-piperidin-1-yl)-phenyl]-amine (<b>33</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.49 (d, <i>J</i> = 6.4 Hz, 1H), 8.26 (d, <i>J</i> = 8.0 Hz, 2H), 8.08 (d, <i>J</i> = 7.1 Hz, 2H), 7.66 (d, <i>J</i> = 8.0 Hz, 2H), 7.35 (s, 1H), 7.24–7.18 (m, 1H), 7.01 (d, <i>J</i> = 6.7 Hz, 1H), 6.96 (d, <i>J</i> = 7.9 Hz, 1H), 6.84 (s, 1H), 6.60 (d, <i>J</i> = 8.4 Hz, 1H), 3.81 (d, <i>J</i> = 11.7 Hz, 2H), 3.77–3.72 (m, 4H), 3.10 (s, 3H), 2.78 (t, <i>J</i> = 11.8 Hz, 2H), 2.63–2.58 (m, 4H), 2.40–2.30 (m, 1H), 1.97 (d, <i>J</i> = 12.7 Hz, 2H), 1.74–1.62 (m, 2H); mp 230–236 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 533.16 (M + H)<sup>+</sup>. HPLC: 94 A%.</div></div><div id="sec5_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-{3-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-phenyl}-amine (<b>34</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.49 (d, <i>J</i> = 6.5 Hz, 1H), 8.25 (d, <i>J</i> = 6.9 Hz, 2H), 8.08 (d, <i>J</i> = 7.7 Hz, 2H), 7.65 (d, <i>J</i> = 7.1 Hz, 1H), 7.31 (s, 1H), 7.24–7.18 (m, 1H), 7.04–6.95 (m, 2H), 6.82 (s, 1H), 6.60 (d, <i>J</i> = 7.9 Hz, 1H), 3.81 (d, <i>J</i> = 11.4 Hz, 2H), 3.10 (s, 3H), 2.77 (t, <i>J</i> = 12.2 Hz, 2H), 2.72–2.33 (m, 9H), 2.30 (s, 3H), 1.96 (d, <i>J</i> = 11.2 Hz, 2H), 1.75–1.63 (m, 2H); mp 237–239 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 546.20 (M + H)<sup>+</sup>. HPLC: 94 A%.</div></div><div id="sec5_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-[3-(1-methyl-piperidin-4-yl)-phenyl]-amine (<b>35</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.51 (d, <i>J</i> = 6.5 Hz, 1H), 8.08 (d, <i>J</i> = 8.3 Hz, 2H), 8.10 (d, <i>J</i> = 7.3 Hz, 2H), 7.66 (d, <i>J</i> = 6.6 Hz, 1H), 7.55 (s, 1H), 7.38 (d, <i>J</i> = 8.7 Hz, 1H), 7.31–7.25 (m, 1H), 7.02 (t, <i>J</i> = 7.4 Hz, 1H), 6.91–6.85 (m, 2H), 3.10 (s, 3H), 3.01 (d, <i>J</i> = 10.9 Hz, 2H), 2.57–2.45 (m, 1H), 2.35 (S, 3H), 2.11–2.03 (m, 2H), 1.92–1.83 (m, 4H); mp 208–210 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 462.16 (M + H)<sup>+</sup>. HPLC: 91 A%.</div></div><div id="sec5_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> [3-(4-Methyl-piperazin-1-yl)-phenyl]-{8-[4-(propane-2-sulfonyl)-phenyl]-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl}-amine (<b>36</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.49 (d, <i>J</i> = 6.7 Hz, 1H), 8.27 (d, <i>J</i> = 7.7 Hz, 2H), 8.01 (d, <i>J</i> = 7.9 Hz, 2H), 7.67 (d, <i>J</i> = 7.3 Hz, 1H), 7.39 (s, 1H), 7.26–7.20 (m, 1H), 7.04–6.95 (m, 2H), 6.85 (s, 1H), 6.60 (d, <i>J</i> = 7.7 Hz, 1H), 3.31–3.19 (m, 5H), 2.63–2.58 (m, 4H), 2.38 (s, 3H), 1.35 (d, <i>J</i> = 6.7 Hz, 6H). LC/MS (ESI+) <i>m</i>/<i>z</i> 491.19 (M + H)<sup>+</sup>. HPLC: 85 A%.</div></div><div id="sec5_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> [3-(4-Methyl-piperazin-1-yl)-phenyl]-[8-(4-trifluoromethyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-amine (<b>37</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.46 (d, <i>J</i> = 7.0 Hz, 1H), 8.15 (d, <i>J</i> = 7.7 Hz, 2H), 7.76 (d, <i>J</i> = 8.2 Hz, 2H), 7.62 (d, <i>J</i> = 7.2 Hz, 1H), 7.48 (s, 1H), 7.25–7.19 (m, 1H), 7.02–6.97 (m, 1H), 6.92 (d, <i>J</i> = 7.3 Hz, 1H), 6.83 (s, 1H), 6.59 (d, <i>J</i> = 7.8 Hz, 1H), 3.30–3.25 (m, 4H), 2.62–2.57 (m, 4H), 2.37 (s, 3H); mp 234–236 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 453.15 (M + H)<sup>+</sup>. HPLC: 97 A%.</div></div><div id="sec5_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> [8-(4-Fluoro-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-[3-(4-methyl-piperazin-1-yl)-phenyl]-amine (<b>38</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.56 (s, 1H), 8.78 (d, 1H), 8.20 (m, 2H), 7.85 (d, 1H), 7.50 (s, 1H), 7.35 (m, 2H), 7.10 (m, 3H), 6.45 (m, 1H), 3.12 (m, 4H), 2.46 (m, 4H), 2.23 (s, 3H); mp 194–196 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 403 (M + H)<sup>+</sup>. HPLC: 95 A%.</div></div><div id="sec5_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> {8-[4-(Dimethyl-phosphinoyl)-phenyl]-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl}-[3-(4-methyl-piperazin-1-yl)-phenyl]-amine (<b>39</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.46 (d, <i>J</i> = 6.2 Hz, 1H), 8.15 (d, <i>J</i> = 8.0 Hz, 2H), 7.92–7.84 (m, 2H), 7.63–7.50 (m, 1H), 7.34 (s, 1H), 7.23 (t, <i>J</i> = 8.2 Hz, 1H), 7.02–6.96 (m, 2H), 6.84 (s, 1H), 6.59 (d, <i>J</i> = 7.8 Hz, 1H), 3.30–3.25 (m, 4H), 2.63–2.58 (m, 4H), 2.37 (s, 3H), 1.80 (s, 3H), 1.77 (s, 3H); mp 243–246 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 461.0 (M + H)<sup>+</sup>. HPLC: 100 A%.</div></div><div id="sec5_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> [8-(4-Methanesulfonyl-phenyl)-6-trifluoromethyl-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-[4-(4-methyl-piperazin-1-yl)-phenyl]-amine (<b>40</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.82 (s, 1H), 8.25 (d, <i>J</i> = 7.8 Hz, 2H), 8.13 (d, <i>J</i> =  7.3 Hz, 2H), 7.79 (s, 1H), 7.49 (d, <i>J</i> =  8.2 Hz, 2H), 6.99 (d, <i>J</i> =  8.2 Hz, 2H), 6.88 (s, 1H), 3.21 (bm, 4H), 3.13 (s, 3H), 2.66 (bm, 4H), 2.40 (s, 3H); mp 126–134 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 531.0 (M + H)<sup>+</sup>. HPLC: 98 A%.</div></div><div id="sec5_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> [6-Fluoro-8-(4-methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridin-2-yl]-[4-(4-methyl-piperazin-1-yl)-phenyl]-amine (<b>41</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.45 (s, 1H), 8.26 (d, <i>J</i> =  8.0 Hz, 2H), 8.11 (d, <i>J</i> = 7.7 Hz, 2H), 7.58 (d, <i>J</i> = 9.0 Hz, 1H), 7.48 (dd, <i>J</i> = 11.5 Hz, 7.8 Hz, 2H), 6.98 (d, <i>J</i> = 7.9 Hz, 2H), 6.76 (s, 1H), 3.27 (bm, 4H), 3.12 (s, 3H), 2.62 (bm, 4H), 2.38 (s, 3H); mp 130–138 °C. LC/MS (ESI+) <i>m</i>/<i>z</i> 481.2 (M + H)<sup>+</sup>. HPLC: 95 A%.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Enzyme Assays for JAK1, JAK2, and JAK3</h3><div class="NLM_p last">The kinase activity of baculovirus-expressed human JAK1, JAK2, or JAK3 was measured using the time-resolved fluorescence detection system as previously described.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Each 96-well Costar high binding plate (Corning, Corning, NY) was coated with 100 μL/well of 10 μg/mL neutravidin (Pierce Biotechnology, Rockford, IL) in TBS at 37 °C for 2 h, followed by 100 μL/well of 1 μg/mL 15-mer peptide substrate (biotinyl-amino-hexanoyl-EQEDEPEGDYFEWLE-amide, Infinity Biotech Research and Resource, Aston, PA) at 37 °C for 1 h. The kinase assay mixture (total volume = 100 μL/well) consisting of 20 mM HEPES (pH 7.2), ATP (0.2 μM ATP for JAK1 and JAK2 and 0.1 μM ATP for JAK3), 1 mM MnCl<sub>2</sub>, 0.1% BSA, and test compound (diluted in DMSO, 2.5% DMSO final in assay) was added to the assay plate. Enzyme was added and the reaction was allowed to proceed for 20 min at room temperature (RT). Detection of the phosphorylated product was performed by adding 100 μL/well of diluted Eu–N1 labeled PY100 antibody (PerkinElmer, Boston, MA). Samples were incubated at RT for 1 h, followed by addition of 100 μL enhancement solution (PerkinElmer). Plates were agitated for 10 min, and the fluorescence of the resulting solution measured using the PerkinElmer EnVision 2102 or 2104 multilabel plate reader. IC<sub>50</sub> values were determined using the 4-parameter logistic model in XLFit 4 (IDBS, Ltd., Guildford, UK).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Cell-Based Assay for JAK2</h3><div class="NLM_p last">The JAK2 cell-based assay was performed using a modified GeneBLAzer assay for the CellSensor irf1-bla TF-1 cell line.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Cryopreserved cells were suspended at 1.25 × 106 cells/mL in assay media containing modified DMEM/F12 (Invitrogen, Carlsbad, CA), 0.5% dialyzed FBS, 2 mM glutamine (Invitrogen), 100 U/mL penicillin, and 100 μg/mL streptomycin (Mediatech, Manassas, VA). The cell suspension (40 μL/well) was dispensed into the 384-well assay plates (Corning, Corning, NY) and incubated overnight at 5% CO<sub>2</sub>, 37 °C. Test compound/DMSO (100 nL) was then added to the assay plates. For the negative control wells, an internal JAK2 reference inhibitor was delivered at a concentration that produced 100% inhibition; positive control wells received only DMSO. Assay plates were incubated for 1 h prior to adding 5 μL/well of GM-CSF (Invitrogen) diluted in assay media (1 ng/mL final concentration in assay, equivalent to its EC<sub>80</sub>). The plates were then incubated for 5 h at 5% CO<sub>2</sub>, 37 °C. Development was initiated by addition of 8 μL LiveBLAzer FRET β-lactamase loading solution per well (Invitrogen), and the plate was incubated for 4 h at RT. Detection was performed on the EnVision 2102 plate reader (PerkinElmer). IC<sub>50</sub> values were determined using the 4-parameter logistic model in XLFit 4 (IDBS, Ltd.).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> PK Assay</h3><div class="NLM_p last">Adult animals (Charles River, Kingston, New York; <i>n</i> = 3/time point) were used in all experiments. IV administration was via the lateral tail vein, and oral doses were administered by gavage using a fixed dose volume of 100 μL. Compounds were administered IV in a vehicle of 25% hydroxyl-propyl-β-cyclodextrin and formulated in 100% PEG400 for oral dosing. The mice were sacrificed by decapitation, and trunk blood was collected into heparinized tubes at predetermined sampling times through 6 or 24 h. The blood samples were placed on wet ice until centrifuged to separate plasma. The plasma fraction was transferred into clean, dry tubes, frozen on dry ice, and stored at approximately −20 °C pending analysis. Plasma samples were analyzed for test compounds using a preliminary method, consisting of high-performance liquid chromatography (HPLC) coupled with tandem mass spectrometry. Pharmacokinetic parameters were estimated using noncompartmental methods.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> PD Assay</h3><div class="NLM_p last">Nude mice bearing CWR22 xenografts were dosed orally with 55 mg/kg of compound <b>29</b> or a vehicle (PEG400). At 2, 6, and 24 h after dosing animals (3/group) were sacrificed, tumors were excised and plasma samples were prepared. Tumor extracts were prepared using Triton-based extraction buffer supplemented with inhibitors of proteases and phosphatases. Equal amounts of extracts were resolved on SDS-PAGE gels and STAT3 phosphorylation and expression were analyzed by Western blot using specific antibodies (Cell Signaling). Specific bands were quantified using the GelPro program and STAT3 activation in each sample was determined as a ratio of phosphoSTAT3/total STAT3. Results were graphed as a mean STAT3 phophorylation per group relative to the vehicle group which was set at 100%.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Efficacy Studies</h3><div class="NLM_p last">CWR22 prostate carcinoma cells or HDLM-2 (classical Hodgkin lymphoma) cells were injected into the flanks of nude (CWR22) or SCID/NOD mice. After tumors became palpable, animals were grouped (10 mice/group) and dosed with a vehicle (PEG400) or 30 mg/kg bid (CWR22) or 30 mg/kg bid and 55 mg/kg bid (HDLM-2) of compound <b>29</b>. Tumor volume was measured every 3–4 days.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm300248q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin J. Dugan</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e082849587818ea083859088818c8f8ece838f8d"><span class="__cf_email__" data-cfemail="3b595f4e5c5a557b585e4b535a57545515585456">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diane E. Gingrich</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eugen F. Mesaros</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen L. Milkiewicz</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew A. Curry</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allison L. Zulli</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pawel Dobrzanski</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cynthia Serdikoff</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mahfuza Jan</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thelma S. Angeles</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark S. Albom</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer L. Mason</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa D. Aimone</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sheryl L. Meyer</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zeqi Huang</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin J. Wells-Knecht</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark A. Ator</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce A. Ruggeri</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce D. Dorsey</span> - <span class="hlFld-Affiliation affiliation">Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380, United States </span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d175e3002-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the following people: Torsten Herbertz and Arup Ghose for molecular modeling, Kelli Zeigler and Damaris Rolon-Steele for animal studies, Katrin Przyuski, Daniel Levy, and Joseph Sclafani for assistance in multigram scale preparation of intermediates and CEP-33779 (<b>29</b>), and Ulrike Hars of Crelux GmbH for generating the JAK2/inhibitor cocrystal structure of <b>28</b>.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i56" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i56"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> Abbreviations Used</h2><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transduction and transcription</p></td></tr><tr><td class="NLM_term">TYK</td><td class="NLM_def"><p class="first last">tyrosine kinase</p></td></tr><tr><td class="NLM_term">TPP</td><td class="NLM_def"><p class="first last">triphenylphosphine</p></td></tr><tr><td class="NLM_term">SCID/NOD</td><td class="NLM_def"><p class="first last">severe combined immune deficiency/nonobese diabetic</p></td></tr><tr><td class="NLM_term">MQL</td><td class="NLM_def"><p class="first last">minimum quantifiable level</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span> </span><span class="NLM_article-title">The STATs of Cancer—New Molecular Targets Come of Age</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1038%2Fnrc1275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=14964307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlaqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=97-105&author=H.+Yuauthor=R.+Jove&title=The+STATs+of+Cancer%E2%80%94New+Molecular+Targets+Come+of+Age"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The STATs of cancer - new molecular targets come of age</span></div><div class="casAuthors">Yu, Hua; Jove, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-105</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor cells acquire the ability to proliferate uncontrollably, resist apoptosis, sustain angiogenesis and evade immune surveillance.  STAT proteins - esp. STAT3 and STAT5 - regulate all of these processes and are persistently activated in a surprisingly large no. of human cancers.  Consequently, STAT proteins are emerging - unexpectedly - as ideal targets for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdnLoVoH4d1rVg90H21EOLACvtfcHk0lhxxPah8Mpc2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlaqtb0%253D&md5=3e342db4856310cac2465240e36d3226</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnrc1275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1275%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DJove%26aufirst%3DR.%26atitle%3DThe%2520STATs%2520of%2520Cancer%25E2%2580%2594New%2520Molecular%2520Targets%2520Come%2520of%2520Age%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D97%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dagvadorj, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jomain, J.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdulghani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zellweger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alanen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirtti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visakorpi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubendorf, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goffin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, M. T.</span><span> </span><span class="NLM_article-title">Autocrine Prolactin Promotes Prostate Cancer Cell Growth via Janus Kinase-2-Signal Transducer and Activator of Transcription-5a/b Signaling Pathway</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">3089</span><span class="NLM_x">–</span> <span class="NLM_lpage">3101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=3089-3101&author=A.+Dagvadorjauthor=S.+Collinsauthor=J.-B.+Jomainauthor=J.+Abdulghaniauthor=J.+Karrasauthor=T.+Zellwegerauthor=H.+Liauthor=M.+Nurmiauthor=K.+Alanenauthor=T.+Mirttiauthor=T.+Visakorpiauthor=L.+Bubendorfauthor=V.+Goffinauthor=M.+T.+Nevalainen&title=Autocrine+Prolactin+Promotes+Prostate+Cancer+Cell+Growth+via+Janus+Kinase-2-Signal+Transducer+and+Activator+of+Transcription-5a%2Fb+Signaling+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDagvadorj%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DS.%26aulast%3DJomain%26aufirst%3DJ.-B.%26aulast%3DAbdulghani%26aufirst%3DJ.%26aulast%3DKarras%26aufirst%3DJ.%26aulast%3DZellweger%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DNurmi%26aufirst%3DM.%26aulast%3DAlanen%26aufirst%3DK.%26aulast%3DMirtti%26aufirst%3DT.%26aulast%3DVisakorpi%26aufirst%3DT.%26aulast%3DBubendorf%26aufirst%3DL.%26aulast%3DGoffin%26aufirst%3DV.%26aulast%3DNevalainen%26aufirst%3DM.%2BT.%26atitle%3DAutocrine%2520Prolactin%2520Promotes%2520Prostate%2520Cancer%2520Cell%2520Growth%2520via%2520Janus%2520Kinase-2-Signal%2520Transducer%2520and%2520Activator%2520of%2520Transcription-5a%252Fb%2520Signaling%2520Pathway%26jtitle%3DEndocrinology%26date%3D2007%26volume%3D148%26spage%3D3089%26epage%3D3101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pardanani, A.</span><span> </span><span class="NLM_article-title">JAK2 Inhibitor Therapy in Myeloproliferative Disorders: Rationale, Preclinical Studies and Ongoing Clinical Trials</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=22-30&author=A.+Pardanani&title=JAK2+Inhibitor+Therapy+in+Myeloproliferative+Disorders%3A+Rationale%2C+Preclinical+Studies+and+Ongoing+Clinical+Trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardanani%26aufirst%3DA.%26atitle%3DJAK2%2520Inhibitor%2520Therapy%2520in%2520Myeloproliferative%2520Disorders%253A%2520Rationale%252C%2520Preclinical%2520Studies%2520and%2520Ongoing%2520Clinical%2520Trials%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D22%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kortylewski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kujawski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilon-Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mule, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardoll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span> </span><span class="NLM_article-title">Inhibiting Stat3 Signaling in the Hematopoietic System Elicits Multicomponent Antitumor Immunity</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1314</span><span class="NLM_x">–</span> <span class="NLM_lpage">1321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=1314-1321&author=M.+Kortylewskiauthor=M.+Kujawskiauthor=T.+Wangauthor=S.+Weiauthor=S.+Zhangauthor=S.+Pilon-Thomasauthor=G.+Niuauthor=H.+Kayauthor=J.+Muleauthor=W.+G.+Kerrauthor=R.+Joveauthor=D.+Pardollauthor=H.+Yu&title=Inhibiting+Stat3+Signaling+in+the+Hematopoietic+System+Elicits+Multicomponent+Antitumor+Immunity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKortylewski%26aufirst%3DM.%26aulast%3DKujawski%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DPilon-Thomas%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DG.%26aulast%3DKay%26aufirst%3DH.%26aulast%3DMule%26aufirst%3DJ.%26aulast%3DKerr%26aufirst%3DW.%2BG.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DPardoll%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DH.%26atitle%3DInhibiting%2520Stat3%2520Signaling%2520in%2520the%2520Hematopoietic%2520System%2520Elicits%2520Multicomponent%2520Antitumor%2520Immunity%26jtitle%3DNature%2520Med.%26date%3D2005%26volume%3D11%26spage%3D1314%26epage%3D1321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nefedova, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrilovich, D. I.</span><span> </span><span class="NLM_article-title">Targeting of Jak/STAT Pathway in Antigen Presenting Cells in Cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.2174%2F156800907780006887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=17305479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVOgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=71-77&author=Y.+Nefedovaauthor=D.+I.+Gabrilovich&title=Targeting+of+Jak%2FSTAT+Pathway+in+Antigen+Presenting+Cells+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of Jak/STAT pathway in antigen presenting cells in cancer</span></div><div class="casAuthors">Nefedova, Yulia; Gabrilovich, Dmitry I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-77</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the major mechanisms of tumor escape is the inability of antigen presenting cells (APC), and specifically the most potent APC dendritic cells (DC), to induce potent antitumor immune response.  The defects in APC are caused by the variety of tumor-derived factors.  Here, the authors discuss recent findings which indicate that the members of the family of signal transducers and activators of transcription (STATs), and more specifically STAT3, could be responsible for the abnormal DC differentiation and function in cancer.  The different approaches to pharmacol. regulation of this pathway and their effects on DC function and antitumor immune responses are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNux9rZUb2ZbVg90H21EOLACvtfcHk0lh_eXaYFysJ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVOgtr0%253D&md5=23d9c7bd5646e49d0a79a191dab9d2cf</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.2174%2F156800907780006887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800907780006887%26sid%3Dliteratum%253Aachs%26aulast%3DNefedova%26aufirst%3DY.%26aulast%3DGabrilovich%26aufirst%3DD.%2BI.%26atitle%3DTargeting%2520of%2520Jak%252FSTAT%2520Pathway%2520in%2520Antigen%2520Presenting%2520Cells%2520in%2520Cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2007%26volume%3D7%26spage%3D71%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lin, W.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">A cytokine-mediated link between innate immunity, inflammation, and cancer</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=1175-1183&author=W.-W.+Linauthor=M.+Karin&title=A+cytokine-mediated+link+between+innate+immunity%2C+inflammation%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DW.-W.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DA%2520cytokine-mediated%2520link%2520between%2520innate%2520immunity%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D1175%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pardanani, A.</span><span> </span><span class="NLM_article-title">JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=23-30&author=A.+Pardanani&title=JAK2+inhibitor+therapy+in+myeloproliferative+disorders%3A+rationale%2C+preclinical+studies+and+ongoing+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardanani%26aufirst%3DA.%26atitle%3DJAK2%2520inhibitor%2520therapy%2520in%2520myeloproliferative%2520disorders%253A%2520rationale%252C%2520preclinical%2520studies%2520and%2520ongoing%2520clinical%2520trials%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D23%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Marotta, L. L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almendro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marusyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipitsin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloustain-Qimron, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhury, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gönen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvey, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessarabova, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolsky, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyak, K.</span><span> </span><span class="NLM_article-title">The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell-like breast cancer cells in human tumors</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">2723</span><span class="NLM_x">–</span> <span class="NLM_lpage">2735</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=2723-2735&author=L.+L.+C.+Marottaauthor=V.+Almendroauthor=A.+Marusykauthor=M.+Shipitsinauthor=J.+Schemmeauthor=S.+R.+Walkerauthor=N.+Bloustain-Qimronauthor=J.+J.+Kimauthor=S.+A.+Choudhuryauthor=R.+Maruyamaauthor=Z.+Wuauthor=M.+G%C3%B6nenauthor=L.+A.+Mulveyauthor=M.+O.+Bessarabovaauthor=S.+J.+Huhauthor=S.+J.+Silverauthor=S.+Y.+Kimauthor=S.+Y.+Parkauthor=H.+E.+Leeauthor=K.+S.+Andersonauthor=A.+L.+Richardsonauthor=T.+Nikolskayaauthor=Y.+Nikolskyauthor=X.+S.+Liuauthor=D.+E.+Rootauthor=W.+C.+Hahnauthor=D.+A.+Frankauthor=K.+Polyak&title=The+JAK2%2FSTAT3+signaling+pathway+is+required+for+growth+of+CD44%2BCD24%E2%80%93+stem+cell-like+breast+cancer+cells+in+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarotta%26aufirst%3DL.%2BL.%2BC.%26aulast%3DAlmendro%26aufirst%3DV.%26aulast%3DMarusyk%26aufirst%3DA.%26aulast%3DShipitsin%26aufirst%3DM.%26aulast%3DSchemme%26aufirst%3DJ.%26aulast%3DWalker%26aufirst%3DS.%2BR.%26aulast%3DBloustain-Qimron%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DJ.%2BJ.%26aulast%3DChoudhury%26aufirst%3DS.%2BA.%26aulast%3DMaruyama%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DG%25C3%25B6nen%26aufirst%3DM.%26aulast%3DMulvey%26aufirst%3DL.%2BA.%26aulast%3DBessarabova%26aufirst%3DM.%2BO.%26aulast%3DHuh%26aufirst%3DS.%2BJ.%26aulast%3DSilver%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DH.%2BE.%26aulast%3DAnderson%26aufirst%3DK.%2BS.%26aulast%3DRichardson%26aufirst%3DA.%2BL.%26aulast%3DNikolskaya%26aufirst%3DT.%26aulast%3DNikolsky%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%2BS.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DFrank%26aufirst%3DD.%2BA.%26aulast%3DPolyak%26aufirst%3DK.%26atitle%3DThe%2520JAK2%252FSTAT3%2520signaling%2520pathway%2520is%2520required%2520for%2520growth%2520of%2520CD44%252BCD24%25E2%2580%2593%2520stem%2520cell-like%2520breast%2520cancer%2520cells%2520in%2520human%2520tumors%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D2723%26epage%3D2735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundarsanam, S.</span><span> </span><span class="NLM_article-title">The Protein Kinase Complement of the Human Genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sundarsanam&title=The+Protein+Kinase+Complement+of+the+Human+Genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0lhQFYO6ZTv-1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSundarsanam%26aufirst%3DS.%26atitle%3DThe%2520Protein%2520Kinase%2520Complement%2520of%2520the%2520Human%2520Genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahonen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alanen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBaron, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pretlow, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ealley, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martikainen, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, M. T.</span><span> </span><span class="NLM_article-title">Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer is Associated with High Histological Grade</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">4774</span><span class="NLM_x">–</span> <span class="NLM_lpage">4782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4774-4782&author=H.+Liauthor=T.+J.+Ahonenauthor=K.+Alanenauthor=J.+Xieauthor=M.+J.+LeBaronauthor=T.+G.+Pretlowauthor=E.+L.+Ealleyauthor=Y.+Zhangauthor=M.+Nurmiauthor=B.+Singhauthor=P.+M.+Martikainenauthor=M.+T.+Nevalainen&title=Activation+of+Signal+Transducer+and+Activator+of+Transcription+5+in+Human+Prostate+Cancer+is+Associated+with+High+Histological+Grade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DAhonen%26aufirst%3DT.%2BJ.%26aulast%3DAlanen%26aufirst%3DK.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DLeBaron%26aufirst%3DM.%2BJ.%26aulast%3DPretlow%26aufirst%3DT.%2BG.%26aulast%3DEalley%26aufirst%3DE.%2BL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DNurmi%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DMartikainen%26aufirst%3DP.%2BM.%26aulast%3DNevalainen%26aufirst%3DM.%2BT.%26atitle%3DActivation%2520of%2520Signal%2520Transducer%2520and%2520Activator%2520of%2520Transcription%25205%2520in%2520Human%2520Prostate%2520Cancer%2520is%2520Associated%2520with%2520High%2520Histological%2520Grade%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D4774%26epage%3D4782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tan, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, M. T.</span><span> </span><span class="NLM_article-title">Signal Transducer and Activator of Transcription 5A/B in Prostate and Breast Cancers</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=367-390&author=S.-H.+Tanauthor=M.+T.+Nevalainen&title=Signal+Transducer+and+Activator+of+Transcription+5A%2FB+in+Prostate+and+Breast+Cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.-H.%26aulast%3DNevalainen%26aufirst%3DM.%2BT.%26atitle%3DSignal%2520Transducer%2520and%2520Activator%2520of%2520Transcription%25205A%252FB%2520in%2520Prostate%2520and%2520Breast%2520Cancers%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2008%26volume%3D15%26spage%3D367%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Quintas-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Janus Kinase Inhibitors for the Treatment of Myeloproliferative Neoplasias and Beyond</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=127-140&author=A.+Quintas-Cardamaauthor=H.+Kantarjianauthor=J.+Cortesauthor=S.+Verstovsek&title=Janus+Kinase+Inhibitors+for+the+Treatment+of+Myeloproliferative+Neoplasias+and+Beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuintas-Cardama%26aufirst%3DA.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DJanus%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Myeloproliferative%2520Neoplasias%2520and%2520Beyond%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D127%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Borie, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">JAK3 inhibition as a new concept for immune suppression</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1297</span><span class="NLM_x">–</span> <span class="NLM_lpage">1303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=1297-1303&author=D.+C.+Borieauthor=M.-S.+Siauthor=R.+E.+Morrisauthor=B.+A.+Reitzauthor=P.+S.+Changelian&title=JAK3+inhibition+as+a+new+concept+for+immune+suppression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorie%26aufirst%3DD.%2BC.%26aulast%3DSi%26aufirst%3DM.-S.%26aulast%3DMorris%26aufirst%3DR.%2BE.%26aulast%3DReitz%26aufirst%3DB.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DJAK3%2520inhibition%2520as%2520a%2520new%2520concept%2520for%2520immune%2520suppression%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D4%26spage%3D1297%26epage%3D1303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borie, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">A New Modality for Immunosuppression: Targeting the JAK/STAT Pathway</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=555-564&author=J.+J.+O%E2%80%99Sheaauthor=M.+Pesuauthor=D.+C.+Borieauthor=P.+S.+Changelian&title=A+New+Modality+for+Immunosuppression%3A+Targeting+the+JAK%2FSTAT+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DA%2520New%2520Modality%2520for%2520Immunosuppression%253A%2520Targeting%2520the%2520JAK%252FSTAT%2520Pathway%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D4%26spage%3D555%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Flex, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrangeli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiaretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoops, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariola, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clappier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoloni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fragale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavolaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzaniga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzolo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tornesello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battistini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cave, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renauld, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantinescu, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartaglia, M.</span><span> </span><span class="NLM_article-title">Somatically acquired <i>JAK1</i> mutations in adult acute lymphoblastic leukemia</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2008&pages=751-758&author=E.+Flexauthor=V.+Petrangeliauthor=L.+Stellaauthor=S.+Chiarettiauthor=T.+Hornakovaauthor=L.+Knoopsauthor=C.+Ariolaauthor=V.+Fodaleauthor=E.+Clappierauthor=F.+Paoloniauthor=S.+Martinelliauthor=A.+Fragaleauthor=M.+Sanchezauthor=S.+Tavolaroauthor=M.+Messinaauthor=G.+Cazzanigaauthor=A.+Cameraauthor=G.+Pizzoloauthor=A.+Torneselloauthor=M.+Vignettiauthor=A.+Battistiniauthor=H.+Caveauthor=B.+D.+Gelbauthor=J.-C.+Renauldauthor=A.+Biondiauthor=S.+N.+Constantinescuauthor=R.+Foaauthor=M.+Tartaglia&title=Somatically+acquired+JAK1+mutations+in+adult+acute+lymphoblastic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlex%26aufirst%3DE.%26aulast%3DPetrangeli%26aufirst%3DV.%26aulast%3DStella%26aufirst%3DL.%26aulast%3DChiaretti%26aufirst%3DS.%26aulast%3DHornakova%26aufirst%3DT.%26aulast%3DKnoops%26aufirst%3DL.%26aulast%3DAriola%26aufirst%3DC.%26aulast%3DFodale%26aufirst%3DV.%26aulast%3DClappier%26aufirst%3DE.%26aulast%3DPaoloni%26aufirst%3DF.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DM.%26aulast%3DTavolaro%26aufirst%3DS.%26aulast%3DMessina%26aufirst%3DM.%26aulast%3DCazzaniga%26aufirst%3DG.%26aulast%3DCamera%26aufirst%3DA.%26aulast%3DPizzolo%26aufirst%3DG.%26aulast%3DTornesello%26aufirst%3DA.%26aulast%3DVignetti%26aufirst%3DM.%26aulast%3DBattistini%26aufirst%3DA.%26aulast%3DCave%26aufirst%3DH.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DRenauld%26aufirst%3DJ.-C.%26aulast%3DBiondi%26aufirst%3DA.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DFoa%26aufirst%3DR.%26aulast%3DTartaglia%26aufirst%3DM.%26atitle%3DSomatically%2520acquired%2520JAK1%2520mutations%2520in%2520adult%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2008%26volume%3D205%26spage%3D751%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Minegishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morio, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agematsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuge, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yachie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessho, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujieda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakiguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abinun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochs, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belohradsky, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyawaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasuyama, H.</span><span> </span><span class="NLM_article-title">Human Tyrosine Kinase 2 Deficiency Reveals Its Requisite Roles in Multiple Cytokine Signals Involved in Innate and Acquired Immunity</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1016%2Fj.immuni.2006.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=17088085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Gnt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=745-755&author=Y.+Minegishiauthor=M.+Saitoauthor=T+Morioauthor=K.+Watanabeauthor=K.+Agematsuauthor=S.+Tsuchiyaauthor=H.+Takadaauthor=T.+Haraauthor=N.+Kawamuraauthor=T.+Arigaauthor=H.+Kanekoauthor=N.+Kondaauthor=I.+Tsugeauthor=A.+Yachieauthor=Y.+Sakiyamaauthor=T.+Iwataauthor=F.+Besshoauthor=T.+Ohishiauthor=K.+Johauthor=K.+Imaiauthor=K.+Kogawaauthor=M.+Shinoharaauthor=M.+Fujiedaauthor=H.+Wakiguchiauthor=S.+Pasicauthor=M.+Abinunauthor=H.+D.+Ochsauthor=E.+D.+Rennerauthor=A.+Janssonauthor=B.+H.+Belohradskyauthor=A.+Metinauthor=N.+Shimizuauthor=S.+Mizutaniauthor=T.+Miyawakiauthor=S.+Nonoyamaauthor=H.+Karasuyama&title=Human+Tyrosine+Kinase+2+Deficiency+Reveals+Its+Requisite+Roles+in+Multiple+Cytokine+Signals+Involved+in+Innate+and+Acquired+Immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity</span></div><div class="casAuthors">Minegishi, Yoshiyuki; Saito, Masako; Morio, Tomohiro; Watanabe, Ken; Agematsu, Kazunaga; Tsuchiya, Shigeru; Takada, Hidetoshi; Hara, Toshiro; Kawamura, Nobuaki; Ariga, Tadashi; Kaneko, Hideo; Kondo, Naomi; Tsuge, Ikuya; Yachie, Akihiro; Sakiyama, Yukio; Iwata, Tsutomu; Bessho, Fumio; Ohishi, Tsutomu; Joh, Kosuke; Imai, Kohsuke; Kogawa, Kazuhiro; Shinohara, Miwa; Fujieda, Mikiya; Wakiguchi, Hiroshi; Pasic, Srdjan; Abinun, Mario; Ochs, Hans D.; Renner, Eleonore D.; Jansson, Annette; Belohradsky, Bernd H.; Metin, Ayse; Shimizu, Norio; Mizutani, Shuki; Miyawaki, Toshio; Nonoyama, Shigeaki; Karasuyama, Hajime</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">745-755</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tyrosine kinase 2 (Tyk2) is a nonreceptor tyrosine kinase that belongs to the Janus kinase (Jak) family.  Here we identified a homozygous Tyk2 mutation in a patient who had been clin. diagnosed with hyper-IgE syndrome.  This patient showed unusual susceptibility to various microorganisms including virus, fungi, and mycobacteria and suffered from atopic dermatitis with elevated serum IgE.  The patient's cells displayed defects in multiple cytokine signaling pathways including those for type I interferon (IFN), interleukin (IL)-6, IL-10, IL-12, and IL-23.  The cytokine signals were successfully restored by transducing the intact Tyk2 gene.  Thus, the Tyk2 deficiency is likely to account for the patient's complex clin. manifestations, including the phenotype of impaired T helper 1 (Th1) differentiation and accelerated Th2 differentiation.  This study identifies human Tyk2 deficiency and demonstrates that Tyk2 plays obligatory roles in multiple cytokine signals involved in innate and acquired immunity of humans, which differs substantially from Tyk2 function in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9TTbAIzXM-bVg90H21EOLACvtfcHk0ljIc1r2sogKcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Gnt7zI&md5=debec30b44a7e1dc111d7cfb1c92f7dd</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2006.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2006.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DMinegishi%26aufirst%3DY.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DMorio%26aufirst%3DT%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DAgematsu%26aufirst%3DK.%26aulast%3DTsuchiya%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DKawamura%26aufirst%3DN.%26aulast%3DAriga%26aufirst%3DT.%26aulast%3DKaneko%26aufirst%3DH.%26aulast%3DKonda%26aufirst%3DN.%26aulast%3DTsuge%26aufirst%3DI.%26aulast%3DYachie%26aufirst%3DA.%26aulast%3DSakiyama%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DT.%26aulast%3DBessho%26aufirst%3DF.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DJoh%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DK.%26aulast%3DKogawa%26aufirst%3DK.%26aulast%3DShinohara%26aufirst%3DM.%26aulast%3DFujieda%26aufirst%3DM.%26aulast%3DWakiguchi%26aufirst%3DH.%26aulast%3DPasic%26aufirst%3DS.%26aulast%3DAbinun%26aufirst%3DM.%26aulast%3DOchs%26aufirst%3DH.%2BD.%26aulast%3DRenner%26aufirst%3DE.%2BD.%26aulast%3DJansson%26aufirst%3DA.%26aulast%3DBelohradsky%26aufirst%3DB.%2BH.%26aulast%3DMetin%26aufirst%3DA.%26aulast%3DShimizu%26aufirst%3DN.%26aulast%3DMizutani%26aufirst%3DS.%26aulast%3DMiyawaki%26aufirst%3DT.%26aulast%3DNonoyama%26aufirst%3DS.%26aulast%3DKarasuyama%26aufirst%3DH.%26atitle%3DHuman%2520Tyrosine%2520Kinase%25202%2520Deficiency%2520Reveals%2520Its%2520Requisite%2520Roles%2520in%2520Multiple%2520Cytokine%2520Signals%2520Involved%2520in%2520Innate%2520and%2520Acquired%2520Immunity%26jtitle%3DImmunity%26date%3D2006%26volume%3D25%26spage%3D745%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bumm, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichberger, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M. W.</span><span> </span><span class="NLM_article-title">CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">5232</span><span class="NLM_x">–</span> <span class="NLM_lpage">5240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=5232-5240&author=J.+W.+Tynerauthor=T.+G.+Bummauthor=J.+Deiningerauthor=L.+Woodauthor=K.+J.+Aichbergerauthor=M.+M.+Loriauxauthor=B.+J.+Drukerauthor=C.+J.+Burnsauthor=E.+Fantinoauthor=M.+W.+Deininger&title=CYT387%2C+a+novel+JAK2+inhibitor%2C+induces+hematologic+responses+and+normalizes+inflammatory+cytokines+in+murine+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DBumm%26aufirst%3DT.%2BG.%26aulast%3DDeininger%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DL.%26aulast%3DAichberger%26aufirst%3DK.%2BJ.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%26atitle%3DCYT387%252C%2520a%2520novel%2520JAK2%2520inhibitor%252C%2520induces%2520hematologic%2520responses%2520and%2520normalizes%2520inflammatory%2520cytokines%2520in%2520murine%2520myeloproliferative%2520neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D5232%26epage%3D5240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Pardanani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotlib, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talpaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schorr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1200%2FJCO.2010.32.8021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=21220608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktlelsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=789-796&author=A.+Pardananiauthor=J.+R.+Gotlibauthor=C.+Jamiesonauthor=J.+E.+Cortesauthor=M.+Talpazauthor=R.+M.+Stoneauthor=M.+H.+Silvermanauthor=D.+G.+Gillilandauthor=J.+Schorrauthor=A.+Tefferi&title=Safety+and+Efficacy+of+TG101348%2C+a+Selective+JAK2+Inhibitor%2C+in+Myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis</span></div><div class="casAuthors">Pardanani, Animesh; Gotlib, Jason R.; Jamieson, Catriona; Cortes, Jorge E.; Talpaz, Moshe; Stone, Richard M.; Silverman, Michael H.; Gilliland, D. Gary; Shorr, Jolene; Tefferi, Ayalew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">789-796</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Myelofibrosis is a myeloid malignancy assocd. with anemia, splenomegaly, and constitutional symptoms.  Patients frequently harbor JAK-STAT activating mutations that are sensitive to TG101348, a selective small-mol. Janus kinase 2 (JAK2) inhibitor.  Patients and Methods In a multicenter phase I trial, oral TG101348 was administered once a day to patients with high- or intermediate-risk primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.  Results Fifty-nine patients were treated, including 28 in the dose-escalation phase.  The max.-tolerated dose was 680 mg/d, and dose-limiting toxicity was a reversible and asymptomatic increase in the serum amylase level.  Forty-three patients (73%) continued treatment beyond six cycles; the median cumulative exposure to TG101348 was 380 days.  Adverse events included nausea, vomiting, diarrhea, anemia, and thrombocytopenia; corresponding grades 3 to 4 incidence rates were 3%, 3%, 10%, 35%, and 24%.  TG101348 treatment had modest effect on serum cytokine levels, but greater than half of the patients with early satiety, night sweats, fatigue, pruritus, and cough achieved rapid and durable improvement in these symptoms.  By six and 12 cycles of treatment, 39% and 47% of patients, resp., had achieved a spleen response per International Working Group criteria.  The majority of patients with leukocytosis or thrombocytosis at baseline (n = 28 and n = 10, resp.) achieved normalization of blood counts after six (57% and 90%, resp.) and 12 (56% and 88%, resp.) cycles.  A significant decrease in JAK2 V617F allele burden was obsd. at 6 mo in mutation-pos. patients (n = 51; P = .04), particularly in the subgroup with allele burden greater than 20% (n = 23; P < .01); the decrease was durable at 12 mo.  Conclusion TG101348 is well tolerated and produces significant redn. in disease burden and durable clin. benefit in patients with myelofibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH4BD7RVGmfLVg90H21EOLACvtfcHk0lhIbaa8a3lM9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktlelsL0%253D&md5=8b69a31d9dcf09b3b121e477f98d103b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.32.8021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.32.8021%26sid%3Dliteratum%253Aachs%26aulast%3DPardanani%26aufirst%3DA.%26aulast%3DGotlib%26aufirst%3DJ.%2BR.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DCortes%26aufirst%3DJ.%2BE.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DSilverman%26aufirst%3DM.%2BH.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DSchorr%26aufirst%3DJ.%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DSafety%2520and%2520Efficacy%2520of%2520TG101348%252C%2520a%2520Selective%2520JAK2%2520Inhibitor%252C%2520in%2520Myelofibrosis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D789%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shilling, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedza, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emm, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Punwani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvanitis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galya, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeleswaram, S.</span><span> </span><span class="NLM_article-title">Metabolism, Excretion, and Pharmacokinetics of [<sup>14</sup>C]INCB018424, a Selective Janus Tyrosine Kinase 1/2 Inhibitor, in Humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">2023</span><span class="NLM_x">–</span> <span class="NLM_lpage">2031</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=2023-2031&author=A.+D.+Shillingauthor=F.+M.+Nedzaauthor=T.+Emmauthor=S.+Diamondauthor=E.+McKeeverauthor=N.+Punwaniauthor=W.+Williamsauthor=A.+Arvanitisauthor=L.+G.+Galyaauthor=M.+Liauthor=S.+Shepardauthor=J.+Rodgersauthor=T.-Y.+Yueauthor=S.+Yeleswaram&title=Metabolism%2C+Excretion%2C+and+Pharmacokinetics+of+%5B14C%5DINCB018424%2C+a+Selective+Janus+Tyrosine+Kinase+1%2F2+Inhibitor%2C+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShilling%26aufirst%3DA.%2BD.%26aulast%3DNedza%26aufirst%3DF.%2BM.%26aulast%3DEmm%26aufirst%3DT.%26aulast%3DDiamond%26aufirst%3DS.%26aulast%3DMcKeever%26aufirst%3DE.%26aulast%3DPunwani%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DW.%26aulast%3DArvanitis%26aufirst%3DA.%26aulast%3DGalya%26aufirst%3DL.%2BG.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DJ.%26aulast%3DYue%26aufirst%3DT.-Y.%26aulast%3DYeleswaram%26aufirst%3DS.%26atitle%3DMetabolism%252C%2520Excretion%252C%2520and%2520Pharmacokinetics%2520of%2520%255B14C%255DINCB018424%252C%2520a%2520Selective%2520Janus%2520Tyrosine%2520Kinase%25201%252F2%2520Inhibitor%252C%2520in%2520Humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D2023%26epage%3D2031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> Ruxolitinib was granted approval by the United States Food and Drug administration on November 16,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">, </span>: <a href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm280102.htm" class="extLink">http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm280102.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Ruxolitinib+was+granted+approval+by+the+United+States+Food+and+Drug+administration+on+November+16%2C+2011%2C+%3A+http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm280102.htm."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Hevdat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozgit, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowolik, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morosini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=487-497&author=M.+Hevdatauthor=D.+Huszarauthor=A.+Herrmannauthor=J.+M.+Gozgitauthor=A.+Schroederauthor=A.+Sheehyauthor=R.+Buettnerauthor=D.+Proiaauthor=C.+M.+Kowolikauthor=H.+Xinauthor=B.+Armstrongauthor=G.+Bebernitzauthor=S.+Wengauthor=L.+Wangauthor=M.+Yeauthor=K.+McEachernauthor=H.+Chenauthor=D.+Morosiniauthor=K.+Bellauthor=M.+Alimzhanovauthor=S.+Ioannidisauthor=P.+McCoonauthor=Z.+A.+Caoauthor=H.+Yuauthor=R.+Joveauthor=M.+Zinda&title=The+JAK2+Inhibitor+AZD1480+Potently+Blocks+Stat3+Signaling+and+Oncogenesis+in+Solid+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHevdat%26aufirst%3DM.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DHerrmann%26aufirst%3DA.%26aulast%3DGozgit%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DA.%26aulast%3DSheehy%26aufirst%3DA.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DProia%26aufirst%3DD.%26aulast%3DKowolik%26aufirst%3DC.%2BM.%26aulast%3DXin%26aufirst%3DH.%26aulast%3DArmstrong%26aufirst%3DB.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DWeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DMcEachern%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DMorosini%26aufirst%3DD.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DMcCoon%26aufirst%3DP.%26aulast%3DCao%26aufirst%3DZ.%2BA.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DThe%2520JAK2%2520Inhibitor%2520AZD1480%2520Potently%2520Blocks%2520Stat3%2520Signaling%2520and%2520Oncogenesis%2520in%2520Solid%2520Tumors%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D16%26spage%3D487%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hexner, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serdikoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swider, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrzanski, P.</span><span> </span><span class="NLM_article-title">Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">5663</span><span class="NLM_x">–</span> <span class="NLM_lpage">5671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=5663-5671&author=E.+O.+Hexnerauthor=C.+Serdikoffauthor=M.+Janauthor=C.+R.+Swiderauthor=C.+Robinsonauthor=S.+Yangauthor=T.+Angelesauthor=S.+G.+Emersonauthor=M.+Carrollauthor=B.+Ruggeriauthor=P.+Dobrzanski&title=Lestaurtinib+%28CEP701%29+is+a+JAK2+inhibitor+that+suppresses+JAK2%2FSTAT5+signaling+and+the+proliferation+of+primary+erythroid+cells+from+patients+with+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHexner%26aufirst%3DE.%2BO.%26aulast%3DSerdikoff%26aufirst%3DC.%26aulast%3DJan%26aufirst%3DM.%26aulast%3DSwider%26aufirst%3DC.%2BR.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DAngeles%26aufirst%3DT.%26aulast%3DEmerson%26aufirst%3DS.%2BG.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DDobrzanski%26aufirst%3DP.%26atitle%3DLestaurtinib%2520%2528CEP701%2529%2520is%2520a%2520JAK2%2520inhibitor%2520that%2520suppresses%2520JAK2%252FSTAT5%2520signaling%2520and%2520the%2520proliferation%2520of%2520primary%2520erythroid%2520cells%2520from%2520patients%2520with%2520myeloproliferative%2520disorders%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D5663%26epage%3D5671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">William, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaraj, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan E. Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaraman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasha, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethirajulu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span> </span><span class="NLM_article-title">Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus 2/Fms-like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and Lymphoma</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4638</span><span class="NLM_x">–</span> <span class="NLM_lpage">4658</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200326p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4638-4658&author=A.+D.+Williamauthor=A.+C.-H.+Leeauthor=S.+Blanchardauthor=A.+Poulsenauthor=E.+L.+Teoauthor=H.+Nagarajauthor=D.+Tan+E.+Chenauthor=M.+Williamsauthor=E.+T.+Sunauthor=K.+C.+Gohauthor=W.+C.+Ongauthor=S.+K.+Gohauthor=S.+Hartauthor=R.+Jayaramanauthor=M.+K.+Pashaauthor=K.+Ethirajuluauthor=J.+M.+Woodauthor=B.+W.+Dymock&title=Discovery+of+the+Macrocycle+11-%282-Pyrrolidin-1-yl-ethoxy%29-14%2C19-dioxa-5%2C7%2C26-triaza-tetracyclo%5B19.3.1.1%282%2C6%29.1%288%2C12%29%5Dheptacosa-1%2825%29%2C2%2826%29%2C3%2C5%2C8%2C10%2C12%2827%29%2C16%2C21%2C23-decaene+%28SB1518%29%2C+a+Potent+Janus+2%2FFms-like+Tyrosine+Kinase-3+%28JAK2%2FFLT3%29+Inhibitor+for+the+Treatment+of+Myelofibrosis+and+Lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm200326p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200326p%26sid%3Dliteratum%253Aachs%26aulast%3DWilliam%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DA.%2BC.-H.%26aulast%3DBlanchard%26aufirst%3DS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DTeo%26aufirst%3DE.%2BL.%26aulast%3DNagaraj%26aufirst%3DH.%26aulast%3DTan%2BE.%2BChen%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DE.%2BT.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DOng%26aufirst%3DW.%2BC.%26aulast%3DGoh%26aufirst%3DS.%2BK.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DPasha%26aufirst%3DM.%2BK.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DDiscovery%2520of%2520the%2520Macrocycle%252011-%25282-Pyrrolidin-1-yl-ethoxy%2529-14%252C19-dioxa-5%252C7%252C26-triaza-tetracyclo%255B19.3.1.1%25282%252C6%2529.1%25288%252C12%2529%255Dheptacosa-1%252825%2529%252C2%252826%2529%252C3%252C5%252C8%252C10%252C12%252827%2529%252C16%252C21%252C23-decaene%2520%2528SB1518%2529%252C%2520a%2520Potent%2520Janus%25202%252FFms-like%2520Tyrosine%2520Kinase-3%2520%2528JAK2%252FFLT3%2529%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Myelofibrosis%2520and%2520Lymphoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4638%26epage%3D4658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Püllmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, S.</span><span> </span><span class="NLM_article-title">Synthetic Access to 2-Amido-5-aryl-8-methoxy-triazolopyridine and 2-Amido-5-morpholino-8-methoxy-triazolopyridine Derivatives as Potential Inhibitors of the Adenosine Receptor Subtypes</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">1649</span><span class="NLM_x">–</span> <span class="NLM_lpage">1652</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1055%2Fs-2003-40874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFWqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=1649-1652&author=M.+Nettekovenauthor=B.+P%C3%BCllmannauthor=S.+Schmitt&title=Synthetic+Access+to+2-Amido-5-aryl-8-methoxy-triazolopyridine+and+2-Amido-5-morpholino-8-methoxy-triazolopyridine+Derivatives+as+Potential+Inhibitors+of+the+Adenosine+Receptor+Subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic access to 2-amido-5-aryl-8-methoxy-triazolopyridine and 2-amido-5-morpholino-8-methoxy-triazolopyridine derivatives as potential inhibitors of the adenosine receptor subtypes</span></div><div class="casAuthors">Nettekoven, Matthias; Puellmann, Bernd; Schmitt, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1649-1652</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Two versatile and complementary synthetic strategies towards 2-amido-5-aryl-8-methoxy-triazolopyridine derivs. and 2-amido-5-morpholino-8-methoxy-triazolopyridine derivs. in five steps are presented.  The key step in each synthetic route can be constituted as the formation of the resp. triazolopyridine deriv. precursors in 78% and 57% yield, resp., through an intermediately formed 4H-[1,2,4]oxadiazol-5-one.  The final Suzuki coupling/amidation allowed the straightforward access to the desired triazolopyridine derivs. which have not been described previously.  Notably, these triazolopyridine-scaffold bears three vectors of diversity which offer max. flexibility in design and combinatorial synthesis of mols. with a potentially useful inhibitory activity towards adenosine receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8zGEeUmY80bVg90H21EOLACvtfcHk0lhe-YNep9tZZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFWqsrw%253D&md5=4114db7a6d5bfbceebbff9f0e3c79434</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1055%2Fs-2003-40874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2003-40874%26sid%3Dliteratum%253Aachs%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DP%25C3%25BCllmann%26aufirst%3DB.%26aulast%3DSchmitt%26aufirst%3DS.%26atitle%3DSynthetic%2520Access%2520to%25202-Amido-5-aryl-8-methoxy-triazolopyridine%2520and%25202-Amido-5-morpholino-8-methoxy-triazolopyridine%2520Derivatives%2520as%2520Potential%2520Inhibitors%2520of%2520the%2520Adenosine%2520Receptor%2520Subtypes%26jtitle%3DSynthesis%26date%3D2003%26spage%3D1649%26epage%3D1652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zificsak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, D. D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theroff, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieu, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underiner, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saville, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husten, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Kane, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrzanski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span> </span><span class="NLM_article-title">Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=133-137&author=C.+A.+Zificsakauthor=D.+E.+Gingrichauthor=H.+J.+Breslinauthor=D.+D+Dunnauthor=K.+L.+Milkiewiczauthor=J.+P.+Theroffauthor=T.+V.+Thieuauthor=T.+L.+Underinerauthor=L.+R.+Weinbergauthor=L.+D.+Aimoneauthor=M.+S.+Albomauthor=J.+L.+Masonauthor=L.+Savilleauthor=J.+Hustenauthor=T.+S.+Angelesauthor=J.+P.+Finnauthor=M.+Janauthor=T.+M.+O%E2%80%99Kaneauthor=P.+Dobrzanskiauthor=B.+D.+Dorsey&title=Optimization+of+a+novel+kinase+inhibitor+scaffold+for+the+dual+inhibition+of+JAK2+and+FAK+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZificsak%26aufirst%3DC.%2BA.%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DBreslin%26aufirst%3DH.%2BJ.%26aulast%3DDunn%26aufirst%3DD.%2BD%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DTheroff%26aufirst%3DJ.%2BP.%26aulast%3DThieu%26aufirst%3DT.%2BV.%26aulast%3DUnderiner%26aufirst%3DT.%2BL.%26aulast%3DWeinberg%26aufirst%3DL.%2BR.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DMason%26aufirst%3DJ.%2BL.%26aulast%3DSaville%26aufirst%3DL.%26aulast%3DHusten%26aufirst%3DJ.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DFinn%26aufirst%3DJ.%2BP.%26aulast%3DJan%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Kane%26aufirst%3DT.%2BM.%26aulast%3DDobrzanski%26aufirst%3DP.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DOptimization%2520of%2520a%2520novel%2520kinase%2520inhibitor%2520scaffold%2520for%2520the%2520dual%2520inhibition%2520of%2520JAK2%2520and%2520FAK%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D133%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Weinberg, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisko, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieu, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underiner, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells-Knect, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span> </span><span class="NLM_article-title">2,7-Pyrrolo[2,1-<i>f</i>][1,2,4]triazines as JAK2 inhibitors: modification of target structure to minimize reactive metabolite formation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7325</span><span class="NLM_x">–</span> <span class="NLM_lpage">7330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7325-7330&author=L.+R.+Weinbergauthor=M.+S.+Albomauthor=T.+S.+Angelesauthor=H.+J.+Breslinauthor=D.+E.+Gingrichauthor=Z.+Huangauthor=J.+G.+Liskoauthor=J.+L.+Masonauthor=K.+L.+Milkiewiczauthor=T.+T.+Thieuauthor=T.+L.+Underinerauthor=G.+J.+Wellsauthor=K.+J.+Wells-Knectauthor=B.+D.+Dorsey&title=2%2C7-Pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazines+as+JAK2+inhibitors%3A+modification+of+target+structure+to+minimize+reactive+metabolite+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberg%26aufirst%3DL.%2BR.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DBreslin%26aufirst%3DH.%2BJ.%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLisko%26aufirst%3DJ.%2BG.%26aulast%3DMason%26aufirst%3DJ.%2BL.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DThieu%26aufirst%3DT.%2BT.%26aulast%3DUnderiner%26aufirst%3DT.%2BL.%26aulast%3DWells%26aufirst%3DG.%2BJ.%26aulast%3DWells-Knect%26aufirst%3DK.%2BJ.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3D2%252C7-Pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2520as%2520JAK2%2520inhibitors%253A%2520modification%2520of%2520target%2520structure%2520to%2520minimize%2520reactive%2520metabolite%2520formation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D7325%26epage%3D7330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Potts, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, J.</span><span> </span><span class="NLM_article-title">Derivatives of <i>s</i>-Triazolo[1,5-<i>a</i>]pyridine Ring System</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01339a058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1966&pages=260-265&author=K.+T.+Pottsauthor=H.+R.+Burtonauthor=J.+Bhattacharyya&title=Derivatives+of+s-Triazolo%5B1%2C5-a%5Dpyridine+Ring+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjo01339a058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01339a058%26sid%3Dliteratum%253Aachs%26aulast%3DPotts%26aufirst%3DK.%2BT.%26aulast%3DBurton%26aufirst%3DH.%2BR.%26aulast%3DBhattacharyya%26aufirst%3DJ.%26atitle%3DDerivatives%2520of%2520s-Triazolo%255B1%252C5-a%255Dpyridine%2520Ring%2520System%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1966%26volume%3D31%26spage%3D260%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Potts, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, S. K.</span><span> </span><span class="NLM_article-title">Reactions of the <i>s</i>-Triazolo[4,3-<i>a</i>]pyridine Ring System</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01339a059" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1966&pages=265-273&author=K.+T.+Pottsauthor=H.+R.+Burtonauthor=S.+K.+Roy&title=Reactions+of+the+s-Triazolo%5B4%2C3-a%5Dpyridine+Ring+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjo01339a059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01339a059%26sid%3Dliteratum%253Aachs%26aulast%3DPotts%26aufirst%3DK.%2BT.%26aulast%3DBurton%26aufirst%3DH.%2BR.%26aulast%3DRoy%26aufirst%3DS.%2BK.%26atitle%3DReactions%2520of%2520the%2520s-Triazolo%255B4%252C3-a%255Dpyridine%2520Ring%2520System%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1966%26volume%3D31%26spage%3D265%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Potts, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surapaneni, C. R.</span><span> </span><span class="NLM_article-title">1,2,4-Triazoles. XXV. The Effect of Pyridine Substitution on the Isomerization of <i>s</i>-Triazolo[4,3-<i>a</i>]pyridines into <i>s</i>-Triazolo[1,5-<i>a</i>]pyridines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1970&pages=1019-1027&author=K.+T.+Pottsauthor=C.+R.+Surapaneni&title=1%2C2%2C4-Triazoles.+XXV.+The+Effect+of+Pyridine+Substitution+on+the+Isomerization+of+s-Triazolo%5B4%2C3-a%5Dpyridines+into+s-Triazolo%5B1%2C5-a%5Dpyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPotts%26aufirst%3DK.%2BT.%26aulast%3DSurapaneni%26aufirst%3DC.%2BR.%26atitle%3D1%252C2%252C4-Triazoles.%2520XXV.%2520The%2520Effect%2520of%2520Pyridine%2520Substitution%2520on%2520the%2520Isomerization%2520of%2520s-Triazolo%255B4%252C3-a%255Dpyridines%2520into%2520s-Triazolo%255B1%252C5-a%255Dpyridines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1970%26volume%3D7%26spage%3D1019%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Verček, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogorevc, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanovnik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tišler, M.</span><span> </span><span class="NLM_article-title">Cyanoamino Compounds in Synthesis: Syntheses of Some Heterocycles</span> <span class="citation_source-journal">Monatsch. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">798</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1007%2FBF01134190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADyaL2cXltFGitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1983&pages=789-798&author=B.+Ver%C4%8Dekauthor=B.+Ogorevcauthor=B.+Stanovnikauthor=M.+Ti%C5%A1ler&title=Cyanoamino+Compounds+in+Synthesis%3A+Syntheses+of+Some+Heterocycles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Cyanoamino compounds in synthesis.  Syntheses of some heterocycles</span></div><div class="casAuthors">Vercek, Bojan; Ogorevc, Bozidar; Stanovnik, Branko; Tisler, Miha</div><div class="citationInfo"><span class="NLM_cas:title">Monatshefte fuer Chemie</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">789-98</span>CODEN:
                <span class="NLM_cas:coden">MOCMB7</span>;
        ISSN:<span class="NLM_cas:issn">0026-9247</span>.
    </div><div class="casAbstract">Transformations of some heterocyclic cyanoamino compds. leading to various heterocyclic systems are described.  s-Triazolo[1,5-a]azines, e.g. I, II, and III, are obtained either in a direct synthetic approach or via the substituted aminotetrazoles, substituted 3-amino-5-oxo-1,2,4-oxadiazolines, and from N-ethoxycarbonyl N'-heteroaryl thioureas or N-heteroaryl N'-hydroxyguanidine.  Thus, 2-(cyanoamino)pyridine cyclized with Me3SiN3 to give the tetrazole IV, which was cyclized with polyphosphoric acid to give I.  The cyanoamino group reacts also with o-difunctional benzenes to give the corresponding substituted derivs. of benzimidazole, benzoxazole or benzothiazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovqVshQOSm87Vg90H21EOLACvtfcHk0lhj-nkUkSXwpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXltFGitQ%253D%253D&md5=32d36961bd0e42a34b73bbed4268a553</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1007%2FBF01134190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01134190%26sid%3Dliteratum%253Aachs%26aulast%3DVer%25C4%258Dek%26aufirst%3DB.%26aulast%3DOgorevc%26aufirst%3DB.%26aulast%3DStanovnik%26aufirst%3DB.%26aulast%3DTi%25C5%25A1ler%26aufirst%3DM.%26atitle%3DCyanoamino%2520Compounds%2520in%2520Synthesis%253A%2520Syntheses%2520of%2520Some%2520Heterocycles%26jtitle%3DMonatsch.%2520Chem.%26date%3D1983%26volume%3D114%26spage%3D789%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Bell, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanwick, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graupner, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. A.</span><span> </span><span class="NLM_article-title">Application of the Tisler Triazolopyrimidine Cyclization to the Synthesis of a Crop Protection Agent and an Intermediate</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1167</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span></span><div class="citationLinks">[<a href="/doi/10.1021/op0601518" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=1167-1171&author=B.+M.+Bellauthor=P.+E.+Fanwickauthor=P.+R.+Graupnerauthor=G.+A.+Roth&title=Application+of+the+Tisler+Triazolopyrimidine+Cyclization+to+the+Synthesis+of+a+Crop+Protection+Agent+and+an+Intermediate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fop0601518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop0601518%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DB.%2BM.%26aulast%3DFanwick%26aufirst%3DP.%2BE.%26aulast%3DGraupner%26aufirst%3DP.%2BR.%26aulast%3DRoth%26aufirst%3DG.%2BA.%26atitle%3DApplication%2520of%2520the%2520Tisler%2520Triazolopyrimidine%2520Cyclization%2520to%2520the%2520Synthesis%2520of%2520a%2520Crop%2520Protection%2520Agent%2520and%2520an%2520Intermediate%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2006%26volume%3D10%26spage%3D1167%26epage%3D1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Swinnen, D.; Jorand-Lebrun, C.; Grippi-Vallotton, T.; Muzerelle, M.; Royle, A.; Macritchie, J; Hill, R.; Shaw, J. P.</span><span> </span><span class="NLM_article-title">Preparation of triazolopyridines as apoptosis signal-regulating kinase (ASK) inhibitors for treatment of autoimmune, inflammatory, cardiovascular, and/or neurodegenerative diseases</span>. Patent WO2009/027283A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+Swinnen&author=C.+Jorand-Lebrun&author=T.+Grippi-Vallotton&author=M.+Muzerelle&author=A.+Royle&author=J+Macritchie&author=R.+Hill&author=J.+P.+Shaw&title=Preparation+of+triazolopyridines+as+apoptosis+signal-regulating+kinase+%28ASK%29+inhibitors+for+treatment+of+autoimmune%2C+inflammatory%2C+cardiovascular%2C+and%2For+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSwinnen%26aufirst%3DD.%26atitle%3DPreparation%2520of%2520triazolopyridines%2520as%2520apoptosis%2520signal-regulating%2520kinase%2520%2528ASK%2529%2520inhibitors%2520for%2520treatment%2520of%2520autoimmune%252C%2520inflammatory%252C%2520cardiovascular%252C%2520and%252For%2520neurodegenerative%2520diseases%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broudy, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span> </span><span class="NLM_article-title">Novel N<sup>9</sup>-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4907</span><span class="NLM_x">–</span> <span class="NLM_lpage">4912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4907-4912&author=Y.+Wangauthor=W.+C.+Shakespeareauthor=W.-S.+Huangauthor=R.+Sundaramoorthiauthor=S.+Lentiniauthor=S.+Dasauthor=S.+Liuauthor=G.+Bandaauthor=D.+Wenauthor=X.+Zhuauthor=Q.+Xuauthor=J.+Keatsauthor=F.+Wangauthor=S.+Wardwellauthor=Y.+Ningauthor=J.+T.+Snodgrassauthor=M.+I.+Broudyauthor=K.+Russianauthor=D.+Dalgarnoauthor=T.+Clacksonauthor=T.+K.+Sawyer&title=Novel+N9-arenethenyl+purines+as+potent+dual+Src%2FAbl+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DHuang%26aufirst%3DW.-S.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DLentini%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DBanda%26aufirst%3DG.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWardwell%26aufirst%3DS.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DSnodgrass%26aufirst%3DJ.%2BT.%26aulast%3DBroudy%26aufirst%3DM.%2BI.%26aulast%3DRussian%26aufirst%3DK.%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DClackson%26aufirst%3DT.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26atitle%3DNovel%2520N9-arenethenyl%2520purines%2520as%2520potent%2520dual%2520Src%252FAbl%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4907%26epage%3D4912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shakespeare, W. C.; Metcalf, C. A.; Sawyer, T. K.; Wang, Y.; Sundaramoorthi, R.; Dalgarno, D. C.; Bohacek, R.; Weigele, M.</span><span> </span><span class="NLM_article-title">Substituted Purine Derivatives</span>. Patent WO2005/009348A2,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=W.+C.+Shakespeare&author=C.+A.+Metcalf&author=T.+K.+Sawyer&author=Y.+Wang&author=R.+Sundaramoorthi&author=D.+C.+Dalgarno&author=R.+Bohacek&author=M.+Weigele&title=Substituted+Purine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26atitle%3DSubstituted%2520Purine%2520Derivatives%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">Kinase selectivity was determined using the Ambit Bioscience KINOMEscan technology, and is expressed as S(90), the fraction of kinases inhibited ≥90% when screened at 1 μM across a panel of 402 kinases.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kinase+selectivity+was+determined+using+the+Ambit+Bioscience+KINOMEscan+technology%2C+and+is+expressed+as+S%2890%29%2C+the+fraction+of+kinases+inhibited+%E2%89%A590%25+when+screened+at+1+%CE%BCM+across+a+panel+of+402+kinases."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A Quantitative Analysis of Kinase Inhibitor Selectivity</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+Quantitative+Analysis+of+Kinase+Inhibitor+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0liwmEOX-2Ve4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520Quantitative%2520Analysis%2520of%2520Kinase%2520Inhibitor%2520Selectivity%26jtitle%3DNature%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Cochet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frelin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyron, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbert, V.</span><span> </span><span class="NLM_article-title">Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1016%2Fj.cellsig.2005.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=15967637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlags73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=449-455&author=O.+Cochetauthor=C.+Frelinauthor=J.-F.+Peyronauthor=V.+Imbert&title=Constitutive+activation+of+STAT+proteins+in+the+HDLM-2+and+L540+Hodgkin+lymphoma-derived+cell+lines+supports+cell+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival</span></div><div class="casAuthors">Cochet, Olivia; Frelin, Catherine; Peyron, Jean-Francois; Imbert, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">449-455</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Survival and proliferation of Hodgkin lymphoma (HL) cells are influenced by many cytokines produced by different cell types in the lymph node microenvironment.  STAT, family of transcription factors, are key mediators of cytokine signaling and their perturbation contributes to various human diseases.  Electrophoretic mobility shift and phosphoprotein immunoblotting analyses were used to study STAT activation in HL cell lines.  We thus obsd. high levels of constitutively activated STAT1, 3, 5 and 6 in HDLM-2 and L540 cells, which could be correlated with JAK kinase activation.  In contrast KM-H2 cells did not display STAT activation.  Preventing constitutive STAT activation by specific JAK kinases inhibitors induced apoptosis of HL cell lines and was assocd. with a strong decrease in the expression of the anti-apoptotic genes IAP-1, IAP-2, Bcl-xL, Bfl1 and Traf1.  Silencing of JAKs by specific siRNAs also induced apoptosis of HL cells.  Altogether, these results suggest that aberrant STAT activation in Hodgkin cells may promote cell survival and as a consequence facilitate oncogenic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX0KpnosM2tLVg90H21EOLACvtfcHk0liwmEOX-2Ve4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlags73P&md5=5049f7b6501bf012c8247b608eb9468c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2005.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2005.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DCochet%26aufirst%3DO.%26aulast%3DFrelin%26aufirst%3DC.%26aulast%3DPeyron%26aufirst%3DJ.-F.%26aulast%3DImbert%26aufirst%3DV.%26atitle%3DConstitutive%2520activation%2520of%2520STAT%2520proteins%2520in%2520the%2520HDLM-2%2520and%2520L540%2520Hodgkin%2520lymphoma-derived%2520cell%2520lines%2520supports%2520cell%2520survival%26jtitle%3DCell.%2520Signalling%26date%3D2006%26volume%3D18%26spage%3D449%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stump, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrzanski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serdikoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugan, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavey, M. M.</span><span> </span><span class="NLM_article-title">A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Res. Ther..</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">R68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=R68&author=K.+L.+Stumpauthor=L.+D.+Luauthor=P.+Dobrzanskiauthor=C.+Serdikoffauthor=D.+E.+Gingrichauthor=B.+J.+Duganauthor=T.+S.+Angelesauthor=M.+S.+Albomauthor=M.+A.+Atorauthor=B.+D.+Dorseyauthor=B.+A.+Ruggeriauthor=M.+M.+Seavey&title=A+highly+selective%2C+orally+active+inhibitor+of+Janus+kinase+2%2C+CEP-33779%2C+ablates+disease+in+two+mouse+models+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStump%26aufirst%3DK.%2BL.%26aulast%3DLu%26aufirst%3DL.%2BD.%26aulast%3DDobrzanski%26aufirst%3DP.%26aulast%3DSerdikoff%26aufirst%3DC.%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DDugan%26aufirst%3DB.%2BJ.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DSeavey%26aufirst%3DM.%2BM.%26atitle%3DA%2520highly%2520selective%252C%2520orally%2520active%2520inhibitor%2520of%2520Janus%2520kinase%25202%252C%2520CEP-33779%252C%2520ablates%2520disease%2520in%2520two%2520mouse%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Res.%2520Ther..%26date%3D2011%26volume%3D13%26spage%3DR68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Seavey, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stump, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, N. H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockeimer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Kane, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrzanski, P.</span><span> </span><span class="NLM_article-title">Therapeutic Efficacy of CEP-33779, a Novel Selective JAK2 Inhibitor, in a Mouse Model of Colitis-induced Colorectal Cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">984</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1158%2F1535-7163.MCT-11-0951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=22334590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BC38Xltl2nurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=984-993&author=M.+M.+Seaveyauthor=L.+D.+Luauthor=K.+L.+Stumpauthor=N.+H+Wallaceauthor=W.+Hockeimerauthor=T.+M.+O%E2%80%99Kaneauthor=B.+Ruggeriauthor=P.+Dobrzanski&title=Therapeutic+Efficacy+of+CEP-33779%2C+a+Novel+Selective+JAK2+Inhibitor%2C+in+a+Mouse+Model+of+Colitis-induced+Colorectal+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Efficacy of CEP-33779, a Novel Selective JAK2 Inhibitor, in a Mouse Model of Colitis-Induced Colorectal Cancer</span></div><div class="casAuthors">Seavey, Matthew M.; Lu, Lily D.; Stump, Kristine L.; Wallace, Nate H.; Hockeimer, William; O'Kane, Teresa M.; Ruggeri, Bruce A.; Dobrzanski, Pawel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">984-993</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Constitutively activated STAT3 and STAT5 are expressed in a wide variety of human malignancies including solid and hematopoietic cancers and often correlate with a poor prognosis and resistance to multiple therapies.  Given the well established role of STAT3 in tumorigenesis, inhibition of Janus-activated kinase 2 (JAK2) activity might represent an attractive therapeutic approach.  Using a mouse model of colitis-induced colorectal cancer, we show that a novel, orally active, selective JAK2 inhibitor, CEP-33779, induced regression of established colorectal tumors, reduced angiogenesis, and reduced proliferation of tumor cells.  Histopathol. anal. confirmed reduced incidence of histol.-grade neoplasia by CEP-33779.  Tumor regression correlated with inhibition of STAT3 and NF-κB (RelA/p65) activation in a CEP-33779 dose-dependent manner.  In addn., the expression of proinflammatory, tumor-promoting cytokines interleukin (IL)-6 and IL-1β was strongly reduced upon JAK2 inhibition.  The ability of CEP-33779 to suppress growth of colorectal tumors by inhibiting the IL-6/JAK2/STAT3 signaling suggests a potential therapeutic utility of JAK2 inhibitors in multiple tumors types, particularly those with a strong inflammatory component.  Mol Cancer Ther; 11(4); 984-93.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeQ4DKhzneDrVg90H21EOLACvtfcHk0liOnEZ9MYYqzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xltl2nurs%253D&md5=90ce0ad4784ca0cf199439224e4c59e3</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0951%26sid%3Dliteratum%253Aachs%26aulast%3DSeavey%26aufirst%3DM.%2BM.%26aulast%3DLu%26aufirst%3DL.%2BD.%26aulast%3DStump%26aufirst%3DK.%2BL.%26aulast%3DWallace%26aufirst%3DN.%2BH%26aulast%3DHockeimer%26aufirst%3DW.%26aulast%3DO%25E2%2580%2599Kane%26aufirst%3DT.%2BM.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DDobrzanski%26aufirst%3DP.%26atitle%3DTherapeutic%2520Efficacy%2520of%2520CEP-33779%252C%2520a%2520Novel%2520Selective%2520JAK2%2520Inhibitor%252C%2520in%2520a%2520Mouse%2520Model%2520of%2520Colitis-induced%2520Colorectal%2520Cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D984%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mason, J., L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holskin, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span> </span><span class="NLM_article-title">Modification of CellSensor Irf1-bla TF-1 and Irf1-bla HEL Assays for Direct Comparison of Wild-type JAK2 and JAK2 V617F Inhibition</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=311-318&author=J.%2C+L.+Masonauthor=B.+P.+Holskinauthor=K.+A.+Murrayauthor=S.+L.+Meyerauthor=M.+A.+Atorauthor=T.+S.+Angeles&title=Modification+of+CellSensor+Irf1-bla+TF-1+and+Irf1-bla+HEL+Assays+for+Direct+Comparison+of+Wild-type+JAK2+and+JAK2+V617F+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%252C%2BL.%26aulast%3DHolskin%26aufirst%3DB.%2BP.%26aulast%3DMurray%26aufirst%3DK.%2BA.%26aulast%3DMeyer%26aufirst%3DS.%2BL.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26atitle%3DModification%2520of%2520CellSensor%2520Irf1-bla%2520TF-1%2520and%2520Irf1-bla%2520HEL%2520Assays%2520for%2520Direct%2520Comparison%2520of%2520Wild-type%2520JAK2%2520and%2520JAK2%2520V617F%2520Inhibition%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2011%26volume%3D9%26spage%3D311%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15a','cit15b'],'ref16':['cit16a','cit16b','cit16c','cit16d'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 36 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Sowmya Ramaswamy Krishnan, Navneet Bung, Gopalakrishnan Bulusu, <span class="NLM_string-name hlFld-ContribAuthor">Arijit Roy</span>. </span><span class="cited-content_cbyCitation_article-title">Accelerating De Novo Drug Design against Novel Proteins Using Deep Learning. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (2)
                                     , 621-630. <a href="https://doi.org/10.1021/acs.jcim.0c01060" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c01060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c01060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c01060%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAccelerating%252BDe%252BNovo%252BDrug%252BDesign%252Bagainst%252BNovel%252BProteins%252BUsing%252BDeep%252BLearning%26aulast%3DKrishnan%26aufirst%3DSowmya%2BRamaswamy%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D10092020%26date%3D25012021%26volume%3D61%26issue%3D2%26spage%3D621%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yahui Huang, Guoqiang Dong, Huanqiu Li, Na Liu, Wannian Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Chunquan Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 6056-6074. <a href="https://doi.org/10.1021/acs.jmedchem.8b00393" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00393%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BJanus%252BKinase%252B2%252B%252528JAK2%252529%252Band%252BHistone%252BDeacetylase%252B%252528HDAC%252529%252BDual%252BInhibitors%252Bas%252Ba%252BNovel%252BStrategy%252Bfor%252Bthe%252BCombinational%252BTreatment%252Bof%252BLeukemia%252Band%252BInvasive%252BFungal%252BInfections%26aulast%3DHuang%26aufirst%3DYahui%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10032018%26date%3D14072018%26date%3D25062018%26volume%3D61%26issue%3D14%26spage%3D6056%26epage%3D6074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Komala  Pandurangan</span>, <span class="hlFld-ContribAuthor ">Anna B.  Aletti</span>, <span class="hlFld-ContribAuthor ">Devis  Montroni</span>, <span class="hlFld-ContribAuthor ">Jonathan. A.  Kitchen</span>, <span class="hlFld-ContribAuthor ">Miguel  Martínez-Calvo</span>, <span class="hlFld-ContribAuthor ">Salvador  Blasco</span>, <span class="hlFld-ContribAuthor ">Thorfinnur  Gunnlaugsson</span>, and <span class="hlFld-ContribAuthor ">Eoin M.  Scanlan</span>  . </span><span class="cited-content_cbyCitation_article-title">Supramolecular Anion Recognition Mediates One-Pot Synthesis of 3-Amino-[1,2,4]-triazolo Pyridines from Thiosemicarbazides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (5)
                                     , 1068-1071. <a href="https://doi.org/10.1021/acs.orglett.6b03645" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b03645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b03645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b03645%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSupramolecular%252BAnion%252BRecognition%252BMediates%252BOne-Pot%252BSynthesis%252Bof%252B3-Amino-%25255B1%25252C2%25252C4%25255D-triazolo%252BPyridines%252Bfrom%252BThiosemicarbazides%26aulast%3DPandurangan%26aufirst%3DKomala%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10012017%26date%3D21022017%26date%3D03032017%26volume%3D19%26issue%3D5%26spage%3D1068%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel V.  Levy</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Sclafani</span>, and <span class="hlFld-ContribAuthor ">Roger P.  Bakale</span>  . </span><span class="cited-content_cbyCitation_article-title">An Improved Synthesis of the Free Base and Diglycolate Salt of CEP-33779; A Janus Kinase 2 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2016,</strong> <em>20 </em>
                                    (12)
                                     , 2085-2091. <a href="https://doi.org/10.1021/acs.oprd.6b00311" title="DOI URL">https://doi.org/10.1021/acs.oprd.6b00311</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.6b00311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.6b00311%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DAn%252BImproved%252BSynthesis%252Bof%252Bthe%252BFree%252BBase%252Band%252BDiglycolate%252BSalt%252Bof%252BCEP-33779%25253B%252BA%252BJanus%252BKinase%252B2%252BInhibitor%26aulast%3DLevy%26aufirst%3DDaniel%2BV.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D20092016%26date%3D30112016%26date%3D16122016%26volume%3D20%26issue%3D12%26spage%3D2085%26epage%3D2091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Wang</span>, <span class="hlFld-ContribAuthor ">Gen-Cheng  Li</span>, <span class="hlFld-ContribAuthor ">Pankaj  Jain</span>, <span class="hlFld-ContribAuthor ">Marcus E.  Farmer</span>, <span class="hlFld-ContribAuthor ">Jian  He</span>, <span class="hlFld-ContribAuthor ">Peng-Xiang  Shen</span>, and <span class="hlFld-ContribAuthor ">Jin-Quan  Yu</span>  . </span><span class="cited-content_cbyCitation_article-title">Ligand-Promoted meta-C–H Amination and Alkynylation. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2016,</strong> <em>138 </em>
                                    (42)
                                     , 14092-14099. <a href="https://doi.org/10.1021/jacs.6b08942" title="DOI URL">https://doi.org/10.1021/jacs.6b08942</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.6b08942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.6b08942%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DLigand-Promoted%252Bmeta-C%2525E2%252580%252593H%252BAmination%252Band%252BAlkynylation%26aulast%3DWang%26aufirst%3DPeng%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D25082016%26date%3D13102016%26date%3D26102016%26date%3D07102016%26volume%3D138%26issue%3D42%26spage%3D14092%26epage%3D14099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dávid  Bajusz</span>, <span class="hlFld-ContribAuthor ">György G.  Ferenczy</span>, and <span class="hlFld-ContribAuthor ">György M.  Keserű</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (1)
                                     , 234-247. <a href="https://doi.org/10.1021/acs.jcim.5b00634" title="DOI URL">https://doi.org/10.1021/acs.jcim.5b00634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.5b00634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.5b00634%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BSubtype%252BSelective%252BJanus%252BKinase%252B%252528JAK%252529%252BInhibitors%252Bby%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DBajusz%26aufirst%3DD%25C3%25A1vid%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D18102015%26date%3D31122015%26date%3D25012016%26date%3D18122015%26volume%3D56%26issue%3D1%26spage%3D234%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lina  Song</span>, <span class="hlFld-ContribAuthor ">Xianhai  Tian</span>, <span class="hlFld-ContribAuthor ">Zhigang  Lv</span>, <span class="hlFld-ContribAuthor ">Ertong  Li</span>, <span class="hlFld-ContribAuthor ">Jie  Wu</span>, <span class="hlFld-ContribAuthor ">Yangxue  Liu</span>, <span class="hlFld-ContribAuthor ">Wenquan  Yu</span>, and <span class="hlFld-ContribAuthor ">Junbiao  Chang</span>  . </span><span class="cited-content_cbyCitation_article-title">I2/KI-Mediated Oxidative N–N Bond Formation for the Synthesis of 1,5-Fused 1,2,4-Triazoles from N-Aryl Amidines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (14)
                                     , 7219-7225. <a href="https://doi.org/10.1021/acs.joc.5b01183" title="DOI URL">https://doi.org/10.1021/acs.joc.5b01183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b01183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b01183%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DI2%25252FKI-Mediated%252BOxidative%252BN%2525E2%252580%252593N%252BBond%252BFormation%252Bfor%252Bthe%252BSynthesis%252Bof%252B1%25252C5-Fused%252B1%25252C2%25252C4-Triazoles%252Bfrom%252BN-Aryl%252BAmidines%26aulast%3DSong%26aufirst%3DLina%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D27052015%26date%3D06072015%26date%3D17072015%26date%3D26062015%26volume%3D80%26issue%3D14%26spage%3D7219%26epage%3D7225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Björn  Bartels</span>, <span class="hlFld-ContribAuthor ">Conor Gordon  Bolas</span>, <span class="hlFld-ContribAuthor ">Philipp  Cueni</span>, <span class="hlFld-ContribAuthor ">Serena  Fantasia</span>, <span class="hlFld-ContribAuthor ">Nicolas  Gaeng</span>, and <span class="hlFld-ContribAuthor ">Andrada Stefania  Trita</span>  . </span><span class="cited-content_cbyCitation_article-title">Cu-Catalyzed Aerobic Oxidative Cyclization of Guanidylpyridines and Derivatives. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (2)
                                     , 1249-1257. <a href="https://doi.org/10.1021/jo502536t" title="DOI URL">https://doi.org/10.1021/jo502536t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo502536t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo502536t%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCu-Catalyzed%252BAerobic%252BOxidative%252BCyclization%252Bof%252BGuanidylpyridines%252Band%252BDerivatives%26aulast%3DBartels%26aufirst%3DBj%25C3%25B6rn%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D06112014%26date%3D24122014%26date%3D16012015%26date%3D11122014%26volume%3D80%26issue%3D2%26spage%3D1249%26epage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zisheng  Zheng</span>, <span class="hlFld-ContribAuthor ">Shuangyu  Ma</span>, <span class="hlFld-ContribAuthor ">Linlin  Tang</span>, <span class="hlFld-ContribAuthor ">Daisy  Zhang-Negrerie</span>, <span class="hlFld-ContribAuthor ">Yunfei  Du</span>, and <span class="hlFld-ContribAuthor ">Kang  Zhao</span>  . </span><span class="cited-content_cbyCitation_article-title">PhI(OCOCF3)2-Mediated Intramolecular Oxidative N–N Bond Formation: Metal-Free Synthesis of 1,2,4-Triazolo[1,5-a]pyridines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (10)
                                     , 4687-4693. <a href="https://doi.org/10.1021/jo500298j" title="DOI URL">https://doi.org/10.1021/jo500298j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo500298j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo500298j%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPhI%252528OCOCF3%2525292-Mediated%252BIntramolecular%252BOxidative%252BN%2525E2%252580%252593N%252BBond%252BFormation%25253A%252BMetal-Free%252BSynthesis%252Bof%252B1%25252C2%25252C4-Triazolo%25255B1%25252C5-a%25255Dpyridines%26aulast%3DZheng%26aufirst%3DZisheng%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D10022014%26date%3D28042014%26date%3D16052014%26date%3D18042014%26volume%3D79%26issue%3D10%26spage%3D4687%26epage%3D4693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenjun  Du</span>, <span class="hlFld-ContribAuthor ">Fuli  Zhang</span>, <span class="hlFld-ContribAuthor ">Pei  Yan</span>, <span class="hlFld-ContribAuthor ">Qingfu  Lai</span>, <span class="hlFld-ContribAuthor ">Junjian  Li</span>, <span class="hlFld-ContribAuthor ">Daqian  Zhu</span>, <span class="hlFld-ContribAuthor ">Lianbao  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, Activity Evaluation and Molecular Docking Study of Novel Janus kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (17)
                                     , 4212-4216. <a href="https://doi.org/10.1002/slct.202100707" title="DOI URL">https://doi.org/10.1002/slct.202100707</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100707%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%25252C%252BActivity%252BEvaluation%252Band%252BMolecular%252BDocking%252BStudy%252Bof%252BNovel%252BJanus%252Bkinase%252BInhibitors%26aulast%3DDu%26aufirst%3DWenjun%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D17%26spage%3D4212%26epage%3D4216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michela  Sperti</span>, <span class="hlFld-ContribAuthor ">Marta  Malavolta</span>, <span class="hlFld-ContribAuthor ">Gloria  Ciniero</span>, <span class="hlFld-ContribAuthor ">Simone  Borrelli</span>, <span class="hlFld-ContribAuthor ">Marco  Cavaglià</span>, <span class="hlFld-ContribAuthor ">Stefano  Muscat</span>, <span class="hlFld-ContribAuthor ">Jack Adam  Tuszynski</span>, <span class="hlFld-ContribAuthor ">Antonella  Afeltra</span>, <span class="hlFld-ContribAuthor ">Domenico Paolo Emanuele  Margiotta</span>, <span class="hlFld-ContribAuthor ">Luca  Navarini</span>. </span><span class="cited-content_cbyCitation_article-title">JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2021,</strong> <em>104 </em>, 107789. <a href="https://doi.org/10.1016/j.jmgm.2020.107789" title="DOI URL">https://doi.org/10.1016/j.jmgm.2020.107789</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2020.107789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2020.107789%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DJAK%252Binhibitors%252Bin%252Bimmune-mediated%252Brheumatic%252Bdiseases%25253A%252BFrom%252Ba%252Bmolecular%252Bperspective%252Bto%252Bclinical%252Bstudies%26aulast%3DSperti%26aufirst%3DMichela%26date%3D2021%26volume%3D104%26spage%3D107789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karima  Alim</span>, <span class="hlFld-ContribAuthor ">Arnaud  Bruyère</span>, <span class="hlFld-ContribAuthor ">Alain  Lescoat</span>, <span class="hlFld-ContribAuthor ">Elodie  Jouan</span>, <span class="hlFld-ContribAuthor ">Valérie  Lecureur</span>, <span class="hlFld-ContribAuthor ">Marc  Le Vée</span>, <span class="hlFld-ContribAuthor ">Olivier  Fardel</span>. </span><span class="cited-content_cbyCitation_article-title">Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Metabolism & Toxicology</span><span> <strong>2021,</strong> <em>17 </em>
                                    (3)
                                     , 259-271. <a href="https://doi.org/10.1080/17425255.2021.1862084" title="DOI URL">https://doi.org/10.1080/17425255.2021.1862084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17425255.2021.1862084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17425255.2021.1862084%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Metabolism%2520%2526%2520Toxicology%26atitle%3DInteractions%252Bof%252Bjanus%252Bkinase%252Binhibitors%252Bwith%252Bdrug%252Btransporters%252Band%252Bconsequences%252Bfor%252Bpharmacokinetics%252Band%252Btoxicity%26aulast%3DAlim%26aufirst%3DKarima%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D3%26spage%3D259%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. V.  Dotsenko</span>, <span class="hlFld-ContribAuthor ">A. N.  Khrustaleva</span>, <span class="hlFld-ContribAuthor ">K. A.  Frolov</span>, <span class="hlFld-ContribAuthor ">N. A.  Aksenov</span>, <span class="hlFld-ContribAuthor ">I. V.  Aksenova</span>, <span class="hlFld-ContribAuthor ">S. G.  Krivokolysko</span>. </span><span class="cited-content_cbyCitation_article-title">1,6-Diamino-2-oxopyridine-3,5-dicarbonitrile Derivatives in the Mannich Reaction. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2021,</strong> <em>91 </em>
                                    (1)
                                     , 44-56. <a href="https://doi.org/10.1134/S1070363221010047" title="DOI URL">https://doi.org/10.1134/S1070363221010047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363221010047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363221010047%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3D1%25252C6-Diamino-2-oxopyridine-3%25252C5-dicarbonitrile%252BDerivatives%252Bin%252Bthe%252BMannich%252BReaction%26aulast%3DDotsenko%26aufirst%3DV.%2BV.%26date%3D2021%26date%3D2021%26volume%3D91%26issue%3D1%26spage%3D44%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruifeng  Wang</span>, <span class="hlFld-ContribAuthor ">Xiangxin  Zhao</span>, <span class="hlFld-ContribAuthor ">Sijia  Yu</span>, <span class="hlFld-ContribAuthor ">Yixuan  Chen</span>, <span class="hlFld-ContribAuthor ">Hengxian  Cui</span>, <span class="hlFld-ContribAuthor ">Tianxiao  Wu</span>, <span class="hlFld-ContribAuthor ">Chenzhou  Hao</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>, <span class="hlFld-ContribAuthor ">Maosheng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>102 </em>, 104092. <a href="https://doi.org/10.1016/j.bioorg.2020.104092" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104092%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252B7H-pyrrolo%25255B2%25252C3-d%25255Dpyridine%252Bderivatives%252Bas%252Bpotent%252BFAK%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bdocking%252Bstudy%26aulast%3DWang%26aufirst%3DRuifeng%26date%3D2020%26volume%3D102%26spage%3D104092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Xu</span>, <span class="hlFld-ContribAuthor ">Pei  Shen</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Xi  Xu</span>, <span class="hlFld-ContribAuthor ">Raoling  Ge</span>, <span class="hlFld-ContribAuthor ">Xinying  Cheng</span>, <span class="hlFld-ContribAuthor ">Qiuyu  Chen</span>, <span class="hlFld-ContribAuthor ">Jinlei  Bian</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>, <span class="hlFld-ContribAuthor ">JuBo  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112155. <a href="https://doi.org/10.1016/j.ejmech.2020.112155" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112155%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DJanus%252Bkinases%252B%252528JAKs%252529%25253A%252BThe%252Befficient%252Btherapeutic%252Btargets%252Bfor%252Bautoimmune%252Bdiseases%252Band%252Bmyeloproliferative%252Bdisorders%26aulast%3DXu%26aufirst%3DPengfei%26date%3D2020%26volume%3D192%26spage%3D112155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanisha  Sachdeva</span>, <span class="hlFld-ContribAuthor ">May Lee  Low</span>, <span class="hlFld-ContribAuthor ">Chun‐Wai  Mai</span>, <span class="hlFld-ContribAuthor ">Siew Lee  Cheong</span>, <span class="hlFld-ContribAuthor ">Yun Khoon  Liew</span>, <span class="hlFld-ContribAuthor ">Marilyn Daisy  Milton</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Characterisation of Novel Phenothiazine‐Based Triazolopyridine Derivatives: Evaluation of Anti‐Breast Cancer Activity on Human Breast Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (43)
                                     , 12701-12707. <a href="https://doi.org/10.1002/slct.201903203" title="DOI URL">https://doi.org/10.1002/slct.201903203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201903203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201903203%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BCharacterisation%252Bof%252BNovel%252BPhenothiazine%2525E2%252580%252590Based%252BTriazolopyridine%252BDerivatives%25253A%252BEvaluation%252Bof%252BAnti%2525E2%252580%252590Breast%252BCancer%252BActivity%252Bon%252BHuman%252BBreast%252BCarcinoma%26aulast%3DSachdeva%26aufirst%3DTanisha%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D43%26spage%3D12701%26epage%3D12707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleksey Yu.  Vorob’ev</span>. </span><span class="cited-content_cbyCitation_article-title">Methods of synthesis of [1,2,4]triazolo[1,5-а]pyridines (microreview). </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2019,</strong> <em>55 </em>
                                    (8)
                                     , 695-697. <a href="https://doi.org/10.1007/s10593-019-02522-5" title="DOI URL">https://doi.org/10.1007/s10593-019-02522-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-019-02522-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-019-02522-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DMethods%252Bof%252Bsynthesis%252Bof%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-%2525D0%2525B0%25255Dpyridines%252B%252528microreview%252529%26aulast%3DVorob%25E2%2580%2599ev%26aufirst%3DAleksey%2BYu.%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D8%26spage%3D695%26epage%3D697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Li</span>, <span class="hlFld-ContribAuthor ">Zenghui  Ye</span>, <span class="hlFld-ContribAuthor ">Na  Chen</span>, <span class="hlFld-ContribAuthor ">Zhenkun  Chen</span>, <span class="hlFld-ContribAuthor ">Fengzhi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular electrochemical dehydrogenative N–N bond formation for the synthesis of 1,2,4-triazolo[1,5-
              a
              ]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2019,</strong> <em>21 </em>
                                    (15)
                                     , 4035-4039. <a href="https://doi.org/10.1039/C9GC01895F" title="DOI URL">https://doi.org/10.1039/C9GC01895F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9GC01895F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9GC01895F%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DIntramolecular%252Belectrochemical%252Bdehydrogenative%252BN%2525E2%252580%252593N%252Bbond%252Bformation%252Bfor%252Bthe%252Bsynthesis%252Bof%252B1%25252C2%25252C4-triazolo%25255B1%25252C5-%252Ba%252B%25255Dpyridines%26aulast%3DLi%26aufirst%3DYong%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D15%26spage%3D4035%26epage%3D4039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. G.  Paronikyan</span>, <span class="hlFld-ContribAuthor ">Sh. Sh.  Dashyan</span>, <span class="hlFld-ContribAuthor ">R. G.  Paronikyan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of New 3-(Alkylsulfanyl)pyrano[3,4-c]-[1,2,4]triazolo[4,3-a]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>55 </em>
                                    (6)
                                     , 818-823. <a href="https://doi.org/10.1134/S1070428019060113" title="DOI URL">https://doi.org/10.1134/S1070428019060113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428019060113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428019060113%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BNew%252B3-%252528Alkylsulfanyl%252529pyrano%25255B3%25252C4-c%25255D-%25255B1%25252C2%25252C4%25255Dtriazolo%25255B4%25252C3-a%25255Dpyridines%26aulast%3DParonikyan%26aufirst%3DE.%2BG.%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D6%26spage%3D818%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingying  Chai</span>, <span class="hlFld-ContribAuthor ">Changfu  Li</span>, <span class="hlFld-ContribAuthor ">Liying  Meng</span>, <span class="hlFld-ContribAuthor ">Xinglong  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhenqiang  Xia</span>, <span class="hlFld-ContribAuthor ">Weimin  Li</span>, <span class="hlFld-ContribAuthor ">Yang  He</span>. </span><span class="cited-content_cbyCitation_article-title">The Diverse supramolecular synthons formed by 2-subsituted 5-morpholinomethylphenyl Triazolo[1,5-a]pyridines in solid state. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1176 </em>, 149-156. <a href="https://doi.org/10.1016/j.molstruc.2018.08.088" title="DOI URL">https://doi.org/10.1016/j.molstruc.2018.08.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2018.08.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2018.08.088%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DThe%252BDiverse%252Bsupramolecular%252Bsynthons%252Bformed%252Bby%252B2-subsituted%252B5-morpholinomethylphenyl%252BTriazolo%25255B1%25252C5-a%25255Dpyridines%252Bin%252Bsolid%252Bstate%26aulast%3DChai%26aufirst%3DYingying%26date%3D2019%26volume%3D1176%26spage%3D149%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianguang  Lv</span>, <span class="hlFld-ContribAuthor ">Zhiqing  He</span>, <span class="hlFld-ContribAuthor ">Jianmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuwei  Guo</span>, <span class="hlFld-ContribAuthor ">Ziwei  Han</span>, <span class="hlFld-ContribAuthor ">Xinhua  Bao</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis of [1,2,4]Triazolo[1,5-a]pyridines from azines and benzylidenemalononitriles via copper-catalyzed tandem cyclization. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (29)
                                     , 3996-4004. <a href="https://doi.org/10.1016/j.tet.2018.06.002" title="DOI URL">https://doi.org/10.1016/j.tet.2018.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.06.002%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DOne-pot%252Bsynthesis%252Bof%252B%25255B1%25252C2%25252C4%25255DTriazolo%25255B1%25252C5-a%25255Dpyridines%252Bfrom%252Bazines%252Band%252Bbenzylidenemalononitriles%252Bvia%252Bcopper-catalyzed%252Btandem%252Bcyclization%26aulast%3DLv%26aufirst%3DJianguang%26date%3D2018%26volume%3D74%26issue%3D29%26spage%3D3996%26epage%3D4004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changfu  Li</span>, <span class="hlFld-ContribAuthor ">Yingying  Chai</span>, <span class="hlFld-ContribAuthor ">Xinglong  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhen  Shen</span>, <span class="hlFld-ContribAuthor ">Beibei  Ma</span>, <span class="hlFld-ContribAuthor ">Bojiang  Chen</span>, <span class="hlFld-ContribAuthor ">Ridong  Huang</span>, <span class="hlFld-ContribAuthor ">Hai  Chen</span>, <span class="hlFld-ContribAuthor ">Weimin  Li</span>, <span class="hlFld-ContribAuthor ">Yang  He</span>. </span><span class="cited-content_cbyCitation_article-title">Choice of hydrogen bonds or halogen bonds by 2-halogenated 5-morpholinomethylphenyl triazolo[1,5-
              a
              ]pyridine. </span><span class="cited-content_cbyCitation_journal-name">CrystEngComm</span><span> <strong>2018,</strong> <em>20 </em>
                                    (22)
                                     , 3006-3010. <a href="https://doi.org/10.1039/C8CE00423D" title="DOI URL">https://doi.org/10.1039/C8CE00423D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CE00423D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CE00423D%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystEngComm%26atitle%3DChoice%252Bof%252Bhydrogen%252Bbonds%252Bor%252Bhalogen%252Bbonds%252Bby%252B2-halogenated%252B5-morpholinomethylphenyl%252Btriazolo%25255B1%25252C5-%252Ba%252B%25255Dpyridine%26aulast%3DLi%26aufirst%3DChangfu%26date%3D2018%26date%3D2018%26volume%3D20%26issue%3D22%26spage%3D3006%26epage%3D3010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changli  Wu</span>, <span class="hlFld-ContribAuthor ">Rong  Li</span>, <span class="hlFld-ContribAuthor ">Haibing  Luo</span>, <span class="hlFld-ContribAuthor ">Mingfeng  Xu</span>, <span class="hlFld-ContribAuthor ">Xiujuan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">JAK2 inhibitor CEP-33779 prevents mouse oocyte maturation in vitro. </span><span class="cited-content_cbyCitation_journal-name">Bioscience Reports</span><span> <strong>2017,</strong> <em>37 </em>
                                    (4)
                                     <a href="https://doi.org/10.1042/BSR20170642" title="DOI URL">https://doi.org/10.1042/BSR20170642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BSR20170642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBSR20170642%26sid%3Dliteratum%253Aachs%26jtitle%3DBioscience%2520Reports%26atitle%3DJAK2%252Binhibitor%252BCEP-33779%252Bprevents%252Bmouse%252Boocyte%252Bmaturation%252Bin%252Bvitro%26aulast%3DWu%26aufirst%3DChangli%26date%3D2017%26date%3D2017%26volume%3D37%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason G.  Kettle</span>, <span class="hlFld-ContribAuthor ">Annika  Åstrand</span>, <span class="hlFld-ContribAuthor ">Matthew  Catley</span>, <span class="hlFld-ContribAuthor ">Neil P.  Grimster</span>, <span class="hlFld-ContribAuthor ">Magnus  Nilsson</span>, <span class="hlFld-ContribAuthor ">Qibin  Su</span>, <span class="hlFld-ContribAuthor ">Richard  Woessner</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (2)
                                     , 127-143. <a href="https://doi.org/10.1080/13543776.2017.1252753" title="DOI URL">https://doi.org/10.1080/13543776.2017.1252753</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1252753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1252753%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DInhibitors%252Bof%252BJAK-family%252Bkinases%25253A%252Ban%252Bupdate%252Bon%252Bthe%252Bpatent%252Bliterature%252B2013-2015%25252C%252Bpart%252B1%26aulast%3DKettle%26aufirst%3DJason%2BG.%26date%3D2017%26date%3D2016%26volume%3D27%26issue%3D2%26spage%3D127%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tingfang  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaofei  Liu</span>, <span class="hlFld-ContribAuthor ">Meixi  Hao</span>, <span class="hlFld-ContribAuthor ">Jianan  Qiao</span>, <span class="hlFld-ContribAuthor ">Caoyun  Ju</span>, <span class="hlFld-ContribAuthor ">Lingjing  Xue</span>, <span class="hlFld-ContribAuthor ">Can  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of pyrrolo[2,3- d ]pyrimidine-phenylamide hybrids as potent Janus kinase 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (12)
                                     , 2936-2941. <a href="https://doi.org/10.1016/j.bmcl.2016.04.027" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.04.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.04.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bpyrrolo%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine-phenylamide%252Bhybrids%252Bas%252Bpotent%252BJanus%252Bkinase%252B2%252Binhibitors%26aulast%3DWang%26aufirst%3DTingfang%26date%3D2016%26volume%3D26%26issue%3D12%26spage%3D2936%26epage%3D2941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Shuai  Mao</span>, <span class="hlFld-ContribAuthor ">Lei  Cao</span>, <span class="hlFld-ContribAuthor ">Xiao-Xiao  Xie</span>, <span class="hlFld-ContribAuthor ">Min-Hang  Xin</span>, <span class="hlFld-ContribAuthor ">Jia-Fang  Lian</span>, <span class="hlFld-ContribAuthor ">Yong-Xiao  Cao</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Modification of N -(6-(2-methoxy-3-(4-fluorophenylsulfonamido)pyridin-5-yl)-[1,2,4]triazolo[1,5- a ]pyridin-2-yl)acetamide as PI3Ks inhibitor by replacement of the acetamide group with alkylurea. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (17)
                                     , 5662-5671. <a href="https://doi.org/10.1016/j.bmc.2015.07.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.07.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.07.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DModification%252Bof%252BN%252B-%2525286-%2525282-methoxy-3-%2525284-fluorophenylsulfonamido%252529pyridin-5-yl%252529-%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-%252Ba%252B%25255Dpyridin-2-yl%252529acetamide%252Bas%252BPI3Ks%252Binhibitor%252Bby%252Breplacement%252Bof%252Bthe%252Bacetamide%252Bgroup%252Bwith%252Balkylurea%26aulast%3DWang%26aufirst%3DXiao-Meng%26date%3D2015%26volume%3D23%26issue%3D17%26spage%3D5662%26epage%3D5671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhisa  Ishimoto</span>, <span class="hlFld-ContribAuthor ">Toshiaki  Nagata</span>, <span class="hlFld-ContribAuthor ">Mika  Murabayashi</span>, <span class="hlFld-ContribAuthor ">Tomomi  Ikemoto</span>. </span><span class="cited-content_cbyCitation_article-title">Oxidative cyclization of 1-(pyridin-2-yl)guanidine derivatives: a synthesis of [1,2,4]triazolo[1,5-a]pyridin-2-amines and an unexpected synthesis of [1,2,4]triazolo[4,3-a]pyridin-3-amines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (3)
                                     , 407-418. <a href="https://doi.org/10.1016/j.tet.2014.12.015" title="DOI URL">https://doi.org/10.1016/j.tet.2014.12.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.12.015%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DOxidative%252Bcyclization%252Bof%252B1-%252528pyridin-2-yl%252529guanidine%252Bderivatives%25253A%252Ba%252Bsynthesis%252Bof%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyridin-2-amines%252Band%252Ban%252Bunexpected%252Bsynthesis%252Bof%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B4%25252C3-a%25255Dpyridin-3-amines%26aulast%3DIshimoto%26aufirst%3DKazuhisa%26date%3D2015%26volume%3D71%26issue%3D3%26spage%3D407%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atanu  Bhaumik</span>, <span class="hlFld-ContribAuthor ">Tarun Kumar  Pal</span>, <span class="hlFld-ContribAuthor ">Tanmaya  Pathak</span>. </span><span class="cited-content_cbyCitation_article-title">1,1-Dioxothiomorpholines with asymmetric environments: protecting group directed diastereoselectivity of glyco divinyl sulfone cyclization. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (35)
                                     , 27706-27710. <a href="https://doi.org/10.1039/C5RA03276H" title="DOI URL">https://doi.org/10.1039/C5RA03276H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA03276H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA03276H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3D1%25252C1-Dioxothiomorpholines%252Bwith%252Basymmetric%252Benvironments%25253A%252Bprotecting%252Bgroup%252Bdirected%252Bdiastereoselectivity%252Bof%252Bglyco%252Bdivinyl%252Bsulfone%252Bcyclization%26aulast%3DBhaumik%26aufirst%3DAtanu%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D35%26spage%3D27706%26epage%3D27710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shang-jun  Tang</span>, <span class="hlFld-ContribAuthor ">Li-kun  Chen</span>, <span class="hlFld-ContribAuthor ">Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Yun-kai  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhen-cong  Huang</span>, <span class="hlFld-ContribAuthor ">Kenneth Kin Wah  To</span>, <span class="hlFld-ContribAuthor ">Xiao-kun  Wang</span>, <span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>, <span class="hlFld-ContribAuthor ">Zhe-sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Wei-qiang  Chen</span>, <span class="hlFld-ContribAuthor ">Li-wu  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2014,</strong> <em>91 </em>
                                    (2)
                                     , 144-156. <a href="https://doi.org/10.1016/j.bcp.2014.07.008" title="DOI URL">https://doi.org/10.1016/j.bcp.2014.07.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2014.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2014.07.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DCEP-33779%252Bantagonizes%252BATP-binding%252Bcassette%252Bsubfamily%252BB%252Bmember%252B1%252Bmediated%252Bmultidrug%252Bresistance%252Bby%252Binhibiting%252Bits%252Btransport%252Bfunction%26aulast%3DTang%26aufirst%3DShang-jun%26date%3D2014%26volume%3D91%26issue%3D2%26spage%3D144%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian W  Dymock</span>, <span class="hlFld-ContribAuthor ">Eugene Guorong  Yang</span>, <span class="hlFld-ContribAuthor ">Yuyi  Chu-Farseeva</span>, <span class="hlFld-ContribAuthor ">Lianbin  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Selective JAK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (12)
                                     , 1439-1471. <a href="https://doi.org/10.4155/fmc.14.92" title="DOI URL">https://doi.org/10.4155/fmc.14.92</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.92%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSelective%252BJAK%252Binhibitors%26aulast%3DDymock%26aufirst%3DBrian%2BW%26date%3D2014%26volume%3D6%26issue%3D12%26spage%3D1439%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer  Bishop</span>, <span class="hlFld-ContribAuthor ">Daksh  Thaper</span>, <span class="hlFld-ContribAuthor ">Amina  Zoubeidi</span>. </span><span class="cited-content_cbyCitation_article-title">The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2014,</strong> <em>6 </em>
                                    (2)
                                     , 829-859. <a href="https://doi.org/10.3390/cancers6020829" title="DOI URL">https://doi.org/10.3390/cancers6020829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers6020829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers6020829%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BMultifaceted%252BRoles%252Bof%252BSTAT3%252BSignaling%252Bin%252Bthe%252BProgression%252Bof%252BProstate%252BCancer%26aulast%3DBishop%26aufirst%3DJennifer%26date%3D2014%26date%3D2014%26volume%3D6%26issue%3D2%26spage%3D829%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Richard  Pastor</span>, <span class="hlFld-ContribAuthor ">Wendy  Liu</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Megan  Berry</span>, <span class="hlFld-ContribAuthor ">Wade S.  Blair</span>, <span class="hlFld-ContribAuthor ">Christine  Chang</span>, <span class="hlFld-ContribAuthor ">Jacob Z.  Chen</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Nico  Ghilardi</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Haiying  He</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Hurley</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">S.  Cyrus Khojasteh</span>, <span class="hlFld-ContribAuthor ">Hoa  Le</span>, <span class="hlFld-ContribAuthor ">Leslie  Lee</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Steve  Magnuson</span>, <span class="hlFld-ContribAuthor ">Rebecca  Pulk</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Mark  Ultsch</span>, <span class="hlFld-ContribAuthor ">Yisong  Xiao</span>, <span class="hlFld-ContribAuthor ">Bing-yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>. </span><span class="cited-content_cbyCitation_article-title">2-Amino-[1,2,4]triazolo[1,5-a]pyridines as JAK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (17)
                                     , 5014-5021. <a href="https://doi.org/10.1016/j.bmcl.2013.06.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.06.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.06.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D2-Amino-%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyridines%252Bas%252BJAK2%252Binhibitors%26aulast%3DSiu%26aufirst%3DMichael%26date%3D2013%26volume%3D23%26issue%3D17%26spage%3D5014%26epage%3D5021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Xu</span>, <span class="hlFld-ContribAuthor ">Yi-Ping  Li</span>, <span class="hlFld-ContribAuthor ">Huan  Li</span>, <span class="hlFld-ContribAuthor ">Cong-Shan  Jiang</span>, <span class="hlFld-ContribAuthor ">Guang-De  Yang</span>, <span class="hlFld-ContribAuthor ">She-Min  Lu</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer activity evaluation of a series of [1,2,4]triazolo[1,5-a]pyridinylpyridines in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>67 </em>, 243-251. <a href="https://doi.org/10.1016/j.ejmech.2013.06.052" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.06.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.06.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.06.052%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bactivity%252Bevaluation%252Bof%252Ba%252Bseries%252Bof%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyridinylpyridines%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DWang%26aufirst%3DXiao-Meng%26date%3D2013%26volume%3D67%26spage%3D243%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian W  Dymock</span>, <span class="hlFld-ContribAuthor ">Cheng Shang  See</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 – 2012. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (4)
                                     , 449-501. <a href="https://doi.org/10.1517/13543776.2013.765862" title="DOI URL">https://doi.org/10.1517/13543776.2013.765862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.765862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.765862%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DInhibitors%252Bof%252BJAK2%252Band%252BJAK3%25253A%252Ban%252Bupdate%252Bon%252Bthe%252Bpatent%252Bliterature%252B2010%252B%2525E2%252580%252593%252B2012%26aulast%3DDymock%26aufirst%3DBrian%2BW%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D4%26spage%3D449%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tara L.S.  Kishbaugh</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 319-355. <a href="https://doi.org/10.1016/B978-0-08-099406-2.00006-6" title="DOI URL">https://doi.org/10.1016/B978-0-08-099406-2.00006-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-099406-2.00006-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-099406-2.00006-6%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%26aulast%3DKishbaugh%26aufirst%3DTara%2BL.S.%26date%3D2013%26spage%3D319%26epage%3D355%26pub%3DElsevier%26date%3D2013%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christel J.  Menet</span>, <span class="hlFld-ContribAuthor ">Luc Van  Rompaey</span>, <span class="hlFld-ContribAuthor ">Raphaël  Geney</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Discovery of Selective JAK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 153-223. <a href="https://doi.org/10.1016/B978-0-444-62652-3.00004-1" title="DOI URL">https://doi.org/10.1016/B978-0-444-62652-3.00004-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-62652-3.00004-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-62652-3.00004-1%26sid%3Dliteratum%253Aachs%26atitle%3DAdvances%252Bin%252Bthe%252BDiscovery%252Bof%252BSelective%252BJAK%252BInhibitors%26aulast%3DMenet%26aufirst%3DChristel%2BJ.%26date%3D2013%26spage%3D153%26epage%3D223%26pub%3DElsevier%26date%3D2013%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of reported JAK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Design rationale. (B) Ribbon representation of JAK2/inhibitor cocrystal structure with <b>28</b>: N-terminal domain in orange, C-terminal domain in green, hinge region in yellow, glycine rich P-loop in darker orange. Key amino acid residues: gatekeeper Met-929, hinge binder Leu-932, and back-pocket salt-bridge of Asp-994 and Lys-882 are explicitly shown in element color-coded stick model. Inhibitor <b>28</b> is represented in a stick model: C, green; N, blue; O, red; S, yellow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Initial Synthesis of Triazolopyridine Derivatives <b>9</b> and <b>22</b>–<b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, <i>p</i>-dioxane, 0 °C to RT, 66–96%; (b) (CH<sub>3</sub>O)<sub>2</sub>SO<sub>2</sub>, <i>p</i>-dioxane, 60 °C; (c) NH<sub>2</sub>OH hydrochloride, (<i>i</i>-Pr)<sub>2</sub>NEt or K<sub>2</sub>CO<sub>3</sub>, <i>p</i>-dioxane, 90 °C; (d) 20% phosgene in toluene, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, RT, 12–58%; (e) Pd(OAc)<sub>2</sub>, TPP, 4-methanesulfonylboronic acid, Na<sub>2</sub>CO<sub>3</sub>, water, <i>p</i>-dioxane, 80 °C, 39–67%. See also Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> (<b>22</b>–<b>24</b>).</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Improved Synthesis of Triazolopyridine Derivatives <b>12</b>–<b>21</b> and <b>25</b>–<b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethoxycarbonyl isothiocyanate, <i>p</i>-dioxane, RT; (b) NH<sub>2</sub>OH hydrochloride, (<i>i</i>-Pr)<sub>2</sub>NEt, EtOH, MeOH, 60 °C, 70%; (c) Pd(OAc)<sub>2</sub>, TPP, R<sup>1</sup>-boronic acid/ester, Na<sub>2</sub>CO<sub>3</sub>, water, <i>p</i>-dioxane, 80 °C, 8–95%; (d) Pd(OAc)<sub>2</sub>, ligand, arylbromide, Cs<sub>2</sub>CO<sub>3</sub>, <i>p</i>-dioxane, 80 °C, 6–77%. See also Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (<b>12</b>–<b>18</b>), Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> (<b>19</b>–<b>21</b>), and Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> (<b>25</b>–<b>41</b>).</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Results of PK/PD experiment in CWR22 xenograft in nude mouse: (A) percent inhibition of STAT3 activation with a single dose of <b>29</b> (55 mg/kg po as a solution in PEG400), (B) plasma and tumor compound concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0015.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antitumor efficacy of <b>29</b> in CWR22 xenograft model, dosed po as a solution in PEG400.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/medium/jm-2012-00248q_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0016.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Results of PK and efficacy experiment in HDLM-2 xenograft in SCID/NOD mouse: (A) antitumor efficacy of <b>29</b>, dosed po as a solution in PEG400, 55 mg/kg bid switched to qd dosing at day 7, (B) plasma and tumor compound levels at 3 h post last dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300248q/production/images/large/jm-2012-00248q_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300248q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i58">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span> </span><span class="NLM_article-title">The STATs of Cancer—New Molecular Targets Come of Age</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1038%2Fnrc1275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=14964307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlaqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=97-105&author=H.+Yuauthor=R.+Jove&title=The+STATs+of+Cancer%E2%80%94New+Molecular+Targets+Come+of+Age"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The STATs of cancer - new molecular targets come of age</span></div><div class="casAuthors">Yu, Hua; Jove, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-105</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor cells acquire the ability to proliferate uncontrollably, resist apoptosis, sustain angiogenesis and evade immune surveillance.  STAT proteins - esp. STAT3 and STAT5 - regulate all of these processes and are persistently activated in a surprisingly large no. of human cancers.  Consequently, STAT proteins are emerging - unexpectedly - as ideal targets for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdnLoVoH4d1rVg90H21EOLACvtfcHk0lhNsh2eVItTOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlaqtb0%253D&md5=3e342db4856310cac2465240e36d3226</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fnrc1275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1275%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DJove%26aufirst%3DR.%26atitle%3DThe%2520STATs%2520of%2520Cancer%25E2%2580%2594New%2520Molecular%2520Targets%2520Come%2520of%2520Age%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D97%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dagvadorj, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jomain, J.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdulghani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zellweger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alanen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirtti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visakorpi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubendorf, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goffin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, M. T.</span><span> </span><span class="NLM_article-title">Autocrine Prolactin Promotes Prostate Cancer Cell Growth via Janus Kinase-2-Signal Transducer and Activator of Transcription-5a/b Signaling Pathway</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">3089</span><span class="NLM_x">–</span> <span class="NLM_lpage">3101</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=3089-3101&author=A.+Dagvadorjauthor=S.+Collinsauthor=J.-B.+Jomainauthor=J.+Abdulghaniauthor=J.+Karrasauthor=T.+Zellwegerauthor=H.+Liauthor=M.+Nurmiauthor=K.+Alanenauthor=T.+Mirttiauthor=T.+Visakorpiauthor=L.+Bubendorfauthor=V.+Goffinauthor=M.+T.+Nevalainen&title=Autocrine+Prolactin+Promotes+Prostate+Cancer+Cell+Growth+via+Janus+Kinase-2-Signal+Transducer+and+Activator+of+Transcription-5a%2Fb+Signaling+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDagvadorj%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DS.%26aulast%3DJomain%26aufirst%3DJ.-B.%26aulast%3DAbdulghani%26aufirst%3DJ.%26aulast%3DKarras%26aufirst%3DJ.%26aulast%3DZellweger%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DNurmi%26aufirst%3DM.%26aulast%3DAlanen%26aufirst%3DK.%26aulast%3DMirtti%26aufirst%3DT.%26aulast%3DVisakorpi%26aufirst%3DT.%26aulast%3DBubendorf%26aufirst%3DL.%26aulast%3DGoffin%26aufirst%3DV.%26aulast%3DNevalainen%26aufirst%3DM.%2BT.%26atitle%3DAutocrine%2520Prolactin%2520Promotes%2520Prostate%2520Cancer%2520Cell%2520Growth%2520via%2520Janus%2520Kinase-2-Signal%2520Transducer%2520and%2520Activator%2520of%2520Transcription-5a%252Fb%2520Signaling%2520Pathway%26jtitle%3DEndocrinology%26date%3D2007%26volume%3D148%26spage%3D3089%26epage%3D3101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pardanani, A.</span><span> </span><span class="NLM_article-title">JAK2 Inhibitor Therapy in Myeloproliferative Disorders: Rationale, Preclinical Studies and Ongoing Clinical Trials</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=22-30&author=A.+Pardanani&title=JAK2+Inhibitor+Therapy+in+Myeloproliferative+Disorders%3A+Rationale%2C+Preclinical+Studies+and+Ongoing+Clinical+Trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardanani%26aufirst%3DA.%26atitle%3DJAK2%2520Inhibitor%2520Therapy%2520in%2520Myeloproliferative%2520Disorders%253A%2520Rationale%252C%2520Preclinical%2520Studies%2520and%2520Ongoing%2520Clinical%2520Trials%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D22%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kortylewski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kujawski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilon-Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mule, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardoll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span> </span><span class="NLM_article-title">Inhibiting Stat3 Signaling in the Hematopoietic System Elicits Multicomponent Antitumor Immunity</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1314</span><span class="NLM_x">–</span> <span class="NLM_lpage">1321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=1314-1321&author=M.+Kortylewskiauthor=M.+Kujawskiauthor=T.+Wangauthor=S.+Weiauthor=S.+Zhangauthor=S.+Pilon-Thomasauthor=G.+Niuauthor=H.+Kayauthor=J.+Muleauthor=W.+G.+Kerrauthor=R.+Joveauthor=D.+Pardollauthor=H.+Yu&title=Inhibiting+Stat3+Signaling+in+the+Hematopoietic+System+Elicits+Multicomponent+Antitumor+Immunity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKortylewski%26aufirst%3DM.%26aulast%3DKujawski%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DPilon-Thomas%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DG.%26aulast%3DKay%26aufirst%3DH.%26aulast%3DMule%26aufirst%3DJ.%26aulast%3DKerr%26aufirst%3DW.%2BG.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DPardoll%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DH.%26atitle%3DInhibiting%2520Stat3%2520Signaling%2520in%2520the%2520Hematopoietic%2520System%2520Elicits%2520Multicomponent%2520Antitumor%2520Immunity%26jtitle%3DNature%2520Med.%26date%3D2005%26volume%3D11%26spage%3D1314%26epage%3D1321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nefedova, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrilovich, D. I.</span><span> </span><span class="NLM_article-title">Targeting of Jak/STAT Pathway in Antigen Presenting Cells in Cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.2174%2F156800907780006887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=17305479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVOgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=71-77&author=Y.+Nefedovaauthor=D.+I.+Gabrilovich&title=Targeting+of+Jak%2FSTAT+Pathway+in+Antigen+Presenting+Cells+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of Jak/STAT pathway in antigen presenting cells in cancer</span></div><div class="casAuthors">Nefedova, Yulia; Gabrilovich, Dmitry I.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-77</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the major mechanisms of tumor escape is the inability of antigen presenting cells (APC), and specifically the most potent APC dendritic cells (DC), to induce potent antitumor immune response.  The defects in APC are caused by the variety of tumor-derived factors.  Here, the authors discuss recent findings which indicate that the members of the family of signal transducers and activators of transcription (STATs), and more specifically STAT3, could be responsible for the abnormal DC differentiation and function in cancer.  The different approaches to pharmacol. regulation of this pathway and their effects on DC function and antitumor immune responses are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNux9rZUb2ZbVg90H21EOLACvtfcHk0lhNsh2eVItTOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVOgtr0%253D&md5=23d9c7bd5646e49d0a79a191dab9d2cf</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.2174%2F156800907780006887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800907780006887%26sid%3Dliteratum%253Aachs%26aulast%3DNefedova%26aufirst%3DY.%26aulast%3DGabrilovich%26aufirst%3DD.%2BI.%26atitle%3DTargeting%2520of%2520Jak%252FSTAT%2520Pathway%2520in%2520Antigen%2520Presenting%2520Cells%2520in%2520Cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2007%26volume%3D7%26spage%3D71%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lin, W.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">A cytokine-mediated link between innate immunity, inflammation, and cancer</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=1175-1183&author=W.-W.+Linauthor=M.+Karin&title=A+cytokine-mediated+link+between+innate+immunity%2C+inflammation%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DW.-W.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DA%2520cytokine-mediated%2520link%2520between%2520innate%2520immunity%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D1175%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pardanani, A.</span><span> </span><span class="NLM_article-title">JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=23-30&author=A.+Pardanani&title=JAK2+inhibitor+therapy+in+myeloproliferative+disorders%3A+rationale%2C+preclinical+studies+and+ongoing+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardanani%26aufirst%3DA.%26atitle%3DJAK2%2520inhibitor%2520therapy%2520in%2520myeloproliferative%2520disorders%253A%2520rationale%252C%2520preclinical%2520studies%2520and%2520ongoing%2520clinical%2520trials%26jtitle%3DLeukemia%26date%3D2008%26volume%3D22%26spage%3D23%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Marotta, L. L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almendro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marusyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipitsin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schemme, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloustain-Qimron, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhury, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gönen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvey, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessarabova, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silver, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolsky, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyak, K.</span><span> </span><span class="NLM_article-title">The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell-like breast cancer cells in human tumors</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">2723</span><span class="NLM_x">–</span> <span class="NLM_lpage">2735</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=2723-2735&author=L.+L.+C.+Marottaauthor=V.+Almendroauthor=A.+Marusykauthor=M.+Shipitsinauthor=J.+Schemmeauthor=S.+R.+Walkerauthor=N.+Bloustain-Qimronauthor=J.+J.+Kimauthor=S.+A.+Choudhuryauthor=R.+Maruyamaauthor=Z.+Wuauthor=M.+G%C3%B6nenauthor=L.+A.+Mulveyauthor=M.+O.+Bessarabovaauthor=S.+J.+Huhauthor=S.+J.+Silverauthor=S.+Y.+Kimauthor=S.+Y.+Parkauthor=H.+E.+Leeauthor=K.+S.+Andersonauthor=A.+L.+Richardsonauthor=T.+Nikolskayaauthor=Y.+Nikolskyauthor=X.+S.+Liuauthor=D.+E.+Rootauthor=W.+C.+Hahnauthor=D.+A.+Frankauthor=K.+Polyak&title=The+JAK2%2FSTAT3+signaling+pathway+is+required+for+growth+of+CD44%2BCD24%E2%80%93+stem+cell-like+breast+cancer+cells+in+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarotta%26aufirst%3DL.%2BL.%2BC.%26aulast%3DAlmendro%26aufirst%3DV.%26aulast%3DMarusyk%26aufirst%3DA.%26aulast%3DShipitsin%26aufirst%3DM.%26aulast%3DSchemme%26aufirst%3DJ.%26aulast%3DWalker%26aufirst%3DS.%2BR.%26aulast%3DBloustain-Qimron%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DJ.%2BJ.%26aulast%3DChoudhury%26aufirst%3DS.%2BA.%26aulast%3DMaruyama%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DG%25C3%25B6nen%26aufirst%3DM.%26aulast%3DMulvey%26aufirst%3DL.%2BA.%26aulast%3DBessarabova%26aufirst%3DM.%2BO.%26aulast%3DHuh%26aufirst%3DS.%2BJ.%26aulast%3DSilver%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DH.%2BE.%26aulast%3DAnderson%26aufirst%3DK.%2BS.%26aulast%3DRichardson%26aufirst%3DA.%2BL.%26aulast%3DNikolskaya%26aufirst%3DT.%26aulast%3DNikolsky%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DX.%2BS.%26aulast%3DRoot%26aufirst%3DD.%2BE.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DFrank%26aufirst%3DD.%2BA.%26aulast%3DPolyak%26aufirst%3DK.%26atitle%3DThe%2520JAK2%252FSTAT3%2520signaling%2520pathway%2520is%2520required%2520for%2520growth%2520of%2520CD44%252BCD24%25E2%2580%2593%2520stem%2520cell-like%2520breast%2520cancer%2520cells%2520in%2520human%2520tumors%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D2723%26epage%3D2735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundarsanam, S.</span><span> </span><span class="NLM_article-title">The Protein Kinase Complement of the Human Genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sundarsanam&title=The+Protein+Kinase+Complement+of+the+Human+Genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0liecjMTVmF1HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSundarsanam%26aufirst%3DS.%26atitle%3DThe%2520Protein%2520Kinase%2520Complement%2520of%2520the%2520Human%2520Genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahonen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alanen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBaron, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pretlow, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ealley, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurmi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martikainen, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, M. T.</span><span> </span><span class="NLM_article-title">Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer is Associated with High Histological Grade</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">4774</span><span class="NLM_x">–</span> <span class="NLM_lpage">4782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4774-4782&author=H.+Liauthor=T.+J.+Ahonenauthor=K.+Alanenauthor=J.+Xieauthor=M.+J.+LeBaronauthor=T.+G.+Pretlowauthor=E.+L.+Ealleyauthor=Y.+Zhangauthor=M.+Nurmiauthor=B.+Singhauthor=P.+M.+Martikainenauthor=M.+T.+Nevalainen&title=Activation+of+Signal+Transducer+and+Activator+of+Transcription+5+in+Human+Prostate+Cancer+is+Associated+with+High+Histological+Grade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DAhonen%26aufirst%3DT.%2BJ.%26aulast%3DAlanen%26aufirst%3DK.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DLeBaron%26aufirst%3DM.%2BJ.%26aulast%3DPretlow%26aufirst%3DT.%2BG.%26aulast%3DEalley%26aufirst%3DE.%2BL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DNurmi%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DMartikainen%26aufirst%3DP.%2BM.%26aulast%3DNevalainen%26aufirst%3DM.%2BT.%26atitle%3DActivation%2520of%2520Signal%2520Transducer%2520and%2520Activator%2520of%2520Transcription%25205%2520in%2520Human%2520Prostate%2520Cancer%2520is%2520Associated%2520with%2520High%2520Histological%2520Grade%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D4774%26epage%3D4782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tan, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, M. T.</span><span> </span><span class="NLM_article-title">Signal Transducer and Activator of Transcription 5A/B in Prostate and Breast Cancers</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=367-390&author=S.-H.+Tanauthor=M.+T.+Nevalainen&title=Signal+Transducer+and+Activator+of+Transcription+5A%2FB+in+Prostate+and+Breast+Cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.-H.%26aulast%3DNevalainen%26aufirst%3DM.%2BT.%26atitle%3DSignal%2520Transducer%2520and%2520Activator%2520of%2520Transcription%25205A%252FB%2520in%2520Prostate%2520and%2520Breast%2520Cancers%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2008%26volume%3D15%26spage%3D367%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Quintas-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Janus Kinase Inhibitors for the Treatment of Myeloproliferative Neoplasias and Beyond</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=127-140&author=A.+Quintas-Cardamaauthor=H.+Kantarjianauthor=J.+Cortesauthor=S.+Verstovsek&title=Janus+Kinase+Inhibitors+for+the+Treatment+of+Myeloproliferative+Neoplasias+and+Beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuintas-Cardama%26aufirst%3DA.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DJanus%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Myeloproliferative%2520Neoplasias%2520and%2520Beyond%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D127%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Borie, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">JAK3 inhibition as a new concept for immune suppression</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1297</span><span class="NLM_x">–</span> <span class="NLM_lpage">1303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=1297-1303&author=D.+C.+Borieauthor=M.-S.+Siauthor=R.+E.+Morrisauthor=B.+A.+Reitzauthor=P.+S.+Changelian&title=JAK3+inhibition+as+a+new+concept+for+immune+suppression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorie%26aufirst%3DD.%2BC.%26aulast%3DSi%26aufirst%3DM.-S.%26aulast%3DMorris%26aufirst%3DR.%2BE.%26aulast%3DReitz%26aufirst%3DB.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DJAK3%2520inhibition%2520as%2520a%2520new%2520concept%2520for%2520immune%2520suppression%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D4%26spage%3D1297%26epage%3D1303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borie, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">A New Modality for Immunosuppression: Targeting the JAK/STAT Pathway</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=555-564&author=J.+J.+O%E2%80%99Sheaauthor=M.+Pesuauthor=D.+C.+Borieauthor=P.+S.+Changelian&title=A+New+Modality+for+Immunosuppression%3A+Targeting+the+JAK%2FSTAT+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DA%2520New%2520Modality%2520for%2520Immunosuppression%253A%2520Targeting%2520the%2520JAK%252FSTAT%2520Pathway%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D4%26spage%3D555%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Flex, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrangeli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiaretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoops, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariola, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodale, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clappier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paoloni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fragale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavolaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cazzaniga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzolo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tornesello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battistini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cave, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renauld, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantinescu, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartaglia, M.</span><span> </span><span class="NLM_article-title">Somatically acquired <i>JAK1</i> mutations in adult acute lymphoblastic leukemia</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2008&pages=751-758&author=E.+Flexauthor=V.+Petrangeliauthor=L.+Stellaauthor=S.+Chiarettiauthor=T.+Hornakovaauthor=L.+Knoopsauthor=C.+Ariolaauthor=V.+Fodaleauthor=E.+Clappierauthor=F.+Paoloniauthor=S.+Martinelliauthor=A.+Fragaleauthor=M.+Sanchezauthor=S.+Tavolaroauthor=M.+Messinaauthor=G.+Cazzanigaauthor=A.+Cameraauthor=G.+Pizzoloauthor=A.+Torneselloauthor=M.+Vignettiauthor=A.+Battistiniauthor=H.+Caveauthor=B.+D.+Gelbauthor=J.-C.+Renauldauthor=A.+Biondiauthor=S.+N.+Constantinescuauthor=R.+Foaauthor=M.+Tartaglia&title=Somatically+acquired+JAK1+mutations+in+adult+acute+lymphoblastic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlex%26aufirst%3DE.%26aulast%3DPetrangeli%26aufirst%3DV.%26aulast%3DStella%26aufirst%3DL.%26aulast%3DChiaretti%26aufirst%3DS.%26aulast%3DHornakova%26aufirst%3DT.%26aulast%3DKnoops%26aufirst%3DL.%26aulast%3DAriola%26aufirst%3DC.%26aulast%3DFodale%26aufirst%3DV.%26aulast%3DClappier%26aufirst%3DE.%26aulast%3DPaoloni%26aufirst%3DF.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DM.%26aulast%3DTavolaro%26aufirst%3DS.%26aulast%3DMessina%26aufirst%3DM.%26aulast%3DCazzaniga%26aufirst%3DG.%26aulast%3DCamera%26aufirst%3DA.%26aulast%3DPizzolo%26aufirst%3DG.%26aulast%3DTornesello%26aufirst%3DA.%26aulast%3DVignetti%26aufirst%3DM.%26aulast%3DBattistini%26aufirst%3DA.%26aulast%3DCave%26aufirst%3DH.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DRenauld%26aufirst%3DJ.-C.%26aulast%3DBiondi%26aufirst%3DA.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DFoa%26aufirst%3DR.%26aulast%3DTartaglia%26aufirst%3DM.%26atitle%3DSomatically%2520acquired%2520JAK1%2520mutations%2520in%2520adult%2520acute%2520lymphoblastic%2520leukemia%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2008%26volume%3D205%26spage%3D751%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Minegishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morio, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agematsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuge, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yachie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessho, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujieda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakiguchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abinun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochs, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belohradsky, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyawaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasuyama, H.</span><span> </span><span class="NLM_article-title">Human Tyrosine Kinase 2 Deficiency Reveals Its Requisite Roles in Multiple Cytokine Signals Involved in Innate and Acquired Immunity</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1016%2Fj.immuni.2006.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=17088085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Gnt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=745-755&author=Y.+Minegishiauthor=M.+Saitoauthor=T+Morioauthor=K.+Watanabeauthor=K.+Agematsuauthor=S.+Tsuchiyaauthor=H.+Takadaauthor=T.+Haraauthor=N.+Kawamuraauthor=T.+Arigaauthor=H.+Kanekoauthor=N.+Kondaauthor=I.+Tsugeauthor=A.+Yachieauthor=Y.+Sakiyamaauthor=T.+Iwataauthor=F.+Besshoauthor=T.+Ohishiauthor=K.+Johauthor=K.+Imaiauthor=K.+Kogawaauthor=M.+Shinoharaauthor=M.+Fujiedaauthor=H.+Wakiguchiauthor=S.+Pasicauthor=M.+Abinunauthor=H.+D.+Ochsauthor=E.+D.+Rennerauthor=A.+Janssonauthor=B.+H.+Belohradskyauthor=A.+Metinauthor=N.+Shimizuauthor=S.+Mizutaniauthor=T.+Miyawakiauthor=S.+Nonoyamaauthor=H.+Karasuyama&title=Human+Tyrosine+Kinase+2+Deficiency+Reveals+Its+Requisite+Roles+in+Multiple+Cytokine+Signals+Involved+in+Innate+and+Acquired+Immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity</span></div><div class="casAuthors">Minegishi, Yoshiyuki; Saito, Masako; Morio, Tomohiro; Watanabe, Ken; Agematsu, Kazunaga; Tsuchiya, Shigeru; Takada, Hidetoshi; Hara, Toshiro; Kawamura, Nobuaki; Ariga, Tadashi; Kaneko, Hideo; Kondo, Naomi; Tsuge, Ikuya; Yachie, Akihiro; Sakiyama, Yukio; Iwata, Tsutomu; Bessho, Fumio; Ohishi, Tsutomu; Joh, Kosuke; Imai, Kohsuke; Kogawa, Kazuhiro; Shinohara, Miwa; Fujieda, Mikiya; Wakiguchi, Hiroshi; Pasic, Srdjan; Abinun, Mario; Ochs, Hans D.; Renner, Eleonore D.; Jansson, Annette; Belohradsky, Bernd H.; Metin, Ayse; Shimizu, Norio; Mizutani, Shuki; Miyawaki, Toshio; Nonoyama, Shigeaki; Karasuyama, Hajime</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">745-755</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tyrosine kinase 2 (Tyk2) is a nonreceptor tyrosine kinase that belongs to the Janus kinase (Jak) family.  Here we identified a homozygous Tyk2 mutation in a patient who had been clin. diagnosed with hyper-IgE syndrome.  This patient showed unusual susceptibility to various microorganisms including virus, fungi, and mycobacteria and suffered from atopic dermatitis with elevated serum IgE.  The patient's cells displayed defects in multiple cytokine signaling pathways including those for type I interferon (IFN), interleukin (IL)-6, IL-10, IL-12, and IL-23.  The cytokine signals were successfully restored by transducing the intact Tyk2 gene.  Thus, the Tyk2 deficiency is likely to account for the patient's complex clin. manifestations, including the phenotype of impaired T helper 1 (Th1) differentiation and accelerated Th2 differentiation.  This study identifies human Tyk2 deficiency and demonstrates that Tyk2 plays obligatory roles in multiple cytokine signals involved in innate and acquired immunity of humans, which differs substantially from Tyk2 function in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9TTbAIzXM-bVg90H21EOLACvtfcHk0lh5htAyCn-JQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Gnt7zI&md5=debec30b44a7e1dc111d7cfb1c92f7dd</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2006.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2006.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DMinegishi%26aufirst%3DY.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DMorio%26aufirst%3DT%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DAgematsu%26aufirst%3DK.%26aulast%3DTsuchiya%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DKawamura%26aufirst%3DN.%26aulast%3DAriga%26aufirst%3DT.%26aulast%3DKaneko%26aufirst%3DH.%26aulast%3DKonda%26aufirst%3DN.%26aulast%3DTsuge%26aufirst%3DI.%26aulast%3DYachie%26aufirst%3DA.%26aulast%3DSakiyama%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DT.%26aulast%3DBessho%26aufirst%3DF.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DJoh%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DK.%26aulast%3DKogawa%26aufirst%3DK.%26aulast%3DShinohara%26aufirst%3DM.%26aulast%3DFujieda%26aufirst%3DM.%26aulast%3DWakiguchi%26aufirst%3DH.%26aulast%3DPasic%26aufirst%3DS.%26aulast%3DAbinun%26aufirst%3DM.%26aulast%3DOchs%26aufirst%3DH.%2BD.%26aulast%3DRenner%26aufirst%3DE.%2BD.%26aulast%3DJansson%26aufirst%3DA.%26aulast%3DBelohradsky%26aufirst%3DB.%2BH.%26aulast%3DMetin%26aufirst%3DA.%26aulast%3DShimizu%26aufirst%3DN.%26aulast%3DMizutani%26aufirst%3DS.%26aulast%3DMiyawaki%26aufirst%3DT.%26aulast%3DNonoyama%26aufirst%3DS.%26aulast%3DKarasuyama%26aufirst%3DH.%26atitle%3DHuman%2520Tyrosine%2520Kinase%25202%2520Deficiency%2520Reveals%2520Its%2520Requisite%2520Roles%2520in%2520Multiple%2520Cytokine%2520Signals%2520Involved%2520in%2520Innate%2520and%2520Acquired%2520Immunity%26jtitle%3DImmunity%26date%3D2006%26volume%3D25%26spage%3D745%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bumm, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichberger, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M. W.</span><span> </span><span class="NLM_article-title">CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">5232</span><span class="NLM_x">–</span> <span class="NLM_lpage">5240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=5232-5240&author=J.+W.+Tynerauthor=T.+G.+Bummauthor=J.+Deiningerauthor=L.+Woodauthor=K.+J.+Aichbergerauthor=M.+M.+Loriauxauthor=B.+J.+Drukerauthor=C.+J.+Burnsauthor=E.+Fantinoauthor=M.+W.+Deininger&title=CYT387%2C+a+novel+JAK2+inhibitor%2C+induces+hematologic+responses+and+normalizes+inflammatory+cytokines+in+murine+myeloproliferative+neoplasms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DBumm%26aufirst%3DT.%2BG.%26aulast%3DDeininger%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DL.%26aulast%3DAichberger%26aufirst%3DK.%2BJ.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%26atitle%3DCYT387%252C%2520a%2520novel%2520JAK2%2520inhibitor%252C%2520induces%2520hematologic%2520responses%2520and%2520normalizes%2520inflammatory%2520cytokines%2520in%2520murine%2520myeloproliferative%2520neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D5232%26epage%3D5240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Pardanani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotlib, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talpaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schorr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1200%2FJCO.2010.32.8021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=21220608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktlelsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=789-796&author=A.+Pardananiauthor=J.+R.+Gotlibauthor=C.+Jamiesonauthor=J.+E.+Cortesauthor=M.+Talpazauthor=R.+M.+Stoneauthor=M.+H.+Silvermanauthor=D.+G.+Gillilandauthor=J.+Schorrauthor=A.+Tefferi&title=Safety+and+Efficacy+of+TG101348%2C+a+Selective+JAK2+Inhibitor%2C+in+Myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis</span></div><div class="casAuthors">Pardanani, Animesh; Gotlib, Jason R.; Jamieson, Catriona; Cortes, Jorge E.; Talpaz, Moshe; Stone, Richard M.; Silverman, Michael H.; Gilliland, D. Gary; Shorr, Jolene; Tefferi, Ayalew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">789-796</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose Myelofibrosis is a myeloid malignancy assocd. with anemia, splenomegaly, and constitutional symptoms.  Patients frequently harbor JAK-STAT activating mutations that are sensitive to TG101348, a selective small-mol. Janus kinase 2 (JAK2) inhibitor.  Patients and Methods In a multicenter phase I trial, oral TG101348 was administered once a day to patients with high- or intermediate-risk primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.  Results Fifty-nine patients were treated, including 28 in the dose-escalation phase.  The max.-tolerated dose was 680 mg/d, and dose-limiting toxicity was a reversible and asymptomatic increase in the serum amylase level.  Forty-three patients (73%) continued treatment beyond six cycles; the median cumulative exposure to TG101348 was 380 days.  Adverse events included nausea, vomiting, diarrhea, anemia, and thrombocytopenia; corresponding grades 3 to 4 incidence rates were 3%, 3%, 10%, 35%, and 24%.  TG101348 treatment had modest effect on serum cytokine levels, but greater than half of the patients with early satiety, night sweats, fatigue, pruritus, and cough achieved rapid and durable improvement in these symptoms.  By six and 12 cycles of treatment, 39% and 47% of patients, resp., had achieved a spleen response per International Working Group criteria.  The majority of patients with leukocytosis or thrombocytosis at baseline (n = 28 and n = 10, resp.) achieved normalization of blood counts after six (57% and 90%, resp.) and 12 (56% and 88%, resp.) cycles.  A significant decrease in JAK2 V617F allele burden was obsd. at 6 mo in mutation-pos. patients (n = 51; P = .04), particularly in the subgroup with allele burden greater than 20% (n = 23; P < .01); the decrease was durable at 12 mo.  Conclusion TG101348 is well tolerated and produces significant redn. in disease burden and durable clin. benefit in patients with myelofibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH4BD7RVGmfLVg90H21EOLACvtfcHk0lh5htAyCn-JQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktlelsL0%253D&md5=8b69a31d9dcf09b3b121e477f98d103b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.32.8021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.32.8021%26sid%3Dliteratum%253Aachs%26aulast%3DPardanani%26aufirst%3DA.%26aulast%3DGotlib%26aufirst%3DJ.%2BR.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DCortes%26aufirst%3DJ.%2BE.%26aulast%3DTalpaz%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DSilverman%26aufirst%3DM.%2BH.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DSchorr%26aufirst%3DJ.%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DSafety%2520and%2520Efficacy%2520of%2520TG101348%252C%2520a%2520Selective%2520JAK2%2520Inhibitor%252C%2520in%2520Myelofibrosis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3D789%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shilling, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedza, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emm, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Punwani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvanitis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galya, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeleswaram, S.</span><span> </span><span class="NLM_article-title">Metabolism, Excretion, and Pharmacokinetics of [<sup>14</sup>C]INCB018424, a Selective Janus Tyrosine Kinase 1/2 Inhibitor, in Humans</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">2023</span><span class="NLM_x">–</span> <span class="NLM_lpage">2031</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=2023-2031&author=A.+D.+Shillingauthor=F.+M.+Nedzaauthor=T.+Emmauthor=S.+Diamondauthor=E.+McKeeverauthor=N.+Punwaniauthor=W.+Williamsauthor=A.+Arvanitisauthor=L.+G.+Galyaauthor=M.+Liauthor=S.+Shepardauthor=J.+Rodgersauthor=T.-Y.+Yueauthor=S.+Yeleswaram&title=Metabolism%2C+Excretion%2C+and+Pharmacokinetics+of+%5B14C%5DINCB018424%2C+a+Selective+Janus+Tyrosine+Kinase+1%2F2+Inhibitor%2C+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShilling%26aufirst%3DA.%2BD.%26aulast%3DNedza%26aufirst%3DF.%2BM.%26aulast%3DEmm%26aufirst%3DT.%26aulast%3DDiamond%26aufirst%3DS.%26aulast%3DMcKeever%26aufirst%3DE.%26aulast%3DPunwani%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DW.%26aulast%3DArvanitis%26aufirst%3DA.%26aulast%3DGalya%26aufirst%3DL.%2BG.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DJ.%26aulast%3DYue%26aufirst%3DT.-Y.%26aulast%3DYeleswaram%26aufirst%3DS.%26atitle%3DMetabolism%252C%2520Excretion%252C%2520and%2520Pharmacokinetics%2520of%2520%255B14C%255DINCB018424%252C%2520a%2520Selective%2520Janus%2520Tyrosine%2520Kinase%25201%252F2%2520Inhibitor%252C%2520in%2520Humans%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D2023%26epage%3D2031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> Ruxolitinib was granted approval by the United States Food and Drug administration on November 16,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">, </span>: <a href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm280102.htm" class="extLink">http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm280102.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Ruxolitinib+was+granted+approval+by+the+United+States+Food+and+Drug+administration+on+November+16%2C+2011%2C+%3A+http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm280102.htm."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Hevdat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozgit, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowolik, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morosini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">487</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=487-497&author=M.+Hevdatauthor=D.+Huszarauthor=A.+Herrmannauthor=J.+M.+Gozgitauthor=A.+Schroederauthor=A.+Sheehyauthor=R.+Buettnerauthor=D.+Proiaauthor=C.+M.+Kowolikauthor=H.+Xinauthor=B.+Armstrongauthor=G.+Bebernitzauthor=S.+Wengauthor=L.+Wangauthor=M.+Yeauthor=K.+McEachernauthor=H.+Chenauthor=D.+Morosiniauthor=K.+Bellauthor=M.+Alimzhanovauthor=S.+Ioannidisauthor=P.+McCoonauthor=Z.+A.+Caoauthor=H.+Yuauthor=R.+Joveauthor=M.+Zinda&title=The+JAK2+Inhibitor+AZD1480+Potently+Blocks+Stat3+Signaling+and+Oncogenesis+in+Solid+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHevdat%26aufirst%3DM.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DHerrmann%26aufirst%3DA.%26aulast%3DGozgit%26aufirst%3DJ.%2BM.%26aulast%3DSchroeder%26aufirst%3DA.%26aulast%3DSheehy%26aufirst%3DA.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DProia%26aufirst%3DD.%26aulast%3DKowolik%26aufirst%3DC.%2BM.%26aulast%3DXin%26aufirst%3DH.%26aulast%3DArmstrong%26aufirst%3DB.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DWeng%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DMcEachern%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DMorosini%26aufirst%3DD.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DMcCoon%26aufirst%3DP.%26aulast%3DCao%26aufirst%3DZ.%2BA.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DThe%2520JAK2%2520Inhibitor%2520AZD1480%2520Potently%2520Blocks%2520Stat3%2520Signaling%2520and%2520Oncogenesis%2520in%2520Solid%2520Tumors%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D16%26spage%3D487%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hexner, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serdikoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swider, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrzanski, P.</span><span> </span><span class="NLM_article-title">Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">5663</span><span class="NLM_x">–</span> <span class="NLM_lpage">5671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=5663-5671&author=E.+O.+Hexnerauthor=C.+Serdikoffauthor=M.+Janauthor=C.+R.+Swiderauthor=C.+Robinsonauthor=S.+Yangauthor=T.+Angelesauthor=S.+G.+Emersonauthor=M.+Carrollauthor=B.+Ruggeriauthor=P.+Dobrzanski&title=Lestaurtinib+%28CEP701%29+is+a+JAK2+inhibitor+that+suppresses+JAK2%2FSTAT5+signaling+and+the+proliferation+of+primary+erythroid+cells+from+patients+with+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHexner%26aufirst%3DE.%2BO.%26aulast%3DSerdikoff%26aufirst%3DC.%26aulast%3DJan%26aufirst%3DM.%26aulast%3DSwider%26aufirst%3DC.%2BR.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DAngeles%26aufirst%3DT.%26aulast%3DEmerson%26aufirst%3DS.%2BG.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DDobrzanski%26aufirst%3DP.%26atitle%3DLestaurtinib%2520%2528CEP701%2529%2520is%2520a%2520JAK2%2520inhibitor%2520that%2520suppresses%2520JAK2%252FSTAT5%2520signaling%2520and%2520the%2520proliferation%2520of%2520primary%2520erythroid%2520cells%2520from%2520patients%2520with%2520myeloproliferative%2520disorders%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D5663%26epage%3D5671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">William, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaraj, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan E. Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaraman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasha, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethirajulu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span> </span><span class="NLM_article-title">Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus 2/Fms-like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and Lymphoma</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4638</span><span class="NLM_x">–</span> <span class="NLM_lpage">4658</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200326p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4638-4658&author=A.+D.+Williamauthor=A.+C.-H.+Leeauthor=S.+Blanchardauthor=A.+Poulsenauthor=E.+L.+Teoauthor=H.+Nagarajauthor=D.+Tan+E.+Chenauthor=M.+Williamsauthor=E.+T.+Sunauthor=K.+C.+Gohauthor=W.+C.+Ongauthor=S.+K.+Gohauthor=S.+Hartauthor=R.+Jayaramanauthor=M.+K.+Pashaauthor=K.+Ethirajuluauthor=J.+M.+Woodauthor=B.+W.+Dymock&title=Discovery+of+the+Macrocycle+11-%282-Pyrrolidin-1-yl-ethoxy%29-14%2C19-dioxa-5%2C7%2C26-triaza-tetracyclo%5B19.3.1.1%282%2C6%29.1%288%2C12%29%5Dheptacosa-1%2825%29%2C2%2826%29%2C3%2C5%2C8%2C10%2C12%2827%29%2C16%2C21%2C23-decaene+%28SB1518%29%2C+a+Potent+Janus+2%2FFms-like+Tyrosine+Kinase-3+%28JAK2%2FFLT3%29+Inhibitor+for+the+Treatment+of+Myelofibrosis+and+Lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm200326p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200326p%26sid%3Dliteratum%253Aachs%26aulast%3DWilliam%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DA.%2BC.-H.%26aulast%3DBlanchard%26aufirst%3DS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DTeo%26aufirst%3DE.%2BL.%26aulast%3DNagaraj%26aufirst%3DH.%26aulast%3DTan%2BE.%2BChen%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DE.%2BT.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DOng%26aufirst%3DW.%2BC.%26aulast%3DGoh%26aufirst%3DS.%2BK.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DPasha%26aufirst%3DM.%2BK.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DDiscovery%2520of%2520the%2520Macrocycle%252011-%25282-Pyrrolidin-1-yl-ethoxy%2529-14%252C19-dioxa-5%252C7%252C26-triaza-tetracyclo%255B19.3.1.1%25282%252C6%2529.1%25288%252C12%2529%255Dheptacosa-1%252825%2529%252C2%252826%2529%252C3%252C5%252C8%252C10%252C12%252827%2529%252C16%252C21%252C23-decaene%2520%2528SB1518%2529%252C%2520a%2520Potent%2520Janus%25202%252FFms-like%2520Tyrosine%2520Kinase-3%2520%2528JAK2%252FFLT3%2529%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Myelofibrosis%2520and%2520Lymphoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4638%26epage%3D4658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Püllmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, S.</span><span> </span><span class="NLM_article-title">Synthetic Access to 2-Amido-5-aryl-8-methoxy-triazolopyridine and 2-Amido-5-morpholino-8-methoxy-triazolopyridine Derivatives as Potential Inhibitors of the Adenosine Receptor Subtypes</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">1649</span><span class="NLM_x">–</span> <span class="NLM_lpage">1652</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1055%2Fs-2003-40874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFWqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=1649-1652&author=M.+Nettekovenauthor=B.+P%C3%BCllmannauthor=S.+Schmitt&title=Synthetic+Access+to+2-Amido-5-aryl-8-methoxy-triazolopyridine+and+2-Amido-5-morpholino-8-methoxy-triazolopyridine+Derivatives+as+Potential+Inhibitors+of+the+Adenosine+Receptor+Subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic access to 2-amido-5-aryl-8-methoxy-triazolopyridine and 2-amido-5-morpholino-8-methoxy-triazolopyridine derivatives as potential inhibitors of the adenosine receptor subtypes</span></div><div class="casAuthors">Nettekoven, Matthias; Puellmann, Bernd; Schmitt, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1649-1652</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Two versatile and complementary synthetic strategies towards 2-amido-5-aryl-8-methoxy-triazolopyridine derivs. and 2-amido-5-morpholino-8-methoxy-triazolopyridine derivs. in five steps are presented.  The key step in each synthetic route can be constituted as the formation of the resp. triazolopyridine deriv. precursors in 78% and 57% yield, resp., through an intermediately formed 4H-[1,2,4]oxadiazol-5-one.  The final Suzuki coupling/amidation allowed the straightforward access to the desired triazolopyridine derivs. which have not been described previously.  Notably, these triazolopyridine-scaffold bears three vectors of diversity which offer max. flexibility in design and combinatorial synthesis of mols. with a potentially useful inhibitory activity towards adenosine receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8zGEeUmY80bVg90H21EOLACvtfcHk0ljjlGjeAxfw7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFWqsrw%253D&md5=4114db7a6d5bfbceebbff9f0e3c79434</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1055%2Fs-2003-40874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2003-40874%26sid%3Dliteratum%253Aachs%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DP%25C3%25BCllmann%26aufirst%3DB.%26aulast%3DSchmitt%26aufirst%3DS.%26atitle%3DSynthetic%2520Access%2520to%25202-Amido-5-aryl-8-methoxy-triazolopyridine%2520and%25202-Amido-5-morpholino-8-methoxy-triazolopyridine%2520Derivatives%2520as%2520Potential%2520Inhibitors%2520of%2520the%2520Adenosine%2520Receptor%2520Subtypes%26jtitle%3DSynthesis%26date%3D2003%26spage%3D1649%26epage%3D1652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zificsak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, D. D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theroff, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieu, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underiner, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saville, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husten, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Kane, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrzanski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span> </span><span class="NLM_article-title">Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=133-137&author=C.+A.+Zificsakauthor=D.+E.+Gingrichauthor=H.+J.+Breslinauthor=D.+D+Dunnauthor=K.+L.+Milkiewiczauthor=J.+P.+Theroffauthor=T.+V.+Thieuauthor=T.+L.+Underinerauthor=L.+R.+Weinbergauthor=L.+D.+Aimoneauthor=M.+S.+Albomauthor=J.+L.+Masonauthor=L.+Savilleauthor=J.+Hustenauthor=T.+S.+Angelesauthor=J.+P.+Finnauthor=M.+Janauthor=T.+M.+O%E2%80%99Kaneauthor=P.+Dobrzanskiauthor=B.+D.+Dorsey&title=Optimization+of+a+novel+kinase+inhibitor+scaffold+for+the+dual+inhibition+of+JAK2+and+FAK+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZificsak%26aufirst%3DC.%2BA.%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DBreslin%26aufirst%3DH.%2BJ.%26aulast%3DDunn%26aufirst%3DD.%2BD%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DTheroff%26aufirst%3DJ.%2BP.%26aulast%3DThieu%26aufirst%3DT.%2BV.%26aulast%3DUnderiner%26aufirst%3DT.%2BL.%26aulast%3DWeinberg%26aufirst%3DL.%2BR.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DMason%26aufirst%3DJ.%2BL.%26aulast%3DSaville%26aufirst%3DL.%26aulast%3DHusten%26aufirst%3DJ.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DFinn%26aufirst%3DJ.%2BP.%26aulast%3DJan%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Kane%26aufirst%3DT.%2BM.%26aulast%3DDobrzanski%26aufirst%3DP.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DOptimization%2520of%2520a%2520novel%2520kinase%2520inhibitor%2520scaffold%2520for%2520the%2520dual%2520inhibition%2520of%2520JAK2%2520and%2520FAK%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D133%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Weinberg, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisko, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieu, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underiner, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells-Knect, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span> </span><span class="NLM_article-title">2,7-Pyrrolo[2,1-<i>f</i>][1,2,4]triazines as JAK2 inhibitors: modification of target structure to minimize reactive metabolite formation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7325</span><span class="NLM_x">–</span> <span class="NLM_lpage">7330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7325-7330&author=L.+R.+Weinbergauthor=M.+S.+Albomauthor=T.+S.+Angelesauthor=H.+J.+Breslinauthor=D.+E.+Gingrichauthor=Z.+Huangauthor=J.+G.+Liskoauthor=J.+L.+Masonauthor=K.+L.+Milkiewiczauthor=T.+T.+Thieuauthor=T.+L.+Underinerauthor=G.+J.+Wellsauthor=K.+J.+Wells-Knectauthor=B.+D.+Dorsey&title=2%2C7-Pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazines+as+JAK2+inhibitors%3A+modification+of+target+structure+to+minimize+reactive+metabolite+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberg%26aufirst%3DL.%2BR.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DBreslin%26aufirst%3DH.%2BJ.%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLisko%26aufirst%3DJ.%2BG.%26aulast%3DMason%26aufirst%3DJ.%2BL.%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DThieu%26aufirst%3DT.%2BT.%26aulast%3DUnderiner%26aufirst%3DT.%2BL.%26aulast%3DWells%26aufirst%3DG.%2BJ.%26aulast%3DWells-Knect%26aufirst%3DK.%2BJ.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3D2%252C7-Pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazines%2520as%2520JAK2%2520inhibitors%253A%2520modification%2520of%2520target%2520structure%2520to%2520minimize%2520reactive%2520metabolite%2520formation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D7325%26epage%3D7330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Potts, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, J.</span><span> </span><span class="NLM_article-title">Derivatives of <i>s</i>-Triazolo[1,5-<i>a</i>]pyridine Ring System</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01339a058" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1966&pages=260-265&author=K.+T.+Pottsauthor=H.+R.+Burtonauthor=J.+Bhattacharyya&title=Derivatives+of+s-Triazolo%5B1%2C5-a%5Dpyridine+Ring+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjo01339a058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01339a058%26sid%3Dliteratum%253Aachs%26aulast%3DPotts%26aufirst%3DK.%2BT.%26aulast%3DBurton%26aufirst%3DH.%2BR.%26aulast%3DBhattacharyya%26aufirst%3DJ.%26atitle%3DDerivatives%2520of%2520s-Triazolo%255B1%252C5-a%255Dpyridine%2520Ring%2520System%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1966%26volume%3D31%26spage%3D260%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Potts, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, S. K.</span><span> </span><span class="NLM_article-title">Reactions of the <i>s</i>-Triazolo[4,3-<i>a</i>]pyridine Ring System</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01339a059" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1966&pages=265-273&author=K.+T.+Pottsauthor=H.+R.+Burtonauthor=S.+K.+Roy&title=Reactions+of+the+s-Triazolo%5B4%2C3-a%5Dpyridine+Ring+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjo01339a059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01339a059%26sid%3Dliteratum%253Aachs%26aulast%3DPotts%26aufirst%3DK.%2BT.%26aulast%3DBurton%26aufirst%3DH.%2BR.%26aulast%3DRoy%26aufirst%3DS.%2BK.%26atitle%3DReactions%2520of%2520the%2520s-Triazolo%255B4%252C3-a%255Dpyridine%2520Ring%2520System%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1966%26volume%3D31%26spage%3D265%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Potts, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surapaneni, C. R.</span><span> </span><span class="NLM_article-title">1,2,4-Triazoles. XXV. The Effect of Pyridine Substitution on the Isomerization of <i>s</i>-Triazolo[4,3-<i>a</i>]pyridines into <i>s</i>-Triazolo[1,5-<i>a</i>]pyridines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1970&pages=1019-1027&author=K.+T.+Pottsauthor=C.+R.+Surapaneni&title=1%2C2%2C4-Triazoles.+XXV.+The+Effect+of+Pyridine+Substitution+on+the+Isomerization+of+s-Triazolo%5B4%2C3-a%5Dpyridines+into+s-Triazolo%5B1%2C5-a%5Dpyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPotts%26aufirst%3DK.%2BT.%26aulast%3DSurapaneni%26aufirst%3DC.%2BR.%26atitle%3D1%252C2%252C4-Triazoles.%2520XXV.%2520The%2520Effect%2520of%2520Pyridine%2520Substitution%2520on%2520the%2520Isomerization%2520of%2520s-Triazolo%255B4%252C3-a%255Dpyridines%2520into%2520s-Triazolo%255B1%252C5-a%255Dpyridines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1970%26volume%3D7%26spage%3D1019%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Verček, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogorevc, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanovnik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tišler, M.</span><span> </span><span class="NLM_article-title">Cyanoamino Compounds in Synthesis: Syntheses of Some Heterocycles</span> <span class="citation_source-journal">Monatsch. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">798</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1007%2FBF01134190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADyaL2cXltFGitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1983&pages=789-798&author=B.+Ver%C4%8Dekauthor=B.+Ogorevcauthor=B.+Stanovnikauthor=M.+Ti%C5%A1ler&title=Cyanoamino+Compounds+in+Synthesis%3A+Syntheses+of+Some+Heterocycles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Cyanoamino compounds in synthesis.  Syntheses of some heterocycles</span></div><div class="casAuthors">Vercek, Bojan; Ogorevc, Bozidar; Stanovnik, Branko; Tisler, Miha</div><div class="citationInfo"><span class="NLM_cas:title">Monatshefte fuer Chemie</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">789-98</span>CODEN:
                <span class="NLM_cas:coden">MOCMB7</span>;
        ISSN:<span class="NLM_cas:issn">0026-9247</span>.
    </div><div class="casAbstract">Transformations of some heterocyclic cyanoamino compds. leading to various heterocyclic systems are described.  s-Triazolo[1,5-a]azines, e.g. I, II, and III, are obtained either in a direct synthetic approach or via the substituted aminotetrazoles, substituted 3-amino-5-oxo-1,2,4-oxadiazolines, and from N-ethoxycarbonyl N'-heteroaryl thioureas or N-heteroaryl N'-hydroxyguanidine.  Thus, 2-(cyanoamino)pyridine cyclized with Me3SiN3 to give the tetrazole IV, which was cyclized with polyphosphoric acid to give I.  The cyanoamino group reacts also with o-difunctional benzenes to give the corresponding substituted derivs. of benzimidazole, benzoxazole or benzothiazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovqVshQOSm87Vg90H21EOLACvtfcHk0lhDKfnD1Ztd1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXltFGitQ%253D%253D&md5=32d36961bd0e42a34b73bbed4268a553</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1007%2FBF01134190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01134190%26sid%3Dliteratum%253Aachs%26aulast%3DVer%25C4%258Dek%26aufirst%3DB.%26aulast%3DOgorevc%26aufirst%3DB.%26aulast%3DStanovnik%26aufirst%3DB.%26aulast%3DTi%25C5%25A1ler%26aufirst%3DM.%26atitle%3DCyanoamino%2520Compounds%2520in%2520Synthesis%253A%2520Syntheses%2520of%2520Some%2520Heterocycles%26jtitle%3DMonatsch.%2520Chem.%26date%3D1983%26volume%3D114%26spage%3D789%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Bell, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanwick, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graupner, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G. A.</span><span> </span><span class="NLM_article-title">Application of the Tisler Triazolopyrimidine Cyclization to the Synthesis of a Crop Protection Agent and an Intermediate</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1167</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span></span><div class="citationLinks">[<a href="/doi/10.1021/op0601518" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=1167-1171&author=B.+M.+Bellauthor=P.+E.+Fanwickauthor=P.+R.+Graupnerauthor=G.+A.+Roth&title=Application+of+the+Tisler+Triazolopyrimidine+Cyclization+to+the+Synthesis+of+a+Crop+Protection+Agent+and+an+Intermediate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fop0601518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop0601518%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DB.%2BM.%26aulast%3DFanwick%26aufirst%3DP.%2BE.%26aulast%3DGraupner%26aufirst%3DP.%2BR.%26aulast%3DRoth%26aufirst%3DG.%2BA.%26atitle%3DApplication%2520of%2520the%2520Tisler%2520Triazolopyrimidine%2520Cyclization%2520to%2520the%2520Synthesis%2520of%2520a%2520Crop%2520Protection%2520Agent%2520and%2520an%2520Intermediate%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2006%26volume%3D10%26spage%3D1167%26epage%3D1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Swinnen, D.; Jorand-Lebrun, C.; Grippi-Vallotton, T.; Muzerelle, M.; Royle, A.; Macritchie, J; Hill, R.; Shaw, J. P.</span><span> </span><span class="NLM_article-title">Preparation of triazolopyridines as apoptosis signal-regulating kinase (ASK) inhibitors for treatment of autoimmune, inflammatory, cardiovascular, and/or neurodegenerative diseases</span>. Patent WO2009/027283A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+Swinnen&author=C.+Jorand-Lebrun&author=T.+Grippi-Vallotton&author=M.+Muzerelle&author=A.+Royle&author=J+Macritchie&author=R.+Hill&author=J.+P.+Shaw&title=Preparation+of+triazolopyridines+as+apoptosis+signal-regulating+kinase+%28ASK%29+inhibitors+for+treatment+of+autoimmune%2C+inflammatory%2C+cardiovascular%2C+and%2For+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSwinnen%26aufirst%3DD.%26atitle%3DPreparation%2520of%2520triazolopyridines%2520as%2520apoptosis%2520signal-regulating%2520kinase%2520%2528ASK%2529%2520inhibitors%2520for%2520treatment%2520of%2520autoimmune%252C%2520inflammatory%252C%2520cardiovascular%252C%2520and%252For%2520neurodegenerative%2520diseases%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broudy, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span> </span><span class="NLM_article-title">Novel N<sup>9</sup>-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4907</span><span class="NLM_x">–</span> <span class="NLM_lpage">4912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4907-4912&author=Y.+Wangauthor=W.+C.+Shakespeareauthor=W.-S.+Huangauthor=R.+Sundaramoorthiauthor=S.+Lentiniauthor=S.+Dasauthor=S.+Liuauthor=G.+Bandaauthor=D.+Wenauthor=X.+Zhuauthor=Q.+Xuauthor=J.+Keatsauthor=F.+Wangauthor=S.+Wardwellauthor=Y.+Ningauthor=J.+T.+Snodgrassauthor=M.+I.+Broudyauthor=K.+Russianauthor=D.+Dalgarnoauthor=T.+Clacksonauthor=T.+K.+Sawyer&title=Novel+N9-arenethenyl+purines+as+potent+dual+Src%2FAbl+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DHuang%26aufirst%3DW.-S.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DLentini%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DBanda%26aufirst%3DG.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWardwell%26aufirst%3DS.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DSnodgrass%26aufirst%3DJ.%2BT.%26aulast%3DBroudy%26aufirst%3DM.%2BI.%26aulast%3DRussian%26aufirst%3DK.%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DClackson%26aufirst%3DT.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26atitle%3DNovel%2520N9-arenethenyl%2520purines%2520as%2520potent%2520dual%2520Src%252FAbl%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4907%26epage%3D4912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shakespeare, W. C.; Metcalf, C. A.; Sawyer, T. K.; Wang, Y.; Sundaramoorthi, R.; Dalgarno, D. C.; Bohacek, R.; Weigele, M.</span><span> </span><span class="NLM_article-title">Substituted Purine Derivatives</span>. Patent WO2005/009348A2,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=W.+C.+Shakespeare&author=C.+A.+Metcalf&author=T.+K.+Sawyer&author=Y.+Wang&author=R.+Sundaramoorthi&author=D.+C.+Dalgarno&author=R.+Bohacek&author=M.+Weigele&title=Substituted+Purine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26atitle%3DSubstituted%2520Purine%2520Derivatives%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">Kinase selectivity was determined using the Ambit Bioscience KINOMEscan technology, and is expressed as S(90), the fraction of kinases inhibited ≥90% when screened at 1 μM across a panel of 402 kinases.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kinase+selectivity+was+determined+using+the+Ambit+Bioscience+KINOMEscan+technology%2C+and+is+expressed+as+S%2890%29%2C+the+fraction+of+kinases+inhibited+%E2%89%A590%25+when+screened+at+1+%CE%BCM+across+a+panel+of+402+kinases."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A Quantitative Analysis of Kinase Inhibitor Selectivity</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+Quantitative+Analysis+of+Kinase+Inhibitor+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0ljCyNhSv3Mb6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520Quantitative%2520Analysis%2520of%2520Kinase%2520Inhibitor%2520Selectivity%26jtitle%3DNature%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Cochet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frelin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyron, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbert, V.</span><span> </span><span class="NLM_article-title">Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1016%2Fj.cellsig.2005.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=15967637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlags73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=449-455&author=O.+Cochetauthor=C.+Frelinauthor=J.-F.+Peyronauthor=V.+Imbert&title=Constitutive+activation+of+STAT+proteins+in+the+HDLM-2+and+L540+Hodgkin+lymphoma-derived+cell+lines+supports+cell+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival</span></div><div class="casAuthors">Cochet, Olivia; Frelin, Catherine; Peyron, Jean-Francois; Imbert, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">449-455</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Survival and proliferation of Hodgkin lymphoma (HL) cells are influenced by many cytokines produced by different cell types in the lymph node microenvironment.  STAT, family of transcription factors, are key mediators of cytokine signaling and their perturbation contributes to various human diseases.  Electrophoretic mobility shift and phosphoprotein immunoblotting analyses were used to study STAT activation in HL cell lines.  We thus obsd. high levels of constitutively activated STAT1, 3, 5 and 6 in HDLM-2 and L540 cells, which could be correlated with JAK kinase activation.  In contrast KM-H2 cells did not display STAT activation.  Preventing constitutive STAT activation by specific JAK kinases inhibitors induced apoptosis of HL cell lines and was assocd. with a strong decrease in the expression of the anti-apoptotic genes IAP-1, IAP-2, Bcl-xL, Bfl1 and Traf1.  Silencing of JAKs by specific siRNAs also induced apoptosis of HL cells.  Altogether, these results suggest that aberrant STAT activation in Hodgkin cells may promote cell survival and as a consequence facilitate oncogenic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX0KpnosM2tLVg90H21EOLACvtfcHk0ljCyNhSv3Mb6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlags73P&md5=5049f7b6501bf012c8247b608eb9468c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2005.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2005.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DCochet%26aufirst%3DO.%26aulast%3DFrelin%26aufirst%3DC.%26aulast%3DPeyron%26aufirst%3DJ.-F.%26aulast%3DImbert%26aufirst%3DV.%26atitle%3DConstitutive%2520activation%2520of%2520STAT%2520proteins%2520in%2520the%2520HDLM-2%2520and%2520L540%2520Hodgkin%2520lymphoma-derived%2520cell%2520lines%2520supports%2520cell%2520survival%26jtitle%3DCell.%2520Signalling%26date%3D2006%26volume%3D18%26spage%3D449%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stump, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrzanski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serdikoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugan, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavey, M. M.</span><span> </span><span class="NLM_article-title">A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Res. Ther..</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">R68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=R68&author=K.+L.+Stumpauthor=L.+D.+Luauthor=P.+Dobrzanskiauthor=C.+Serdikoffauthor=D.+E.+Gingrichauthor=B.+J.+Duganauthor=T.+S.+Angelesauthor=M.+S.+Albomauthor=M.+A.+Atorauthor=B.+D.+Dorseyauthor=B.+A.+Ruggeriauthor=M.+M.+Seavey&title=A+highly+selective%2C+orally+active+inhibitor+of+Janus+kinase+2%2C+CEP-33779%2C+ablates+disease+in+two+mouse+models+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStump%26aufirst%3DK.%2BL.%26aulast%3DLu%26aufirst%3DL.%2BD.%26aulast%3DDobrzanski%26aufirst%3DP.%26aulast%3DSerdikoff%26aufirst%3DC.%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DDugan%26aufirst%3DB.%2BJ.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DSeavey%26aufirst%3DM.%2BM.%26atitle%3DA%2520highly%2520selective%252C%2520orally%2520active%2520inhibitor%2520of%2520Janus%2520kinase%25202%252C%2520CEP-33779%252C%2520ablates%2520disease%2520in%2520two%2520mouse%2520models%2520of%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Res.%2520Ther..%26date%3D2011%26volume%3D13%26spage%3DR68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Seavey, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stump, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, N. H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockeimer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Kane, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrzanski, P.</span><span> </span><span class="NLM_article-title">Therapeutic Efficacy of CEP-33779, a Novel Selective JAK2 Inhibitor, in a Mouse Model of Colitis-induced Colorectal Cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">984</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Fjm300248q&amp;key=10.1158%2F1535-7163.MCT-11-0951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Fjm300248q&amp;key=22334590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Fjm300248q&amp;key=1%3ACAS%3A528%3ADC%252BC38Xltl2nurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=984-993&author=M.+M.+Seaveyauthor=L.+D.+Luauthor=K.+L.+Stumpauthor=N.+H+Wallaceauthor=W.+Hockeimerauthor=T.+M.+O%E2%80%99Kaneauthor=B.+Ruggeriauthor=P.+Dobrzanski&title=Therapeutic+Efficacy+of+CEP-33779%2C+a+Novel+Selective+JAK2+Inhibitor%2C+in+a+Mouse+Model+of+Colitis-induced+Colorectal+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Efficacy of CEP-33779, a Novel Selective JAK2 Inhibitor, in a Mouse Model of Colitis-Induced Colorectal Cancer</span></div><div class="casAuthors">Seavey, Matthew M.; Lu, Lily D.; Stump, Kristine L.; Wallace, Nate H.; Hockeimer, William; O'Kane, Teresa M.; Ruggeri, Bruce A.; Dobrzanski, Pawel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">984-993</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Constitutively activated STAT3 and STAT5 are expressed in a wide variety of human malignancies including solid and hematopoietic cancers and often correlate with a poor prognosis and resistance to multiple therapies.  Given the well established role of STAT3 in tumorigenesis, inhibition of Janus-activated kinase 2 (JAK2) activity might represent an attractive therapeutic approach.  Using a mouse model of colitis-induced colorectal cancer, we show that a novel, orally active, selective JAK2 inhibitor, CEP-33779, induced regression of established colorectal tumors, reduced angiogenesis, and reduced proliferation of tumor cells.  Histopathol. anal. confirmed reduced incidence of histol.-grade neoplasia by CEP-33779.  Tumor regression correlated with inhibition of STAT3 and NF-κB (RelA/p65) activation in a CEP-33779 dose-dependent manner.  In addn., the expression of proinflammatory, tumor-promoting cytokines interleukin (IL)-6 and IL-1β was strongly reduced upon JAK2 inhibition.  The ability of CEP-33779 to suppress growth of colorectal tumors by inhibiting the IL-6/JAK2/STAT3 signaling suggests a potential therapeutic utility of JAK2 inhibitors in multiple tumors types, particularly those with a strong inflammatory component.  Mol Cancer Ther; 11(4); 984-93.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeQ4DKhzneDrVg90H21EOLACvtfcHk0ljfwTcCMUmUGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xltl2nurs%253D&md5=90ce0ad4784ca0cf199439224e4c59e3</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0951%26sid%3Dliteratum%253Aachs%26aulast%3DSeavey%26aufirst%3DM.%2BM.%26aulast%3DLu%26aufirst%3DL.%2BD.%26aulast%3DStump%26aufirst%3DK.%2BL.%26aulast%3DWallace%26aufirst%3DN.%2BH%26aulast%3DHockeimer%26aufirst%3DW.%26aulast%3DO%25E2%2580%2599Kane%26aufirst%3DT.%2BM.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DDobrzanski%26aufirst%3DP.%26atitle%3DTherapeutic%2520Efficacy%2520of%2520CEP-33779%252C%2520a%2520Novel%2520Selective%2520JAK2%2520Inhibitor%252C%2520in%2520a%2520Mouse%2520Model%2520of%2520Colitis-induced%2520Colorectal%2520Cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D984%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mason, J., L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holskin, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span> </span><span class="NLM_article-title">Modification of CellSensor Irf1-bla TF-1 and Irf1-bla HEL Assays for Direct Comparison of Wild-type JAK2 and JAK2 V617F Inhibition</span> <span class="citation_source-journal">Assay Drug Dev. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=311-318&author=J.%2C+L.+Masonauthor=B.+P.+Holskinauthor=K.+A.+Murrayauthor=S.+L.+Meyerauthor=M.+A.+Atorauthor=T.+S.+Angeles&title=Modification+of+CellSensor+Irf1-bla+TF-1+and+Irf1-bla+HEL+Assays+for+Direct+Comparison+of+Wild-type+JAK2+and+JAK2+V617F+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DJ.%252C%2BL.%26aulast%3DHolskin%26aufirst%3DB.%2BP.%26aulast%3DMurray%26aufirst%3DK.%2BA.%26aulast%3DMeyer%26aufirst%3DS.%2BL.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26atitle%3DModification%2520of%2520CellSensor%2520Irf1-bla%2520TF-1%2520and%2520Irf1-bla%2520HEL%2520Assays%2520for%2520Direct%2520Comparison%2520of%2520Wild-type%2520JAK2%2520and%2520JAK2%2520V617F%2520Inhibition%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2011%26volume%3D9%26spage%3D311%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AQC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4AQC','PDB','4AQC'); return false;">PDB: 4AQC</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300248q&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm300248q%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-11%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300248q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0b964a86f3285","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
